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Abstract 
The total synthesis of the polyene tetramic acid 
antibiotic a-lipoxnycin has been attempted using a highly 
stereocontrolled, flexible and convergent approach. 
Three target fragments, the tetramic acid fragment, the 
pentanal fragment and the polyene fragment were 
identified, and studies in the synthesis and coupling of 
these fragments were carried out. 
The tetramic acid fragment was prepared by reaction 
of an oxazolidine-2,5-dione with the enolate of an acetic 
ester bearing an isoxazoyl substituent at the a-position. 
-methoxycarbony1 derivatives of glutamic acid were found 
to be convenient precursors of the required oxazolidine-
2,5- dione. 
The pentanal fragment corresponds to the chiral 
sub-unit of the side chain containing the C-12' and C-13' 
asymmetric centres whose absolute and relative 
configuration are unknown. 	The pentanal fragment was 
prepared via 	regioselective reaction of an 
organocuprate with an epoxide which was prepared by the 
catalytic asymmetric epoxidation of an isomerically pure 
allylic alcohol. 
The construction of the polyene fragment and its 
coupling to the pentanal fragment was achieved by 
coupling sub-units of the polyene fragment to the 
pentanal fragment in a highly stereocontrolled stepwise 
procedure. The high regio-, stereo- and enantio-
selectivity of these reactions were determined by n.m.r. 
methods. 
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1. INTRODUCTION 
1.1 The Structure of Tetramic Acids 
The total synthesis of the complex naturally 
occurring polyene tetramic antibiotics is no longer 
beyond our synthetic horizon. In view of this it is 
imperative to consider the properties of the parent 
tetrainic acid nucleus and the structural and stereo-
chemical features of its naturally occurring derivatives. 
Tetramic acids have been represented as derivatives 
of the enolic 4-hydroxy-3-pyrroline-2-one tautomer (.1) of 
the corresponding pyrrolidine-2,4-dione form (2). This 
was based on analogy with tetronic acid (j, on the 
assumption that these compounds with the vinylogous 
carboxylic acid structural feature in common would 
exhibit similar physical and chemical properties. 
Tetronic acid was first synthesised in 18961 and is 
strongly acidic with pKa 3.76 in aqueous solution. The 
solid state infra-red (i.r.) spectrum is consistent with 
the enolic structure (2)2 showing absorption at 1690 cm -1 
(C=O) 1636 cm-1 (C=C) and between 2600-2500 cm -1 due to 
the hydrogen bonded hydroxyl group. The ultraviolet 
(u.v.) spectrum of tetronic acid in aqueous ethanol 
showed absorptions at Xmax. 223 nm and Xmax. 248 nm due 
to the enol (2) and the enolate (4) respectively with the 
proportion of each being pH dependent 4 . Tetramic acid 
was first synthesised in 1972 3  and is a much weaker acid 
than tetronic acid with pKa 6.4 in aqueous solution, and 
exists predominantly in the diketo form (2). The solid 
HO 
H 	 H 
(1) () 
HO 	 _O 
	
hno 0 	 0 





() 	 () 
3 
state i.r. spectrum of tetramic acid (2.) shows 
absorptions at 3230 cm-1 (N-H stretch), 1696 cm- (lactam 
C=O stretch), 1670 cm-1 (N-H bend), and a band at 
1782 cm-1 which was assigned to the C-4 ketone carbonyl 
group. This band was uniquely observed at the same 
wavelength in the solution i.r. spectrum, and so it was 
concluded that the lactam group participates in hydrogen 
bonding in the solid state. Ultraviolet spectroscopy 
provided a useful insight into the tautomeric form of 
•tetramic acid. The u.v. spectrum of tetramic acid showed 
only one absorption at Xivax. 260 nm due to the enolate 
() with the intensity showing strong pH dependence. It 
was concluded that the ionised form (5) exists 
predominantly in equilibrium with the pyrrolidinedione 
tautomer (2.) in aqueous solution, with the enolic 
tautomer (1) being essentially absent 3 . 
Tetramic acids with an acyl or alkoxycarbonyl 
substituent at the 3 position are found to have 
considerably increased acidity. The 3-acyl acids () 
give rise to pKa values between 3.0_3.5516 and the 
3-ethoxycarbonyl derivatives (2) give rise to pKa values 
between 2.3-2.6 3 . Proton n.m.r. spectroscopy of 3-acyl 
tetramic acids indicates complete enolisation of these 
derivaties in deuteriochioroform solution although the 
presence of more than one tautomer complicates the 
spectra. It was considered to be essential for the 
interpretation of n.m.r. spectra of these derivaties 
related to the naturally occurring tetramic acids that 









































• The tautoiuerism proposed for 3-acyl tetramlc acids 
involves two sets of rapidly interchanging internal 
tautomers (aa— ) and (8c ), where each set 
arises from proton transfer along the intramolecular 
hydrogen bond, together with two pairs of slowly 
interconverting external tautomers (8ab) (8cd), 
arising from rotation of the acyl side chain (scheme l). 
The internal tautomerism of these derivatis involves 
I' 
interconvers ions that are rapid on the n.m.r. timescale, 
and is not routinely detectable by n.m.r. methods. The 
external tautoiuerism, however, is detectable by n.m.r. 
methods and n.m.r. provides a useful and interesting 
insight into this dynamic equilibrium. The external 
tautotmer ratios have been determined by Steyn and 
Wessels 8 ' 9 in a comprehensive analysis of the 'H and 'C 
n.m.r. characteristics of 3-acyl tetramic acids of type 
(8) (scheme 1). The two sets of resonances observed in 
the 'H and 13C n.m.r. spectra are attributed to the two 
external tautomers (Bab) and (Scd) with the observed 
chemical shifts and coupling constants representing the 
weighted averages of the corresponding values of the 
internal tautomers ( ) and ( d). 
Steyn and Wessels 8 ' 9 found that 	'C n.m.r. 
spectroscopy has distinct advantages over 'H n.m.r. 
spectroscopy for the study of tautomerism in tetramic 
acids as the chemical shift of the 13 C nucleus depends 
critically on the hybridisation of the carbon atom and is 
hardly affected by the anisotropy of neighbouring 
functional groups. The resonances from the proton- 
6 
bearing carbon atoms of 3-acyl tetramic acids of type. (a) 
were assigned from chemical shift considerations and from 
the multiplicities observed in the off-resonance protpn 
decoupled and single frequency nuclear Overhauser effect 
(n.O.e.) 13C n.m.r. spectra. The pair of signals due to 
C-6 were assigned from the single frequency nuclear 
Overhauser enhancement 13C n • rn. r. spectrum, and 
assignment of the three remaining sets of carbon 
resonances was on the basis of known chemical shifts of 
amide, carbonyl and olefinic carbon atoms. The 
predominant tautomeric forms can therefore be deduced 
from the observed 13C n.m.r. chemical shifts in 
conjunction with the results of Strothers and 
Lauterbur10 . Strothers and Lauterbur showed that enolic 
carbon atoms (e.g. C-6 in () and (u)) resonate at 
lower frequency than the corresponding keto carbon atoms, 
and that hydrogen bonded carbonyl atoms (e.g. C-2 in () 
and C-4 in ()) resonate at higher frequency than a 
corresponding free carbonyl. The enolic forms () and 
(8d) were deduced to be the main tautomers from the 
predominance of the lower frequency C-6 enolic carbon 
atom signal. The predominance of the higher frequency 
C-2 hydrogen bonded carbonyl signal led to the conclusion 
that the 	-enol form () was the main tautomeric 
species. 	The approximate ratios of each of the 
individual internal tautomers, although not directly 
detectable by n.m.r. has additionally been estimated in 
the same study. Observed chemical shifts of the 






intense set of signals, which had been assigned to the 
tautomer pair () were virtually identical to those 
expected for the single tautomer (u), and it was 
concluded that the proportion of the tautomer () was 
negligible. The ratio of tautomers () and (8b) was 
estimated by comparison with the 13 C n.m.r. spectrum of 
2-acetyl-1,3-cyclopentane dione (2) which is known to 
exist as the tautomer shown in solution, along with the 
assumption that the observed carbon chemical shifts are 
independant to a, first approximation of the heteroatom in 
the pyrrolidine dione ring system. This approach led to 
an estimated overall ratio of individual tautomers 
() : () : () : () for simple 3-acyl tetramic acids of 
5:15:0:80. Although these results contradict the 
conclusions of Yamaguchi based on proton spectral ]-, the 
conclusions made by Steyn are substantiated unambiguously 
by the X-ray crystallographic structure determination of 
tetrainic acid (i., R=CHNe2) found to exist in the exo-endo 
form 
These studies in the tautomeric forms of simple 
3-acyl tetramic acids highlight useful spectroscopic 
means of gaining an insight into the structural features 
and properties of tetramic acids, and the conclusions 
have implications for the interpretation of spectroscopic 
data in synthetic studies. 
1.2 The Naturally Occurring Tetrainic Acids 
The naturally occurring tetramic acids have been 
reviewed recently from the point of view of their 
9 
isolation and structural assignment 12 ' 13 . In view of the 
increasing interest and importance attached to their 
biological activity and total synthesis, it is intended 
to review this class of naturally occurring antibiotics, 
mycotoxins, pigments and secondary metabolites from a 
more structural perspective in order to appreciate the 
very real challenge they present to the synthetic 
chemist. 
1.2.1 The Simple 3-Acyl-Tetramic Acids. 
Pyrrolidine-2,4-diones acylated at the 3- position 
constitute an expanding class of. microbially derived 
antibiotics, mycotoxins and pigments termed the 3-acyl 
tetramic acids. The simplest member of this class, 
tenauzonic acid (Q) was isolated by Stickings 14 from the 
culture filtrate of Alternaria tennius auct. Degradation 
by Ozonolysis followed by acid hydrolysis gave 
L-isoleucine, establishing the absolute configuration at 
C-5 and C-8, and its structure was subsequently shown to 
be 3-acyl-5-s-butyl-tetramic acid ( 10 ) 15 . Tenauzonic 
acid displays a low level of antibacterial activity 16 , 
and inhibits a number of viruses at high dose levels 
including Measles (Enders), Vaccinia and Herpes Simplex 
(HF) 17 . Tenauzonic acid also exhibits inhibitory 
activity against human adenocarcinoma grown in the 
embryonated egg 18 . The mode of action has been proposed 
to involve inhibition of incorporation of amino acids 
into proteins 19 . The biosynthesis of tenauzonic acid 

























L-isoleucine () from feeding experiments using [1- 14 C] 
labelled acetate and it was concluded 20 ' 21 ' 22 that the 
biosynthetic route involved cyclisation of an N-aceto-
acetyl-L-isoleucine intermediate () rather than by 
cyclisation of N-acetyl L-isoleucine to deacetyl 
tenauzonic acid (j.) followed by acetylation at the 
3-position (scheme 2). 
The antibiotic magnesidin was isolated by Kohl and 
co-workers 23 from Pseudomonas macinesioruba sp. nov. as a 
1:1 mixture of the two tetramic acids 1-acetyl-5-
ethylidene-3-hexanoyltetramic acid (n), and 1-acetyl-
5-ethyl idene-3-octanoy I tetramic acid 
(). Chemical 
degradation was used to establish the structures of the 
two components, and Magnesidin was shown to inhibit 
various Gram-positive bacteria in very low concentrations 
without the toxicity found with tenauzonic acid. In 
fact, since tenauzonic acid has also been isolated as a 
mixture of magnesium and calcium complexes, and the 
isolation of tenauzonic acid involved acidification 14 it 
has been proposed that naturally occurring tenauzonic 
acid and related compounds may well be covalent metal 
chelates. 
The structurally interesting mycotoxin, a-cyclo-
piazonic acid (j), is produced by the fungus Penicillium 
cyclopium Westling which has been responsible for 
outbreaks fo disease upon ingestion of feed contaminated 
with P. cyclopium24 . Chemical and spectroscopic evidence 
was used by Holzapfel 25 to assign the structure and 





















identified the incorporation of L-trptophan indicating 
the absolute stereochemistry is as shown. 
The unique and structurally interesting features of 
the antibiotic ikarugamycin () are the enoyltetramic 
acid containing macrocyclic lactam and the trans-anti-
gJ-decahydro-—indacene system. Ikarugamycin was 
isolated from the culture broth of Stretomyces 
phaeochromogens var. ikarugamycin Sakai 29 . Its 
biological properties include strong specific 
antiprotozoal activity, in vitro antiamoebic activity and 
activity against some Gram-positive bacteria. The 
structure assignment and absolute configuration of 
ikarugamycin was from a chemical structure proof by Ito 
and Hirata30 . The related antibitic capsimycin3l () 
is the only other naturally occurring tetramic acid 
containing this interesting tricyclic system, and its 
structure was established by comparison of its spectral 
properties with those of ikarugamycin and from X-ray 
data. 
In view of efforts towards a chemical rationalisation 
of the structure and function of biologically active 
tetramic acid, the unique aminomalonic acid moiety of 
malonomycin () is of particular structural interest. 
Nalonoinycin was isolated from Streptomvces rimosus var. 
paroinomycinus and exhibits antiprotozoal activity. The 
aminomalonic acid moiety incorporated into the 3-acyl 
sidechain of the tetramic acid was shown to be essential 
for the biological activity of the compound, with 
decarboxylation being effected by brief treatment in 
0 
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boiling water to give the inactive derivative (2) 32 ' 33 . 
Studies in the biosynthesis of malonomycin have indicated 
that the aminomethyl group at C-5 of malonomycin 
originates from L-2,3-diaminopropionic acid 34 . 
1.2.2 The Polvene Tetrainic Acids 
Pyrrolidine-2,4-diones with a polyenoyl substituent 
at the 3-position form a sub-group of 3-acyl tetramic 
acids which exhibit a range of biological activity 
including antibiotic, antiviral and anti-tumour 
activity35 . The polyene tetramic acids display common 
structural features such as the tetramic acid nucleus and 
polyenoyl substituent at C-3 of the tetramic acid nucleus 
as well as considerable structural diversity in the 
functionalisation of the polyene chain and the 
substitution at the N and C-5 position of the tetramic 
acid nucleus. Streptolydigin () was the first of the 
dienoyltetramic acids to be isolated 36 , and contains 
interesting stereochemical features with far reaching 
synthetic implications such as the methyl propionainide 
substituent at C-5 of the tetramic acid nucleus, the 
2,3,6-trideoxyaldohexose component and the 2,9-dioxabi-
cyclo[3.3.1]nonane subunit. The structure was assigned 
by consideration of the chroinophore of the antibiotic 37 
and by structural studies on streptolic acid (22) 38 , the 
product of periodate oxidation of streptolydigin, 
although the stereochemistry was not determined. 
Synthesis established the stereochemical identity of the 
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2,3, 6-trideoxy-L-threo-aldohexose 39 . 
Tirandamycin A(ll) was isolated from Stretomyces 
tirandis var. tirandis40 and exhibits contrasting 
activity to the simpler naturally occurring 3-acyl 
tetramic acids. In common with streptolydigin (fl), 
tirandamycin has attracted considerable interest due to 
their potent inhibition of bacterial DNA-directed RNA 
polymerase41 , and the selective inhibition of terminal 
deoxynucl eot idyl transferase from leukemic cells 42 . The 
structure of tirandamycin A was assigned by comparing its 
spectra with previous spectra of streptolydigin 43 . The 
absolute stereochemistry of tirandamycin Awas determined 
by X-ray crystal structure studies of the -bromophenacyl 
ester of tirandamycic acid (n), which was obtained from 
periodate oxidation of tirandamycin A 4 . The chemical 
conversion of both streptolic acid () and tirandamycic 
acid () to streptolol (21) (scheme 3) was proof that 
the overall stereochemistry of streptolic acid was the 
same as tirandaiuycic acid, and this enabled the full 
determination of the stereochemistry of streptolydigin 
leading to the assignment of structure (j) to 
streptolydigin4 . This structural proof was recognised as 
being a valuable general method for determination of 
stereochemistry. The very closely related tetramic acid 
tirandaxnycin B was isolated subsequently and was assigned 
to structure (24.) 45 . 
A structurally unique hybrid of the tirandamycin-
streptolydigin families of tetramic acid antibiotics, 
tirandalydigin (), has been isolated46 recently from 
19 





























the fermentation beers of Streptomyces sp. AB-1006A-9. 
This anti-anaerobic47 tetramic acid antibiotic has been 
assigned structure (2..) on the basis of n.m.r., u.v. and 
mass spectrometric data. Although this data, along with 
comparison with data published for streptolydigin (21), 
indicates a molecular structure with the same relative 
stereochemistry as that reported for streptolydigin, no 
evidence was presented.. to exclude the alternative 
absolute configuration, but in view of a postulated 
common biosynthesis tirandalydigin has. been tentatively 
assigned with absolute stereochemistry (a). 
In common with tirandalydigin (28), the structurally 
related tetramic acids Bu2313A () and Bu2313B () both 
exhibited a broad spectrum of antibiotic activity against 
Gram-positive and Gram-negative anaerobic bacteria, and 
also inhibit the growth of some aerobic bacteria such as 
streptococci48 . Isolation of Bu2313A and Bu2313B was 
from an unidentified oligosporic strain of an 
actinomycete48 , and structural assignment was on the 
basis of X-ray studies of the -bromophenacy1ester () 
of their respective periodate oxidation product (fl). 
The naturally occurring tetramic acids with a polyene 
chromophore include the orange-red pigment isolated from 
Penicillium islandicum Sopp., erythroskyrine (13) 49 , 
shown to have the 3-pentaenoyl substituent on the basis 
of spectroscopic evidence. The absolute configuration at 
C-5 of the tetramic acid nucleus was determined as S by 
degradation to L(+)--methy1va1ine, although the 
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remained undetermined. 
Studies in 	the biosynthesis of erythroskyrine 
illustrated from labelling studies, using [1- 14C] or 
[2- 14C] sodium acetate and (1- 14C] or [2- 14C) diethyl-
inalonate, that C-1 9 to C-16' were derived from malonate 
adC-17' and C-18' originated from acetate. The amino 
acid residue constituent in the tetramic acid nucleus was 
shown to originate from L-valine (3j) by the uptake of 
14C-carboxyl labelled material into erythroskyrine. 
Studies in the biosynthetic origin of C-2 and C-3 of the 
tetramic acid nucleus were inconclusive, and the origin 
of the N-methyl group of erythroskyrine was undetermined 
(scheme 4)50. 
The yellow pigment of the slime mould Fulio septica 
(L.) Wiggers was isolated by Steglich 51 , who showed the 
yellow pigment to be due to the occurrence of fuligorubin 
A (n), a tetramic acid with a polyene chromophore. The 
structure () was assigned to fuligorubin A on the basis 
of n.m.r., u.v. and mass spectrometric data. The 
absolute configuration of the tetramic acid nucleus of 
fuligorubin A was determined as 5(R) by studies on the 
chiroptic properties of decahydrofuligorubin A (n). 
The structure determination of the -glycoside 
altamycin A () was carried out by Shenin52 , and was 
based on mass spectrometric data of the oxidative 
degradation products of the antibiotic aglycone. It was 
shown that the tetramic acid antibiotic altarnycin A 
contains the sugar moiety D-digitoxose () and the 
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The structurally related 0-glycoside, a-lipomycin 
(n), exhibiting the same polyene chromophore as the 
pigment erythroskyrine () was isolated from 
Streptomyces aureofaciens 53 and was subsequently assigned 
to structure Methanolysis of a-lipomycin () in 
the presence of a trace of acid afforded 3-lipomycin 
methyl ester (j) and methyl 9-D-digitoxose (j4). The 
stereochemical identity of the sugar moiety was 
determined by comparison with an authentic sample. 
Chromatography of cr-lipomycin on silica get. impregnated 
with oxalic acid afforded the aglycone 3-lipomycin (ia), 
which was found to absorb 5 equivalents of hydrogen on 
hydrogenation giving decahydro--lipomycin (j). The 
decahydro derivative was shown to have similar chemical 
and spectroscopic properties to tenauzonic acid (), the 
simplest naturally occurring tetramic acid, and u.v. 
spectroscopic studies showed that a- and 13-lipomycin 
contained the pentaene chromophore in common with 
erythroskyrine (33). The absolute configuration at C-5 
of the tetramic acid nucleus was determined as S by 
ozonolysis of 3-lipomycin and subsequent acid hydrolysis 
which gave L-j-methy1glutamic acid (j). Two further 
chemical studies were carried out to determine the 
position of the isopropyl group in decahydro-fi-lipomycin 
(j.). Nitric acid oxidation of decahydro-3-lipomycin 
gave two diastereomers of 1,3-dimethyl-1,11-undecanedi-
carboxylic acid (j). Reduction of decahydro-3-lipomycin 
(j) with lithium aluminium hydride and subsequent 
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isomers of 10,12, 14-trimethyl-13-oxopentadecanoic acid 
(41) as well as the two diastereoisomers of 1,3-dimethyl-
1, 11-undecanedicarboxylic acid obtained previously. 
These stereoisomers were separated and their optical 
rotation values recorded, although these structural 
studies presented no data regarding the determination of 
the absolute of relative stereochemistry at the C-12 1 and 
C-13' chiral centres of the lipomycins 54 . In comparison 
with the complete determination of the stereochemical 
identity of tirandamycin A by X-ray studies 44 , the 
ambiguity of the structural assignment of a-lipomycin was 
considered to have far reaching implications for 
strategies employed in its total synthesis. Both 
a-lipomycin and 3-lipomycin exhibited selective 
inhibition of only Gram-positive bacteria 53 , and have no 
effect on the growth of fungi and yeasts. 
The structurally related 3-glycoside oleficin (LO) 
was isolated as a deep red powder from a strain of 
Streptomyces parvulus, and exhibited biological activity 
similar to the lipomycins 55 , with only inhibition of 
Gram-positive bacteria being observed. The assignment of 
structure (j) to oleficin was by way of revision of an 
earlier incorrect structural assignment 56 , such that the 
actual structure of oleficin (jQ) differs only in the 
length of the polyene chain from that of a-lipomycin 57 . 
The stereochemical identity of the C-14 1 , C-15' chiral 
centres remained undetermined, and the revision of the 
structure assigned to oleficin illustrates the 
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The common structural feature of the naturally 
- - . occurring N-acyl-4-methoxy-3-pyrroline-2-ones is the 
tetramic acid nucleus functionalised as the 4-0-methyl 
ether, unsubstituted at C-3 and acylated on the ring 
nitrogen. The first member of. this group to be isolated 
from natural sources was dysidin (j), a chlorine 
containing secondary metabolite isolated from the 
Indopacific sponge Dysidea herbacea58 . The structure 
(j) was assigned to dysidin after X-ray crystal studies, - 
showing the C-5 substitution of the tetramic acid 
nucleus. This structural feature is so far unique among 
naturally occurring N-acyl-4-methoxy-3-pyrroline--2-ones, 
and has far reaching implication in any projected 
synthesis of dysidin. 
Malyngamide A (j), a more complex chlorine 
containing derivative, was isolated from the marine 
cyanophyte Lyngbva maluscula 59 , with its structure being 
assigned on the basis of spectral and chemical data. The 
same workers subsequently isolated a series of related 
natural products, the pukeleiinides, that lacked the 
methoxytetradecenoic structural feature of malyngamide A 
(j) from the same species of algae. The structure of 
Pukeleimide C (.Q) a member of this series of compounds, 
was determined by X-ray crystallography. Studies on the 
circular dichroism of pukeleimide C (Q) revealed that, 

























2-pyrrolidone ring nucleus, pukeleimide C is raceluic in 
its natural form60 . 
Althiomycin (51)61162  was isolated from Streptomyces 
aithioticus and has been the subject of structural 
interest by several groups 63 ' 64 . Althiomycin exhibits a 
wide spectrum of antibacterial activity against both 
Gram-positive and Gram-negative microorganisms, although 
the instability of its biological activity limits its 
practical value. 
1.3 Recent Studies in the Synthesis of Tetraiuic Acids 
It is intended to review the development of synthetic 
strategies used in the sthesis of tetramic acids from 
the perspective of selecting methodology appropriate to 
the structural and stereochemical implications associated 
with the synthesis of the complex naturally occurring 
tetramic acids. 
The first synthesis of a tetrautic acid derivative was 
achieved by Gabrie1 65 . Reaction of phthaliinidoisobutyryl 
chloride () with diethyl sodioivalonate gave ethyl-2-
ethoxycarbonyl-4,4-dimethyl-3 -oxo-4-phthalimidobutanoate 
(n), and brief treatment with concentrated sulphuric 
acid effected cyclisation to the 3-ethoxycarbonyltetramic 
acid () (scheme 5). 
The synthesis of a series of 3,3-disubstituted 
pyrrolidine-2,4-diones () was achieved by similar 
methodology. The 2,2-disubstituted acetoacetic ester 
bromides () were treated with potassium phthalimide to 
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subsequently treated with hydrazine hydrate to give the 
pyrrolidinediones () (scheme 6)66. 
The synthesis of 4-methoxy-3-pyrrol ine-2 -one 
the Q-Inethylether of tetramic acid has been carried out 
by the same methodology. Methylation of ethy1aceto-
acetate with diazomethane gave the 3-methoxycrotonic 
ester (), and subsequent treatment with I—bromo-
succinimide gave the bromo-derivative (). Reaction of 
potassium phthalimide with () and subsequent treatment 
with hydrazine hydrate gave the required methoxy-
pyrrolinone (j) (scheme 7)67. 
This methodology was applied in a recent approach to 
the total synthesis of the naturally occurring tetramic 
acid dysidin (j). The acid chloride of (±)-j-phthal-
oylvaline () was homologated to the ketoester (j) by 
reaction with the dianion of mono-ethyl malonate. 
Q-methylation was carried out by treating 
() 
with 
potassium hydride and methyl fluorosuiphonate and 
subsequent treatment with hydrazine giving the 
methoxypyrrolinone 
() 
(scheme 8)68. However, the 
stereochemical implications of the asymmetric centre at 
C-5 of the tetrainic acid nucleus present in dysidin were 
not addressed. 
The versatility of hippuryl chloride (, R=C1) or 
p-nitrophenyl hippurate (, R=OC6H4NO22) as synthetic 
intermediates in the synthesis of 3-substituted tetramic 
acids has been reported 69 . Condensation of hippuryl 
chloride (, R=Cl) or -nitrophenyl hippurate (, 
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sodiocyanoacetate (Y=CN) and diethyl sodiomalonate 
(Y=CO2Et) gives the corresponding benzoylaminoacetyl 
condensation products (, Y=COMe, CN, CO2Et 
respectively) in moderate yield 7 , and evidence was 
presented that this reaction proceeds by initial 
formation of 2-phenyloxazolone (). Cyclisation of the 
benzoylaminoacetyl condensation products () using 
excess sodium ethoxide was observed to proceed with 
concomitant debenzoylation resulting in the formation of 
the corresponding 3-substituted tetramic acids (j) 
(scheme 9)69. This route was considered to have 
interesting and valuable features in view of the 
structural relationship of the 3-substituted tetramic 
acids () synthesised by this methodology to the complex 
naturally occurring 3-substituted tetrainic acids, 
although no possibility of controlling the stereo-
chemistry of substituents at the C-5 position of the 
tetramic acid nucleus existed. 
The Dieckmann cyclisation of -acy1amino-esters of 
type (ZQ) was considered to be an extremely versatile 
route to the tetramic acid ring system and has been the 
subject of several investigations. The synthesis of 
1-benzyl-3-phenyltetraxnic acid () by treatment of ethyl 
fl-benzyl-j-(phenylacetyl)glycinate (fl) with sodium 
ethoxide was reported by King and McMillan (scheme 10)70. 
The sy,p iu esis of 3-acyltetraic acids from readily 
available a-aminoesters in two convenient steps by a 
modification of this methodology was reported by Lacey 71 . 
























the acetoacetamide (2.4.) which cyclised to the required 
tetramic acid () on treatment with sodium ethoxide 
(scheme 11)71. The naturally occurring 3-acyl tetramic 
acid, tenauzonic acid (Q) was prepared from ethyl 
L-isoleucine and diketene using this methodology 17 , and a 
series of 3-acyltetramic acids from amino acids other-
that L-isoleucine were similarly prepared in order -to 
investigate their biological activity 16 . 
The Dieckivann cyclisation methodology has been 
applied more generally to the synthesis of tetramic acids 
bearing larger and more complex 3-acyl substituents with 
a view to the synthesis of the naturally occurring 
3-acyltetramic acids. This involved cyclisation of 
intermediates of type (.Z)prepareI by acylation of an 
a-aminoester with an activated 13-keto acid. The 
synthesis of 5-benzyl-3-decanoyltetramic acid () from 
ethyl phenylalaninate and 3-oxododecanoyl chloride was 
achieved by this methodology72 1 and Rinehart has 
investigated the applicability of this methodology to the 
synthesis of 3-dienoyl-tetramic acids related to 
streptolydigin (j) and tirandamycin A and B (23 and 
24.) 73 . However, in view of the basic reaction conditions 
and the associated absence of stereocontrol of a C-5 
substituent on the tetramic acid ring nucleus found with 
this methodology, the distinction between the C-5 
unsubstituted tetramic acid constituent in tirandamycin 
and the C-5 substituted tetramic acid nucleus of 
streptolydigin should not be underestimated. 
































dienoylacetyl esters, ethyl 3-oxo-(,) -4, 6-octadienoate 
() and ethyl-6, 8-dimethyl-3-oxo-(L) -4, 6-nonadienoate 
(n), with a range of ethyl j-alkylglycinates (Q). The 
resulting acetoacetamides (j) and () underwent 
cyclisation to the corresponding tetramic acids (3) and 
(84) in 25-45% yields (scheme 12), but the analogous 
attmepted condensation of ethyltirandamycylacetate, 





R=Bzl) 	led 	to 	thermal 
decomposition of the 9-keto ester ()73. This 
methodology was used to synthesis malonomycin () 
although, as in Rinehart's studies 73 , no control of the 
asymmetric centre at C-5 of the tetramic acid nucleus was 
achieved and so this synthesis afforded inalonoinycin () 
in its racemic foriu 74 . 
The acylation of 3-unsubstituted pyrrolidine-2,4-
diones was regarded as a promising alternative strategy 
in view of the requirement of an acyl substituent in the 
3-position of the tetrainic acid nucleus in many of the 
biologically active natural systems, and Kohl was the 
first to use this strategy in the synthesis of magnesidin 
(14, 15)23. The value of this strategy in the synthesis 
of models of the complex naturally occuring 3-polyenoyl 
tetramic acids was investigated further by Jones 75 . The 
methodology involving Lewis-acid mediated acylation of 
the 3-unsubstituted pyrrolidine-2,4-dione at the C-3 
position of the tetramic acid ring nucleus with acid 
chlorides was initially problematic due to loss of 
product in the basic work-up conditions. This was 
39 
,,—CO2Et 
0 	 RNH 	 0 
EtO2C.)L-..2 	 Et02C 	(' R2 
	
R l 
(t)R ' :H ,R2:Me 	 R 
(79) R'= Me, R 2 : .-Pr •(•) R':H ,R 2 : Me 
R':  Me, R 2 : -Pr 
0 
RBzI, 	 HO 
R 	 OMe, 
R: cyclohexyi 	 R 
(3) R':H ,R 2 :Me 
() R 1 : Me, R 2:-Pr 
Scheme 12 
OR 
Me Me Me 
(85) 
a. 
overcome by isolating the 3-acyltetramic acid products as 
their boron trifluoride complexes (), which were 
obtained in 50-78% yield from acylation of pyrrolidine-
dione (). Treatment of these complexes with methanol 
V liberated the 3-acyl tetramic acids () in good yield 
(scheme 13)76. 
The acylation of the thallium (1) enolate 77 of a 
pyrrolidinedione with an acyl fluoride to give the 3-acyl 
tetramic acid, the C-acylation product, was investigated 
by Rinehart73 . Reaction of thallium enolate (), a 
model of streptolydigin (21)1 with sorbyl fluoride gave 
the corresponding -acylation product () in only 4% 
yield. The major product from this reaction arose from 
-acy1ation of the C-5 side chain to give (n), and 
products from Q-acylation were also isolated. This 
acylation strategy clearly lacked the requisite 
selectivity for application to the synthesis of one of 
the complex naturally occurring 3-acyl tetramic acids, 
and additionally was still based on the foundation of 
preparing the tetramic acid ring nucleus by means of 
basic cyclisation of N-acylaminoester derivatives. It 
was appreciated that this approach involving 
deprotonation of positions a to the carbonyl functions 
would inevitably result in loss of the stereocheiuical 
integrity of any substituent at the C-5 position of the 
tetrainic acid ring nucleus. 
An alternative method of acylation at the 3-position 
has been described78 by Jones and its applicability has 
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C-3 of the 4-0-methyl ether of 1-methyl-5-isopropyl-
pyrrolidine-2,4-dione (92) gave the vinyllithium 
derivative () which was reacted with a range of 
aldehydes giving the hydroxyadducts (j) in respectable 
yields78 . Oxidation of the alcohols (flj) with manganese 
dioxide gave the corresponding keto-derivaties () which 
on treatment with sodium hydroxide liberated the free 
tetramic acids () (scheme - 14). The extension of this 
methodology represented a method for the construction of 
3-dienoyl tetramic acids by nucleophilic reaction of the 
3-acyltetramic acids of type () carrying neither 
activation at C-7 nor protection at N-1 80 . 
Boeckmann81 reported the synthesis of a tetramic acid 
nucleus with the acyl group suitably functionalised for 
further elaboration, in the form of the phosphonate-
activated tetraniic acid (102). This was prepared by a 
modification of Lacey's method of synthesising tetramic 
acids bearing an unsaturated 3-acyl side chain. The 
adduct of diketene and acetone (93)82  was converted into 
its anion and treated with hexachioroethane to give the 
chloride (n). Treatment of the chloride with the sodium 
salt of diethyl phosphite gave the phosphonate (.QQ) 
which reacted with glycine methyl ester under mild acid 
catalysis to give the amide (Q), and conversion to the 
activated tetramic acid (.02) was accomplished by 
cyclisation under basic conditions with sodium methoxide 
(scheme 15). Some evidence was presented that the 
stereochemical identity of a C-5 substituent of a 
phosphonate activated tetramic acid could be preserved81, 
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although in view of the basic conditions involved in its 
preparation by this methodology, this was not considered 
to be a synthetically reliable route to a phosphonate 
activated chiral tetrainic acid. 
An alternative route to activated tetramic acid(102) 
via 	fragmentation of an isoxazolium salt has 
been described83 	and more recently reviewed84 . 
Bromination of 5-methylisoxazole (.0..3) with li-bromo- 
succinixnide gave 	(Qj) 	which was heated with 
triethyiphosphite to give the phosphonate The 
requisite salt (Q.) was obtained by alkylation of the 
isoxazole nitrogen with carbethoxymethyltrifluoro-
methanesuiphonate, and treatment of this salt with sodium 
bicarbonate gave the amide (].Q), the intermediate 
obtained previously. As the conventional cyclisation 
procedure was used to prepare the phosphonate activated 
tetramic acid, this variation was not considered a 
methodology capable of encompassing the total synthesis 
of complex naturally occurring tetramic acids with 
substituents at C-5 of the tetramic acid ring nucleus. 
A modification of this strategy was recently applied 
to the total synthesis of (-)-tirandamycin A ()85. 
Reaction of the dianion of (Q) under milder conditions 
than previously possible, with freshly prepared aldehyde 
(.Qi) afforded the Emmons adduct which on 
treatment with trifluoroacetic acid gave (-)-tirandamycin 
A () (scheme 16). The total synthesis of tirandamycin 
A in its racemic form has been achieved by Boeckman 86 and 
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state of the art, the methodology used is of interest. 
The asymmetric synthesis of the 2,9-dioxabicyclo-
[3.3.1)-nonane ring system constituent in tirandamycin.A 
(3) and the asymmetric synthesis of tirandamycic acid 
() have been the focus of considerable synthetic effort 
by several groups8995 since the first asymmetric 
synthesis of tirandainycin acid () from D-glucose 'by 
Ireland88 . 
Now that the total synthesis of (-)-tirandainycin A 
() has been achieved, the synthetic horizon moved to 
the complex naturally occurring polyene tetramic acids 
functionalised at C-5 of the tetramic acid nucleus. 
The implications of the stereochemical features of a 
C-5 substituted tetramic acid nucleus are exemplified in 
current synthetic approaches to streptolydigin (j).  Two 
disconnections are considered in scheme 17. The target 
of disconnection A, streptolic acid () has been 
considered by Ireland 96 , on the basis of previous work 
suggesting that this acid 
() 
can serve as a key 
intermediate in the synthesis of streptolydigin (j). 
This versatile approach provides access to either the 
tirandamycic or the streptolic acid series and is based 
on the use of D-(+)-glucose as the source of absolute 
stereochemistry, and the transfer of asymmetry is 
accomplished by the application of the ester enolate 
Claisen rearrangement and the Sharpless asymmetric 
epoxidation. Reaction of enone (.12)  in tetrahydrofuran 
at -78°C with [(benzyloxy)methyl]lithiuxn afforded the 


























revealed the allylic alcohol unit for the application of 
the Sharpless asymmetric epoxidation, which gave epoxide 
(flj), with no epoxidation of the cyclic allylic alcohol 
being observed. Opening of the epoxide (nj) with 
lithium diinethylcuprate and cyclisation with toluene-
suiphonic acid gave the bicyclic ketal (fl). Oxidation 
of the primary alcohol with PCC and olefination with 
1-ethoxycarbonylethyl idenetriphenylphosphorane gave the 
ester (.]J). Reduction of ester (fl) and silylation of 
the resulting hydroxyl followed by removal of the benzyl 
protecting group with lithium di-tert-butylbiphenyl 
radical anion gave the vicinal diol (112). Treatment of 
this diol with tosylimidazole and sodium hydride at 0°C 
gave the exocyclic epoxide (1J). Deprotection, 
oxidation and Wittig olefination gave ethyl ester (1..2.) 
which afforded streptolic acid (22) on saponification 
(scheme 18). 
Disconnection B (scheme 17), is being pursued by 
Schlessinger97 and is based on the preparation of the 
tetramic acid derived Emmons reagent (.2.0 ) and 
olefination of aldehyde (102)98. However, although the 
(122.) can be synthesised in its enantiomerically pure 
form, the Schlessinger preparation of the Emmons reagent 
(122.) relies on the separation of diastereomers of the 
precursor material, and cannot be considered as an 
asymmetric synthesis. 
In view of this it is clear that the asymmetric 
synthesis of the complex naturally occurring polyene 
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nucleus presents a very real challenge to the synthetic 
chemist. Although promising methodology is now 
available, including the phosphonate activated tetramic 
acids, the problem of controlling the stereochemical 
integrity of the C-5 asymmetric centre of a tetramic acid 
with a C-5 substituent on the tetramic acid nucleus has 
not been satisfactorily overcome. 
1.4 Recent Studies in the Synthesis of Polvene Natural 
Products 
The synthesis of polyene natural products presents a 
demanding challenge to the synthetic chemist in terms of 
stereoselectivity, stability and incorporation of diverse 
functionality99 . Aiuphotericin B (EQ) (scheme 19) is a 
member of the structurally complex class of compounds 
termed the polyene macrolide antibiotics, and is the only 
member of this group widely used for treatment of 
systemic fungal infections 100 . Amphotericin B (.Q) is 
the only polyene macrolide whose absolute structure is 
firmly established by X-ray crystal lography 101 , and a 
recent investigation has involved a comparative study of 
the synthetic methods relevant to the polyene macrolide 
antibiotics with a view to developing a method of 
preparing polyenes that was mild enough to tolerate 
allylic asymmetry as well as sufficiently flexible to 
accommodate preparation of chromophores ranging from four 
to seven double bonds to allow for the variation found 
within this class of compounds 99 . The strategy indicated 
by disconnection A (scheme 19) was based on convergent 
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insertion of the intact polyene stannylphosphonium salt 
(ni) (scheme 20) but this strategy failed as a result of 
the instability of the required intermediates (j) for 
the phosphonium salt (.111). Electrocyclic ring closure 
of (4) followed by aromatization with loss of nBu3SnH 
was found to occur quantitatively at room temperature 
leading to ethyl benzoate (3) (scheme 20). 
Disconnection B (scheme .19) represents a more linear 
approach with a model of the olefination sequence being 
carried out using isobutyraldehyde. However, repeated 
use of the phosphonate (j) resulted in a disappointing 
overall yield of less than 12% (scheme 21). 
It became clear that reagents which would afford 
unsaturated carbonyl compounds in the aldehyde oxidation 
state directly would lead to a significant improvement in 
overall yield. A reagent has been introduced by 
Wollenberg (132)102 which is useful in the synthesis of 
carbonyl compounds possessing extended conjugation. The 
lithium salt (133) derived from 
(). 
via trans-
metalation102 has been applied to the olefination of the 
protected propionate region of amphotericin B ()) to 
provide the key intermediate (].fl) in significantly 
improved overall yield of 48% (scheme 22). However, 
product was isolated as a mixture of E and Z isomers, and 
this methodology was only applicable to the preparation 
of unbranched polyolefinic aldehydes. 
The studies in the degradation and synthesis of 
amphotericin B reported in the communication by 
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fragment of amphotericin B by Kinoshita 10° illustrate the 
synthetic challenges and problems encountered in the 
synthesis of polyene natural products using phosphonate 
intermediates in repeated Wittig type olefinations. In 
a highly stereocontrolled synthetic procedure, the 
methodology employed must be flexible, compatible with 
conserving the stereochemical integrity of an asymmetric 
centre in the position a to the carbonyl function, and 
capable of elaborating the olefin product to the greatest 
possible extent as a single geometrical isomer. 
In recent studies in the synthesis of the macrolide 
(]), a key intermediate in the synthesis of the 
antibiotic elaiophylin, by Seebach104 , the utility of the 
phosphonate Emmons reagent (4.0) and the stabilised ylide 
(.141) in the olefination of the chiral aldehyde () are 
compared (scheme 23). Important features of this 
aldehyde in respect of its reactivity are the chiral 
centre in the position a to the aldehyde, the steric 
hindrance of the methyl group a to the aldehyde and the 
fact that this aldehyde is saturated. Treatment of this 
aldehyde with the enolate of the phosphonate (.14.0) gave 
the desired diene (41) only as a minor product. The 
major product was the unsaturated aldehyde (142), the 
result of silanol elimination with the a-chiral centre 
being lost, due to the enolate of the phosphonate (14) 
being found to be too basic in character. The less basic 
stabilised ylide (.141) was found to effect olefination of 
aldehyde (), conserving the stereochemical integrity 
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was isolated as a mixture of geometrical isomers, which 
could be partly isomerised using iodine in 
dichioromethane. 
Recalling that reagents which would afford 
unsaturated carbonyl compounds in the aldehyde oxidation 
state directly would lead to a significant improvement in 
overall yield, the significance of the closing stages of 
the recent synthesis by McKillop of leukotriene A4 methyl 
ester (149) from D-glucose was apparent 105 . The 
epoxyaldehyde ester (145) was treated with triphenyl-
phosphoranylidenecrotonaldehyde (146) 106 in dichioro-
methane at room temperature to give the aldehyde (141) in 
70% yield. This dienal (lii) was reacted at -78°C with 
the ylide formed from the phosphonium salt (14) and 
n-butyllithium to give leukotriene A4 methyl ester in 
high yield, and in the desired form of geometrical 
isomers. 
In conclusion the synthetic and stereochemical 
implications of these recent studies in the synthesis of 
polyene natural products will be considered in the 
context of our own studies in the synthesis of polyene 
tetramic acid antibiotics. 
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2. DISCUSSION 
The aim of the present work is to achieve the total 
synthesis of the naturally occurring tetramic acid 
antibiotic -lipomycifl () and its stereoisomers in 
their enantiomerically pure form. The first goal of this 
synthesis, in view of the absence of any X-ray crystal 
studies, was to firmly establish the stereochemical 
identity of the polyene chain of the lipomycins. The 
second goal was to develop a flexible stereocontrolled 
synthesis with sufficient latitude to encompass the 
synthesis of other related tetramic acids and their 
stereoisomers to facilitate studies on structure-
activity relationships and to present a chemical 
rationalisation of the structure and function of these 
biologically active compounds. In order to achieve these 
goals, it was necessary to identify the stereochemical 
features of a-lipomycin () with the furthest reaching 
implications in designing a synthesis. In common with 
streptolydigin (n), the tetramic acid nucleus 
constituent in a-lipomycin is substituted at the C-5 
position, and it was considered that epimerisation of 
this chiral centre presented a major synthetic hurdle 
that has not been overcome in the literature. The 
Dieckmann cyclisation of fl-acylaminoesters had been 
observed to result in at least partial, and often 
complete epimerisation of the chiral centre at the C-5 
position of the tetramic acid nucleus in the basic 
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equilibrium deprotonation of (jQ) to give the anion 
(scheme 25). The C-5 position in the tetramic acid 
nucleus has also been shown to epimerise under acidic 
conditions as observed in the hydrolysis of tenauzonic 
acid (.2 0 ) with 0.1N hydrochloric acid which led to 
deacetylated product (152), epimeric at C-5 (scheme 26). 
Tenauzonic acid was even observed to undergo slow 
epiinerisation on prolonged storage, illustrating the 
sensitivity of the C-5 asymmetric centre, and these 
observations indicated the need for an innovative mild 
synthetic approach to overcome this significant problem. 
The asymmetric synthesis of the polyene chains of 
complex naturally occurring polyene tetrainic acids, as 
discussed previously, have been the focus of considerable 
synthetic effort in their own right. In the case of the 
polyene chain of cr-lipomycin, the stereochemical feature 
of the chiral subunit containing the C-12' and C-13' 
asymmetric centres, of unknown stereocheinical identity, 
implies a synthetic approach capable of affording each 
stereoisomer in high enantiomeric purity and in efficient 
yield. The construction of the polyene fragment must 
also be carried out and coupling to the chiral subunit 
must be achieved without loss of stereochemical 
integrity. 
The sugar fragment, D-digitoxose (fl)  is commercially 
available, and its total synthesis has been achieved 109 , 
and therefore the implications of the sugar fragment are 
that a synthetic procedure for its coupling to the 
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The coupling of these fragments without loss of their 
stereochemical integrity undoubtably presents a very 
difficult synthetic challenge. After careful 
consideration of the implications of the stereochemical 
features of a-lipoinycin, a convergent approach to its 
total synthesis was envisaged from the retrosynthetic 
analysis shown in scheme 27 providing three target 
fragments for the aglycone. of a-lipoinycin. However, this 
retrosynthetic analysis would be subject to considerable 
modification, and approaches to each of the three 
fragments will now be discussed. 
2.1 The Tetramic Acid Fraqment 
The novel route to the tetrainic acid ring nucleus 
developed by Mitchell 12 and Jenkins 13 represents a 
significant breakthrough in the synthesis of complex 
naturally occurring tetramic acids. This route involves 
the reaction of an oxazolidine-2,5-dione (a-amino 
acid--carboxyanhydride) with an ester enolate and is 
outlined mechanistically in scheme 28. From this 
mechanism (scheme 28) it is clear that two equivalents of 
the enolate are required. The first equivalent of the 
enolate performs nucleophilic attack at C-5 of the 
oxazolidine-2,5-dione to give the adduct (j). 
The second equivalent of the enolate selectively 
deprotonates (14.) at the 6-position leading to dianion 
(155) where the charge is stabilised by conjugation with 
the three functional groups, CO2R 4 , R3 and 0. In 
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intermediates of type (Q) (scheme 25), this conjugation 
with three functional groups results in sufficient 
stabilisation of dianion () that deprotonation at the 
alternative 6-position is not observed. This is 
rationalised on the basis that any deprotonation at the 
6-position of (1..4) would result in charge delocalisation 
only into the 0 function with significant loss of 
stabilisation. Loss of CO2 to (]) and cyclisation to 
(157) led to isolation of the tetramic acid (158) on 
acidification (scheme 28). From this it is clear that 
the C-5 substituent of the tetrainic acid is derived from 
the C-4 substituent of the oxazolidine-2,5-dione and that 
the 3-substituent of the tetramic acid is derived from 
the a-substituent of the ester enolate. Mitchell and 
Jenkins12 ' 13 have used this approach to prepare a. range 
of tetramic acids () shown in table 1. The retention 
of the stereochemical integrity of tetramic acids bearing 
a 5-(1 1 -methylpropyl) substituent at the C-5 position was 
firmly established by 'C n.m.r. spectroscopy 
demonstrating that this novel route does not lead to 
epimerisation at C-S of the tetramic acids 12 , and the 
significance and applicability of this new method should 
not be underestimated. 
The methods of preparation of oxazolidine-2,5-diones 
(11) from a-amino acids has recently been reviewed by 
Hirschmann 110 1 and there are two main methods illustrated 
in scheme 29. The method described by Fuchs 111 and 
Farthing112 involves the reaction of an a-amino acid 
() with phosgene at 30-60°C in an inert solvent. The 
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alternative method described by Leuchs113 involves the 
halogenation of an N-(alkoxycarbonyl)aiuino acid (lQQ), 
followed by thermal elimination of the appropriate alkyl 
halide (scheme 29). However, the constraints imposed by 
the structural and stereochemical features of the 
tetramic acid constituent in a-lipomycin, in particular 
the preparation of the required N-methylated tetrainic 
acid without racemisation of the C-5 asymmetric centre, 
resulted in the Leuchs procedure being considered to be 
the most expedient route. 
Mitchell 	and 	Jenkins 12 ' 13 	investigated 	the 
application of the procedure for the selective 
-methylation of jj-benzyloxycarbonylamino acids reported 
by McDermott and Benoiton114 , as a route to prepare the 
required oxazolidine-2,5-dione. This procedure was known 
to result in retention of the stereochemical integrity of 
the a-carbon of the amino acid, with the -y-carboxyl group 
being protected as the t-butyl ester in the case of 
glutamic acid. However this was found to be 
problematical at the final stage of cyclisation of the 
urethane of type (.Q..Q) to give the oxazolidine-2,5-dione 
of type (in) (scheme 29) because the benzyl chloride 
produced as a byproduct of the reaction prevented the 
anhydride from crystallising and proved very difficult to 
remove. 
Jenkins 13 found that the use of an alternative 
urethane where the -benzyloxycarbonyl function was 
replaced by the -methoxycarbonyl function resulted in 
the byproduct of the anhydride-forming reaction being 
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volatile, and made the isolation of the required 
crystalline oxazolidine-2,5-dione (ui) less 
problematical. This procedure was adopted in the present 
work with only minor modifications, as shown in scheme 
30. 
L-Glutamic acid (Q) was acylated with methylchloro-
forinate in aqueous alkali solution giving the methoxy-
carbonylamino acid (j) as a, pale yellow syrup. This 
syrup was found to crystallise on trituration with petrol 
in an ultrasonic bath. The a-carboxylic acid group of 
urethane (.62) was esterified selectively on treatment 
with benzyl bromide and triethylamine in dimethyl-
formamide, and the product was isolated and purified as 
its dicrclohexylamine salt isolated in 55% yield. 
The half-ester () was obtained by treating the salt 
(2.) with aqueous citric acid, and was crystallised by 
trituration with petrol in an ultrasonic bath. The half 
ester () then underwent acid-catalysed esterification 
with isobutylene in a sealed tube reaction over a period 
of 10 days to give di-ester (j) as a pale yellow oil, 
which could not be crystallised, in 95% yield. The 
proton spectrum showed splitting of some of the signals 
indicating the presence of rotational isomers. This is 
due to slow rotation about the amide C-N bond as a result 
of the partial double bond character of the N-C=O bond. 
The a-benzyl group was selectively removed by alkaline 
hydrolysis to give the mono-ester () which 
crystallised on trituration with petrol in an ultrasonic 
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of the urethane (j) was carried out by treatment with 3 
equivalents of sodium hydride and 8 equivalents of methyl 
iodide in anhydrous tetrahydrofuran for 5 days, and the 
resultant yellow oil was crystallised by trituration with 
petrol in an ultrasonic bath, giving the required 
N-methylated product (i) in 30% yield. The optical 
rotation of the product was recorded [a]D25  -24.2° (C 
0.98 in CHC13) and n.m.r. spectroscopy again indicated 
the presence of rotational isomers. 
The urethane () was then treated with thionyl 
chloride at 0°C for 10 minutes, and then excess thionyl 
chloride was removed in vacuo. The residue was warmed to 
60°C with the pressure being maintained at ca. 18 mmHg 
for 20 minutes. The residue was allowed to cool at room 
temperature, the pressure was released and the anhydride 
(i) crystallised on trituration with petrol in an 
ultrasonic bath (scheme 30). The i.r. spectrum of the 
oxazolidine-2,5-dione (12) showed three carbonyl 
stretching bands at 1850, 1785 and 1725 cm -1 consistent 
with the anhydride structure. This oxazolidine-2,5-dione 
was to become the central synthon for the tetramic acid 
nucleus of a-lipomycin, with several synthetic avenues 
originating from it being considered worthy of 
investigation as possible routes to an activated chiral 
tetrainic acid. 
Direct routes to the 3-acetoacetyltetramic acid 
(. 72) useful for the prepar,ion of an activated tetramic 
acid, had previously been found to be unsuccessful 12 . In 
view of this, interest was focussed on the preparation of 
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the 3-isoxazoyl tetramic acid (.]fl) and this was the 
synthetic avenue pursued in this work. 
Methyl 3-methyl-5-isoxazoleacetate (.j..Q) (scheme 31) 
was prepared as described by Micetich 115 . Lithiation of 
3,5-dimethylisoxazole (j) with -butyllithium in 
tetrahydrofuran solution at -78°C proceeded exclusively 
at the C-5 methyl group, affording the acid (169) on 
carboxylation. Esterification with diazomethane gave the 
ester (.U.Q) (scheme 31). 
Reaction of the oxazolidine-2,5-dione (ui) with two 
equivalents of the anion generated from methyl 3-methyl-
5-isoxazoleacetate (flQ) gave the tetramic acid (.ifl) as 
yellow crystalline needles on acidification of a solution 
of the water-soluble reaction products (scheme 32). The 
tetramic acid (jfl) had an optical rotation [a]D25  -37.0° 
(C 0.25 in MeOH), and work on this fragment in the 
present project was concluded at this point. 
It was noted that previous investigations had 
achieved the conversion of the 3-isoxazoyltetramic acid 
(171) to (172.) on hydrogenolysis and hydrolysis (scheme 
33). Regioselective reduction of the acetoacetyltetramic 
acid (172.) with sodium borohyd ride gave hydroxybutanoyl-
tetramic acid (171) which was dehydrated with PTSA in 
refluxing benzene to give the enoyltetramic acid (174) 
(scheme 33)12113. 
Future studies on this fragment are to include 
further investigation of the utility of samarium 
diiodide 12 ' 116 in the selective reduction of isoxazoles. 
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acids (175) and (JZ), preserving their stereochemical 
integrity at C-5, are to be investigated. 
Finally, the central importance of the oxazolidine-
2,5-dione (i) as the tetramic acid synthon, is to 
receive further attention in view of the possibility of 
reaction with the anion derived from a more complex ester 
related to the polyene chain of c-lipoiuycin. 
2.2 The Pentanal Fraqment 
The synthesis of the pentanal fragment derived from 
the disconnection outlined in scheme 27 was considered 
central to the total synthesis of a-lipomycin () and 
its stereoisomers in their enantiomerically pure form. 
The synthetic implications of the unknown relative and 
absolute stereochemistry of the C12' and C13' chiral 
centres in the lipomycins are that the chosen route must 
be sufficiently flexible to accommodate the preparation 
of all four possible stereoisomers, and must enable the 
preparation of each stereoisomer in high enantiomeric 
purity. The required hydroxy protected aldehyde (j.fl) 
must enable the coupling to the polyene fragment forming 
the C10 1 -Cll' double bond, and the chosen protecting 
group must allow manipulation in a variety of reaction 
conditions until attachment of the sugar fragment is 
carried out. 
It was clear that the desired aldehyde (].fl) could 
be prepared from the protected alcohol (fl), and that 
the Sharpless asymmetric epoxidation 117 procedure and 
subsequent ring opening of the four possible enantio- 
79 
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merically pure epoxides would provide a flexible and 
highly stereocontrolled route to all four possible 
stereoisomers. The synthetic approach adopted is 
outlined in scheme 34 and scheme 36. Treatment of ethyl 
bromoacetate (17.2) with triphenylphosphine in toluene 
gave ethoxycarbonylmethylenetriphenylphosphoniuiu bromide 
(.Q) in 97% yield, and treatment with sodium hydroxide 
in a two phase dichioromethane-water system gave the 
stabilised ylide, ethoxycarbonylmethylenetriphenyl- 
phosphorane (j) in 80% yield. Stereospecific Wittig 
condensation of this stabilised ylide with iso-
butyraldehyde 
() in dichloromethane at room 
temperature gave the isomerically pure trans alkene 
esters (3.) in 77% yield. The trans relationship of the 
two vinylic protons was established unambiguously by the 
16 Hz coupling constant observed at o 5.74 and 3 6.92 in 
the proton n.m.r. spectrum. Reduction of this ester with 
excess DIBAL gave the isomerically pure allylic alcohol 
(184) in 89% as a clear liquid (scheme 34). 
The titanium tartrate catalysed asymmetic epoxidation 
first reported by Sharpless 117 in 1980 has been widely 
recognised as being a tremendously significant means of 
introducing chirality into achiral substrates. The 
mechanism of the asymmetric epoxidation has been the 
focus of considerable attention 118120 and the 
structura1 122 ' 123 and stereoelectronic 124 characteristics 
of the titanium tartrate catalyst have also been 
investigated. The interest in the Sharpless epoxidation 
in this research, however, was from a more synthetic 
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perspective, and the utility of the asymmetric 
epoxidation in the synthesis of natural products has been 
reviewed125 ' 126 . The absolute stereochemistry of the 
epoxide product for a given tartrate ester is illustrated 
in scheme 35 and has been shown to be reliable for a wide 
range of allylic alcohol substitution patterns 117119 . 
For our purposes, there were two versions of the 
asymmetric epoxidation. The first method involved the 
use of stoichiometric amounts of titanium tetraisoprop-
oxide and L-(+)-diethyl tartrate 117 , although it was 
subsequently noted that using at least 10% excess of 
tartrate esters over Ti(OiPr)4 gave the highest 
enantioselectivity119 . The second method involved 
carrying out the asymmetric epoxidation with lomol% of 
titanium tetraisopropoxide and with 13mol% of L-(+)-
diethyl tartrate in the presence of 4A molecular 
sieves127 . This version results in the simplification of 
the workup and isolation, minimises product stability 
problems and enhances the chemical yield, although the 
enantiomeric excess of product can be more variable. In 
certain cases product with higher enantiomeric excess has 
been isolated and in other cases some loss of 
enantioselectivity compared to the stoichiometric version 
was observed127 . Application of the stoichiometric 
Sharpless epoxidation to the trans substituted allylic 
alcohol () resulted in isolation of product in poor 
yields of up to 30% when the originally reported workup 
procedure recommended by Sharpless 117 was used. In this 
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workup the dialkyl tartrate was removed from the product 
mixture in a two-phase alkaline hydrolysis step which was 
believed to result in loss of some of the water-soluble 
epoxy alcohol (.28). Use of the modified workup 
procedure118 gave an increased yield of the epoxide with 
pure product being isolated in 53% yield. It was 
considered, however, that the application of the 
catalytic Sharpless epoxidation using lOmol% of titanium 
tetraisopropoxide and 13mol% of L-(+)-diethyl tartrate to 
the trans substituted allylic alcohol () would result 
in isolation of the product epoxy alcohol () in high 
enantiomeric purity and markedly increased yield. In 
order to achieve the highest possible enantioselectivity, 
particularly in the catalytic version, it is imperative 
to achieve anhydrous conditions. This involved 
thoroughly drying all glassware and solvents, and 
ensuring the t-butyl hydroperoxide solution was 
absolutely water-free. 	Application of the catalytic 
Sharpless epoxidation using lOmol% 	of titanium 
tetraisopropoxide and 13mol% of L-(+)-diethyl tartrate to 
the trans substituted allylic alcohol (j) followed by 
the modified workup 118 procedure led to isolation of the 
desired epoxy alcohol (.) in 79% yield (scheme 36). 
The excess t-butyl hydroperoxide was destroyed by 
addition of four equivalents of dimethyl sulphide. The 
titanium complexes were destroyed with aqueous sodium 
fluoride, and exhaustive extraction of this mixture with 
dichloromethane gave a mixture of the required epoxide, 
tartrate ester and dimethyl sulphoxide. The tartrate 
84 
ester was removed by distilling the more volatile epoxide 
(.&) from it, and DMSO was removed by flash 
chromatography using ether as eluent to give purified 
product in 79% yield (scheme 36). The product had an 
optical rotation value of _340 (C 1.02 in CHC13), and in 
view of the central importance of this step in the 
synthesis of the pentanal fragment, it was decided to 
investigate the enantioiueriO excess of the epoxide (186) 
prepared by the catalytic Sharpless epoxidation. Two 
interesting complementary methods were undertaken. The 
first method was to investigate the enantiomeric excess 
of the epoxidation product using the lanthanide chiral 
shift reagent tris[3-trifluoroacetyl--camphorato]-
europium (III) (). The alternative method was to use 
h.p.l.c. analysis of diastereomeric esters derived from 
the epoxy alcohol () to determine the enantiomeric 
excess of the epoxide (). The results of the first 
method using the lanthanide chiral shift reagent 
tris(3-trifluoroacetyl]- -camphoratoeuropium (III) are 
illustrated in Figure 1 and Figure 2, and can be compared 
with a previous study on the epoxide product from the 
stoichiometric Sharpless epoxidation procedure by 
Jenkins 13 . Spectrum (g) (Figure 2) is the 360 MHz 
proton spectrum of the pure epoxide () product of the 
catalytic Sharpless epoxidation. The C-1 methylene group 
appears as an ABX system whose two parts are centred at 
o 3.90 and o 3.60 and the C-2 and C-3 epoxide protons 
appear as inultiplets at 0 2.95 and 0 2.73 respectively. 
























depending on the conditions, and is observed at & 2.05 in 
this spectrum. The C-4 proton appears as a septet at 
o 1.56 and the C-4 methyl groups appear as doublets at 
o 0.97 and 0 0.92. 
It was clearly essential to demonstrate that the 
resonances of the enantiomeric epoxides would undergo 
different chemical shifts on interaction with the chiral 
shift reagent before a meaningful investigation of the 
enantioineric excess of the epoxide product of the 
catalytic asymmetric epoxidation could be carried out. 
In view of the known high enantiomeric excess of the 
epoxide prepared by the stoichioinetric asymmetric 
epoxidation, and our intention of comparing the 
enantiomeric excess of the epoxide product of this 
version with the enantioineric excess of the epoxide 
product prepared by the catalytic version, a sample was 
prepared containing 65% of the epoxide product () from 
the catalytic asymmetric epoxidation with L-(+)-diethyl 
tartrate and 35% of the enantiomeric epoxide product 
() previously prepared 13 from the stoichiomeric 
asymmetric epoxidation with D-(-)- diethyl tartrate. 
Spectrum (a) (Figure 1) is the 360 MHz proton spectrum of 
this sample containing 65%:35% of the enantiomeric 
epoxides (j) and (.) respectively, and is essentially 
identical in appearance to spectrum (g) (Figure 2) which 
contains only the epoxide product of the catalytic 
Sharpless epoxidation with L-(+)-diethyl tartrate. 
However, on exposure of the sample containing the 65%:35% 
mixture of enantiomeric epoxides to the chiral shift 
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reagent a clear pattern emerged as illustrated in spectra 
(b), (c) and (d) (Figure 1). Spectra (b), (c) and (d) 
(Figure 1) illustrate the chemical shifts induced on 
exposure of this sample containing the 65%:35% 
enantiomeric mixture to 4.3mol%, 6.2mol% and 7.9mol% of 
tris [3-trifluoroacetyl--camphorato] europium (III) chiral 
shift reagent respectively in an n.m.r. tube. 
The observed chemical shifts of protons in 
interaction with a chiral shift reagent has been 
investigated by McConne11 128 , and are critically 
dependant on the distance of the proton in question from 
the point of interaction. Protons remote from the 
hydroxyl group showed no sign of splitting. The epoxide 
protons on C-2 and C-3 showed differential shifts, but 
these overlapped as illustrated in spectra (b), (C) and 
(d) and were not of diagnostic value. Clear and 
progressive splitting of the C-i methylene AB system was 
observed in the series of spectra (b), (c) and (d) 
(Figure 1). The ratio of the two AB quartets was 
approximately 65%:35% and this indicated that the 
enantiomeric excess of the epoxide () product of the 
catalytic asymmetric epoxidation was very good. It was 
very gratifying, however, to consider the result of the 
interaction of a sample of the pure epoxide (j . ) product 
of the catalytic asymmetric epoxidation with 7.Oinol% of 
the chiral shift reagent illustrated in spectrum (e) 
(Figure 1). No trace of the enantiomeric epoxide () 
was observed, and the actual shifts closely correspond 
with those observed for the major isomer in spectrum (d) 
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(Figure 1). 	Spectrum (f) (Figure 2) illustrates the 
full spectrum of the interaction of the pure epoxide 
() product of the catalytic asymmetric epoxidation 
with 7.0mol% of the chiral shift reagent between a 1.00 
to 6 6.00. It is essentially identical to spectrum (e) 
(Figure 1), but is plotted over the extended range for 
comparison with the normal 360 MHz proton spectrum (g) 
(Figure 2) of the pure epoxide () prepared by the 
catalytic asymmetric epoxidation with L-(+)-diethyl 
tartrate. 
However, at this stage, as the presence of any 
undesired enantiomeric epoxide was below the level 
of detection, no calculation of the enantiomeric excess 
of the epoxide (j) product of the catalytic Sharpless 
epoxidation was possible. It was considered, however, 
that the epoxide must have an enantiomeric excess greater 
than 95%. 
The alternative method of investigating the 
enantioineric excess of the chiral epoxy alcohol () was 
by treating the epoxy alcohol () with R(-)-camphanic 
acid chloride, triethylamine and a catalytic amount of 
DMAP to give the camphanate ester (Q) (scheme 37) which 
was then to be analysed by h.p.l.c. to detect any 
presence of diastereoisomerism. It was recognised that 
h.p.l.c. of the crude reaction mixture would give the 
most meaningful results, and normal phase h.p.l.c. 
studies were attempted using a Waters Associates 3.9 mm 
x 30 cm A Porasil column using 5:95 ether:dichloromethane 
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with the previous experiment, two samples were prepared. 
The first sample was a diastereomeric mixture of 67% of 
camphanate ester (Q) and 33% of camphanate ester (191) 
prepared from a 67%:33% enantiomeric mixture of epoxides 
() and () (scheme 37). The second camphanate ester 
(Q) sample was prepared from the identical pure epoxide 
() product of the catalytic asymmetric epoxidatIon 
used in the chiral shift experiments (scheme 37). Normal 
phase h.p.l.c. analysis was attempted with a u.v. 
detector at 254 run, but after several attempts it was 
concluded that the chromophore was too weak to be 
detected at this wavelength. 
However, the proton n.m.r. spectra of the camphanate 
ester samples were investigated and are illustrated in 
Figure 3. Spectrum (a) is a the full spectrum of the 
crude camphanate ester (Q) prepared from the pure 
epoxide ()) product of the catalytic epoxidation. 
Spectrum (b) (Figure 3) is an expansion of spectrum (a) 
between a 2.00 and a 5.00. Spectrum (c) is the proton 
spectrum of the 67%:33% diastereomeric mixture of 
camphanate esters (j) and (j) (scheme 37) between 
o 2.00 and 0 5.00, and the C-1 methylene ABX system of 
the epoxide moiety is found to have diagnostic value. 
The deshielded doublet of doublet of the C-1 methylene 
ABX system at 0 4.40 in spectrum (C) clearly shows an 
extra overlapping doublet of doublets. The ratio of the 
overlapping doublet of doublets was approximately 
67%:33%, and was clearly the result of the presence of 














and 	 It was very gratifying to observe that the 
corresponding deshielded doublet of doublets in spectrum 
(b) established the absence of any diastereomeric mixture 
in the caxnphanate ester (Q) sample prepared form the 
pure epoxide (i&) product of the catalytic asymmetric 
epoxidat ion. 
However, no numerical value for the enantiomeric 
excess of the chiral epoxy alcohol () prepared by the 
catalytic version of the Sharpless asymmetric epoxidation 
was obtained, although it was considered to be greater 
than 95%, and these studies were of interest in view of 
the contrasting merits of their respective experimental 
procedures. 
Having carefully established the high enantio-
selectivity of the catalytic Sharpless epoxidation of 
this system, attention was refocussed on opening the 
epoxide ring with high regioselectivity and stereo-
selectivity using lithium dimethylcuprate (scheme 36). 
Kishi 131 has demonstrated the high regioselectivity and 
stereoselectivity of epoxide ring opening with organo-
cuprates, and previous studies by Jenkins 13 on epoxy 
alcohol () (scheme 36) illustrated that the best 
regioselectivity was obtained prior to any protection of 
the primary hydroxyl group. Reaction of epoxide (j) 
(scheme 36) with lithium dimethylcuprate was studied at 
-23°C, -40°C and -78°C to investigate the effect of 
temperature on regioselectivity and yield with a view to 
enhancing the desired attack at the C-2 position of the 
epoxide (). Reaction of the epoxide at -23°C with an 
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excess of lithium dimethylcuprate resulted in formation 
of the regio-isomeric ring-opened products (187) and 
() 
in the ratio 6:1 in 98% yield. Carrying out the 
reaction at -40°C resulted in a similar yield with the 
regioselectivity being improved to 7:1, and was 
considered to be the most advantageous combination of 
yield and regioselectivity. Predictably attempting the 
reaction at -78°C was found to result in an unacceptable 
yield (scheme 36). 
To complete the synthesis of the pentanal fragment, 
aldehyde (aQQ) (scheme 40), it was necessary to protect 
the secondary alcohol function of diol 
() 
before 
oxidation of the primary alcohol group. Two problems 
must be overcome in order to achieve completion of this 
fragment. Firstly, an efficient and orthogonal 
protecting group strategy must be developed to accomplish 
initial protection of both the primary and the secondary 
alcohol functions of diol (ui) and subsequent selective 
deprotection of the primary alcohol function. Secondly 
it was necessary to find an efficient means of separating 
the regioisomeric diols (ui) and ( ), or their 
regioisomeric derivatives at a later stage. 
Studies in the protecting group strategy by Jenkins 13 
centred on the two compounds illustrated in table 2. 
Deprotection of 
(, 
R1=MEM, R2=TBDMS) with titanium 
tetrachloride was not selective, and the product was 
identified as being the diol Deprotection of 
(192, R1=TBDMS, R2=MEM) in a selective manner with 
tetra-n-butylanunonium fluoride was achieved, but the 
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preparation of this protected diol was problematical 
requiring large excesses of methoxyethoxymethyl chloride 
and base, and prolonged reaction times. 
The first strategy studied in this investigation to 
develop an improved protection strategy is shown in 
scheme 38. 	Protection of the primary alcohol function 
of the regioisomeric diols (ui) and () with* 
nitrobenzoyl chloride gave the regioisomeric products 
(3) and (14.) (scheme 38). 	The desired regioisomer, 
(2R, 3S) -2,4-dimethyl-3-hydroxy-l-(4 '-nitrobenzoyloxy) - 
pentane (), was then purified conveniently by 
recrystallisation with ethyl acetate/hexane, with the 
undesired regioisoiner being removed in the filtrate. 
Protection of the secondary hydroxyl function of the 
regioisomerically pure () to give (2R,3S)-2,4-di-
methyl-3- (t-butyldimethylsiiyloxy) -1- (4 '-nitrobenzoyl- 
oxy)-pentane 	 however, 	was found to be 
problematical. It was found necessary to carry out the 
silylation at moderately increased temperature to 
overcome the steric hindrance of the 2-methyl and 
4-dimethyl groups. The necessary increase in temperature 
to 50°C to effect silylation was found to induce 
transesterification through a six membered transition 
state as illustrated in scheme 39, resulting in a product 
mixture 	containing 	(2R, 3S)-2,4-dimethyl-3-(t-butyl- 
dimethylsilyloxy) - 1-(4 '-nitrobenzoyloxy)-pentane (), 
diol 	(187) 	and 	(2R,3S)-1,3-bis(4 1 -nitrobenzoyloxy)- 
2,4-diinethylpentane (i) (scheme 39). The presence of 
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by the accurate mass (Found 431.1454, C21H2308N2 (MH+) 
requires 431.1454). However, flash. column purification 
separated the products of transesterification, and the 
desired protected diol (.]i) was isolated in 55% yield 
from 
The advantages of R nitrobenzoyl as a protecting 
group for the primary alcohol function were apparent when 
it was selectively deprotected in a convenient manner 
using aqueous sodium hydroxide in dioxane at 50°C to give 
the desired alcohol () in 84% yield from () (scheme 
38). However, this amounted to a disappointing overall 
yield from the diol (ui) of 38%, and was not considered 
to be a satisfactory synthetic procedure because of the 
occurrence of undesirable transesterification. 
In view of these result it was appreciated that the 
protection of 1,3 diols in particular requires a more 
astute synthetic strategy. Recent studies in the 
synthesis of lipoxins B 130 . illustrated the utility of 
the pivaloyl group as an efficient protecting group for 
the primary alcohol function. The application of this 
strategy in the present research is outlined in scheme 
40. In contrast to the strategy illustrated in scheme 
39, the separation of the regioisonieric diols (ji) and 
() must be carried out chromatographically prior to 
protection, as the pivalate ester product (198) is 
liquid. Regioisomerically pure diol (ui) was obtained 
by flash column chromatography with ether eluent, and 
esterification with pivaloyl chloride gave (2R,3S)-2,4-
dimethyl-3-hydroxy-1- (pivaloyloxy) -pentane () as clear 
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oil in high yield after purification by Kugelrohr 
distillation. Protection of the sterically hindered 
secondary hydroxyl group was achieved without undesired 
trans esterification. This was a result of the steric 
bulk of the pivaloyl group making trans esterification 
energetically disfavoured, although as a consequence of 
this necessary steric bulk, it was necessary to carry out 
the silylation of at. the.higher temperature of 60°C 
(scheme 40). 
Selective deprotection of the pivaloyl group of 
(2R, 3S) -2 ,4-dimethyl-3- (t-butyldiinethylsilyloxy) -1-
(pivaloyloxy)-pentane () (scheme 40) was carried out 
efficiently by reductive cleavage with DIBAL in dichioro-
methane to give the required protected alcohol (2R,3S)-
2, 4-dimethyl-3- (t-butyldimethylsilyloxy) -pentan-l-ol 
(j) (scheme 40), although it was recognised that this 
was a less convenient procedure than the previous 
deprotection of the R nitrobenzoyl group with aqueous 
sodium hydroxide in dioxane illustrated in scheme 39. 
However this represented a synthetically reliable and 
orthogonal protecting group strategy, and the required 
protected alcohol () was prepared in 48% overall yield 
from the diol (JL) by this route (scheme 40). 
In order to complete the synthesis of the pentanal 
fragment in enantiomerically pure form, it was necessary 
to accomplish the final oxidation step. The structural 
feature with the most important implications for this 
step is the chiral centre a to the carbonyl function in 
the required aldehyde (ZQQ) and it was considered 
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essential to accomplish this oxidation without any 
attendant epimerisation of this chiral centre. 
Initial attempts to oxidise the protected alcohol 
() with pyridinium chlorochroivate resulted in very low 
yield of aldehyde (2.00) (scheme 41). This was possibly 
due to over-drying of the PCC after recrystallisation. 
The improved procedure 132 for the rapid and efficient 
oxidation of alcohols using pyridinium dichromate and a 
catalytic amount of anhydrous acetic acid in the presence 
of activated molecular sieves was applied to protected 
alcohol (j) but was found to result in over oxidation 
to the acid (ZQ) (scheme 41). The Moffat oxidation and 
the Swern oxidation were both investigated, and were 
found to give aldehyde (ZQ.Q) in high yield, but as a 
result of purification by flash column chromatography, 
the presence of the undesired aldehyde (ZQ) epimeric at 
C-2 was observed. The method of choice was the modified 
Moffat oxidation using the water soluble carbodiimide, 
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydro-
chloride, excess pyridine, dimethyl suiphoxide and 0.5 
equivalent of trifluoroacetic acid. This method has the 
very significant advantage that the reagents used to 
carry out the oxidation are water soluble and are 
completely removed in the workup. Crude aldehyde (ZQQ) 
(scheme 40) can therefore be produced to a high level of 
purity without resorting to flash column chromatography 
and the associated problems of undesir-able 
epimerisation. 	Purified 	(2R, 3S) -2, 4-dirnethyl-3- 
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was obtained in 71% yield from the protected alcohol 
(.12), although the crude aldehyde was routinely used in 
the next stage. 
The protecting group studies are summarised in scheme 
42. The synthesis of (2R,3S)-2,4-dimethyl-l-(t-butyl- 
dimethylsilyloxy)-pentan-l-al (ZQ.Q) constitutes the 
synthesis of one of the stereoisomers of the pentanal 
fragment in its enantiomerically pure form. The 
synthesis of the enantioiner of aldehyde (ZQ.Q) is clearly 
achievable by the application of the Sharpless 
epoxidation of the trans allylic alcohol (j) with 
D-(-)diethyl tartrate, and the synthesis of the two 
remaining stereoisouiers is to be achieved by the 
Sharpless epoxidation of the cis allylic alcohol (203) 
with L-(+)-diethyl tartrate and with D-(-)-diethyl 
tartrate respectively. 
It is known, however, that the asymmetric epoxidation 
of cis allylic alcohols, particularly those with steric 
bulk at the C-4 position, proceeds with lower rates and 
enantioselectivities 131 . However, Ganem133 has applied 
the stoichiometric Sharpless epoxidation to cis allylic 
alcohol (0.3.) with modest yield and enantioselectivity in 
studies in the synthesis of virginialnycin. It was 
considered that in view of recent developments and 
refinements in the application of the Sharpless 
epoxidation, the enantioselectivity of the aymmetric 
epoxidation of cis allylic alcohol (ZQ) could be 
enhanced. 
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asymmetric epoxidation is the most flexible and overall 
the most highly stereocontrolled means of introducing 
chirality into the achiral precursors required for the 
construction of the pentanal fragment, (2R,3S)-2,4-di-




2.3 The Polyene Fraciment 
The synthesis of the polyene fragment derived from 
the disconnection outlined in scheme 27 and its 
attachment to the pentanal fragment was now to be 
investigated. The relevance of previous studies in the 
synthesis of polyene natural products discussed in the 
introduction, including amphotericin B (EQ), the 
aglycone of elaiophylin (1..3) and leukotriene methyl 
ester (.2.4.) was considered in the context of the 
structural and stereochemical features of the polyene 
chain of a-lipoinycin (n). These studies illustrated the 
importance of the electronic and steric factors of a 
target polyene and the influence these factors have on 
the design of a synthesis. 
In the case of the polyene chain of a-lipomycin (n), 
it became apparent that there were two levels of 
stereochemistry to control; the first level was to 
achieve control of the stereochemistry of the C12' and 
C13' chiral centres in the pentanal fragment, and to 
conserve their stereochemical integrity throughout the 
construction and coupling of the polyene fragment; the 
second level of stereocontrol concerned establishing the 
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highest possible degree of control over the geometrical 
isomerisation of the polyene fragment. In addition it 
was highly desir able to adopt a flexible approach 
compatible with these requirements, that would emcompass 
the synthesis of the polyene fragments of the related 
polyene tetramic acids fuligorubin A (n), altainycin A 
(38) and oleficin (40) and their intermediates to enable 
study of structure-activity relationships. 
Previous studies in the synthesis of the polyene 
fragment by Jenkins 13 were orientated towards the 
preparation of an intact C5' to ClOt synthon, 
functiona].ised differently at each end of the molecule to 
facilitate Wittig coupling reactions at appropriate 
stages in the assembly of the lipomycin side chain. The 
preparation and reactivity of phosphorane (204.) was the 
focus of synthetic effort in this highly convergent 
approach. However, in accordance with the synthetic 
approaches to the polyene fragment of amphotericin B 
(jQ) discussed previously, the preparation of this 
branched polyene phosphorane was found to be 
problematical due to the instability and hygroscopicity 
of its precursors. In addition, when phosphorane (04) 
was finally prepared in situ, its reaction with 
isobutyraldehyde (2) as a model of the pentanal 
fragment led to multiple product formation. The related 
phosphonate (ZQ) was also considered by Jenkins 13 , but 
in view of the studies in the synthesis of the aglycone 
of elaiophylin it was considered that resorting to 
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with the stereochemical priorities in this study, and in 
particular with conserving the stereochemical integrity 
of the exposed C12' asymmetric centre of the polyene 
chain of a-lipomycin. 
The more successful synthetic approach adopted in the 
present research was found to be highly suited to the 
priority of conserving stereochemical integrity. This 
involved coupling sub-units of the polyene fragment to 
the chiral pentanal fragment resulting in the polyene 
fragment being constructed already coupled to the chiral 
pentanal fragment. 
To this end, 1-methoxycarbonylethylidienetripheny].-
phosphorane (ZQ.) was prepared by treating methyl-2-
bromopropionate (ZQ) with triphenyiphosphine in toluene 
at 50°C to give the phosphonium salt (201), which was 
then treated with ice cold aqueous sodium hydroxide in a 
two phase water-dichioromethane system to liberate the 
phosphorane (ZQ.) (scheme 43). 
Wittig reaction of the stabilised phosphorane (ZQ) 
with the pentanal fragment, aldehyde (ZQ.Q), represented 
the first step in this approach (scheme 44). This 
reaction was attempted initially in refluxing 
dichloromethane (41°C) which was found to result in 
incomplete reaction and unsatisfactory yields, and it was 
considered that this was due to the steric bulk of the 
protected aldehyde (ZQ.Q). The reaction was carried out 
in refluxing 1,2-dichioroethane (83°C) and refluxing 
benzene (80°C) yielding methyl (2E,4R,5S)-5-(t-butyl-
dimethylsilyloxy) -2,4, 6-trimethylhept-2-enoate (2.0) in 
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61% and 81% respectively. Studies in the synthesis of 
the aglycone of oleandomycin by Hill 134 illustrated the 
influence of the solvent selected on possible 
isomerisation of the exposed chiral centre a to the 
carbonyl function of the aldehyde. However, in this case 
the implications of the two asymmetric centres 
constituent in the polyene chain of a-lipomycin () were 
that any epimerisation of the exposed chiral centre a to 
the carbonyl function would result in a diastereomeric 
mixture which would be observed in the proton n.m.r. The 
proton n.m.r. spectrum of the methyl ester (ZQ..) was the 
subject of extensive decoupling studies. Proton 
resonances of the methyl ester, the vinylic 2-CH3 and the 
3-H were assigned to 6 3.70, a 1.82 and 6 6.84 
respectively from known chemical shifts. Irradiation of 
the 3-H at 6 1.82 resulted in the collapse of the 
multiplet between a 2.61 - 6 2.64 identifying it as 4-H. 
Irradiation of the 4-H between a 2.61 - 2.64 led to 
assignment of the 4-CH3 and 5-H at 6 0.93 - 0.96 and 
a 3.35 - 3.37 respectively. Irradiation of the 5-H 
between o 3.35 - 3.37 led to assignment of the 6-H at 
& 1.68 - 1.81, and irradiation of the 6-H between a 1.68 
- 1.81 led to assignment of the 6-CH3 1 s at a 0.82 - 0.89. 
Having assigned the proton resonances of the methyl 
ester (ZQ.) unambiguously, the geometry of the ester was 
established as (2E) by nuclear Overhauser enhancement 
(n.O.e.) difference spectroscopy. Figure 4 spectrum (a) 
illustrates the normal 360 MHz proton n.m.r. spectrum of 








the n.0.e. difference spectrum on irradiating the 2-CH3 
at a 1.82 which gives rise to an impressive enhancement 
of 5.9% of the 4-H resonance at 6 2.61 - 2.74. This 
confirms that the 2-CH3 group and the 4-H are close in 
space, and therefore the geometry of the ester (209) was 
established firmly as trans. In the reverse direction, 
irradiation of the 4-H between 6 2.61 - 2.74 gave rise to 
enhancement of the 2-CH3,. 3-H, 4-CH3 and 5-H of 1.8%, 
1.0%, 1.0% and 3.0% respectively. As further 
confirmation of the trans geometry, irradiation of the 
methyl ester at 6 3.70 gave rise to an enhancement of 
1.0% of the 3-H. 
Condensation of the stabilised phosphorane (aQ..) with 
aldehyde (ZQQ) ref luxing 1,2-dichloroethane (83°C) for 3 
hours occurred in a highly stereocontrolled manner, with 
the stereochemical integrity of the exposed chiral centre 
centre o to the carbonyl in aldehyde (aQ.Q) being 
conserved as evidenced by the diagnostic 4-H and 5-H 
resonances. These reaction conditions also established 
a high degree of control over the geometrical isomerism 
of the methyl ester (ZQ.), with less than 5% of the 
undesired (2Z) isomer (Q) being isolated (scheme 44, 
scheme 45). 
In contrast to 1,2-dichloroethane, the phosphorane 
(ZQ..) was not readily soluble in benzene, and 
condensation with aldehyde (ZQ..Q) in refluxing benzene 
(80°C) was carried out over a longer period of 12 hours 
(scheme 44). No epimerisation of the exposed chiral 
centre was observed, although the control of the 
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geometrical isomerism of the methyl ester (209) was 
inferior with ca. 9% of the undesired (2Z) isomer (210) 
being isolated (scheme 44, scheme 45). Reaction in 
benzene was accompanied by a much enhanced chemical yield 
of 81% (scheme 44). This was believed to be due to 
benzene stabilising the intermediates of the Wittig 
condensation more effectively than 1,2 dichloroethane. 
Refluxing toluene (111°C) (scheme 44) was found to be an 
unsuitable solvent system for this Wittig condensation as 
t.l.c. studies illustrated the presence of complex 
product mixtures. 
The stereoselectivity of this Wittig condensation is 
believed to arise from the preferential decomposition of 
the threo betaine diastereomer (.12) rather than the 
alternative erythro betaine diastereotner (fl) (scheme 
45), as in the transition state of the threo isomer (212) 
there is less steric interference with the stabilising 
overlap between the r orbital of the carbonyl function 
and the ir orbital of the incipient double bond (scheme 
45) 
Reduction of the methyl ester (20.2.) to the alcohol 
(211) (scheme 46) was carried out with DIBAL in 
dichloromethane using sodium-potassium tartrate to remove 
the inorganic aluminium salts and exhaustive extraction 
to give (4R,5S)-5-(t-butyldimethylsilyloxy)-2,4,6-trj-
methyl hept-2-en-1-ol (jJ,) in 69% yield (scheme 46). 
Oxidation of allylic alcohol (jJ) was initially 
investigated with PCC 135 , but t.l.c. studies showed only 
traces of aldehyde product. Freshly prepared active 
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manganese dioxide 136 was known to be a mild, selective 
oxidant suitable for the oxidation of allylic alcohols. 
Stirring of the allylic alcohol (jJ) with 10 equivalents 
of freshly prepared active manganese dioxide for 130 
hours at room temperature gave the central intermediate 
(4R, 5S) -5- (t-butyldimethylsilyloxy) -2,4, 6-triiuethylhept-
2-en--l-al (22) (scheme 46) in reasonable yield of 60%. 
However, the use of the new catalytic oxidant 
tetra-N-propylammonium per-ruthenate (TPAP) and N-methyl 
morpholine N-oxide as co-oxidant was found to afford the 
aldehyde (12) (scheme 46) in improved yield of 70%137. 
Catalytic oxidants circumvent the problems of obnoxious 
side products and toxic residues commonly found with 
conventional oxidants. In a typical oxidation the 
alcohol (Z.11) was dissolved in dichloromethane containing 
both 4A° molecular sieves and N-methyl morpholine N-oxide 
(1.5 equivalent). After stirring the reaction mixture 
for 10 minutes, TPAP (0.005 equivalent) was added and the 
resulting green mixture was stirred for 6 hours under 
nitrogen at room temperature. Washing the organic layer 
with sodium sulphite solution, brine, and saturated 
copper (II) sulphate solution followed by isolation and 
purification gave the aldehyde (j) in 70% yield (scheme 
46). 
This aldehyde (21) was to be central to our futher 
studies in the construction of the polyene fragment. The 
electronic and structural features believed to be of 
greatest importance in the development of this synthesis 
were that the carbonyl function constituent in aldehyde 
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(212) is conjugated with the double bond, reducing its 
reactivity, and that the methyl group a to the carbonyl 
function causes steric hindrance reducing the reactivity 
of aldehyde (12.) further. The implications of these 
electronic and structural features were considered in the 
light of the previous studies by Seebach on the synthesis 
of the aglycone of elaiophylin105 and by McKillop on the 
synthesis of leukotriene A4 methyl ester (149)106. 
In view of the desire to adopt a flexible approach 
that would encompass the synthesis of the polyene 
fragments of the related polyene tetramic acids, the 
initial studies in the elongation of aldehyde (1.2) were 
focussed on condensation of this aldehyde with 
ethoxycarbonylmethylenetriphenyiphosphorane (J) (scheme 
46). Condensation of (4R, 5S)-5-(t-butyldimethylsilyl-
oxy) -2,4, 6-trimethylhept-2-en-l-al () with stabilised 
phosphorane (jJ) in refluxing benzene (80°C) for 72 
hours afforded a 4:1 mixture of (2E) and (2Z) isomers 
(Zll) and (j.j) in 66% combined yield. The mixture was 
then isomerised with a catalytic amount of iodine in 
dichloromethane to give a mixture of (2E) and (2Z) 
isomers (j) and (JA) in almost quantitative yield. 
The stereochemical integrity of the exposed C-6 
asymmetric centre was found to have been conserved, 
although the control of the geometrical isomerism was 
found to be less complete. 
The major isomer formed on condensation of aldehyde 
(j) with the alternative phosphonate type Wittig 
reagents was anticipated to be the cis isomer, and this 
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was not considered to be compatible with the 
stereochemical priorities of this synthesis. The major 
isomer formed on condensation of the aldehyde (j) with 
the stabilised phosphorane () was characteristically 
the thermodynamically more stable trans isomer and in 
this case isomerisation with iodine overcame the problem 
of the presence of both isomers in significant 
quantities. 	A pure sample of ethyl (2E,4E,6R,7S)-7- 
(t-butyldimethylsilyloxy) -4,6, 8-trimethyl 	non-2, 4-di- 
enoate (j) could be obtained by flash column 
chromatography, and its geometry was established by 
consideration of the coupling constants and by nuclear 
Overhauser enhancement (n.Oe.) studies. 
From consideration of the proton n.m.r. of ethyl 
(2E,4E,6R,7S)-7-(t-butyldimethylsilyloxy)-4,6,8-tri-
methyl non-2,4-dienoate (21..3), it was clear that H-3 must 
be the most deshielded resonance, and that H-2 was the 
other resonance in the olefin region with a coupling 
constant characteristic of a trans coupling. The H-3 and 
H-2 resonances exhibit mutual coupling of magnitude 
15.6 Hz establishing unambiguously the geometry of the 
diene ester () as (2E). 
In conjunction with this result, the geometry of the 
diene ester was established fully as (2E,4E) by nuclear 
Overhauser enhancement studies. Figure 5, spectrum (a), 
illustrated the normal 360 MHz proton n.m.r. spectrum of 
diene ester (ZU). Figure 5 spectrum (b) illustrates the 
n.O.e. difference spectrum of irradiating the 4-CH3 at 








16% of the 2-H resonance at 5.71 - 5.78, and also the 
significant enhancement of 9% of the 6-H resonance at 
6 2.62 - 2.77. This confirms that the 4-CH3 group is 
close in space to both the 2-H proton and the 6-H proton, 
and as the magnitude of the coupling constants has 
already established diene ester (213) as being (2E), this 
result confirms unambiguously that the geometry of diene 
ester (21.) is (2E,4E). 
Returning to aldehyde (21) (scheme 46), it was clear 
that the methodologies of Seebach 105 and McKillop106 
could result in convenient homologation of the aldehyde 
() to the required polyene fragment. Intense sthetic 
investigation of these two approaches was carried out. 
Methoxycarbonylal lyltriphenyiphosphonium bromide 
() and ethoxycarbonylal lyltriphenylphosphium bromide 
(j .) (scheme 47) were prepared from the respective 
bromides by the literature method 138 . However, the 
methoxy derivative (j) was found to be especially prone 
to hydrolysis and decomposition, and only ethoxy-
carbonylallyltriphenyiphosphonium bromide (j) was 
routinely converted to 3 -ethoxycarbonylallyl idenetri-
phenylphosphorane () (scheme 47). 
Treatment of a suspension of ethoxycarbonylallyl-
triphenylphosphonium bromide (j) and TMEDA in 
tetrahydrofuran with n-butyllithium at -78°C gave an 
orange suspension of 3-ethoxycarbonylallylidene-
triphenyiphosphorane (.j) (scheme 48). The mixture was 
stirred for 1 hour and then benzaldehyde (flQ) was added 
in tetrahydrofuran. The burgundy red reaction mixture 
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was allowed to warm to room temperature and was stirred 
for 18 hours overnight and ethyl 5-phenylpent-2,4-
dienoate 
() 
was isolated in 55% yield in the normal 
way as a mixture of geometrical isomers (scheme 48). 
Crotonaldehyde (2.2..) was considered to be a suitable 
and convenient model for aldehyde (2), and its 
reactivity with 3 -ethoxycarbonylallylidenetriphenyl-
phosphorane (m) was investigated as illustrated in 
scheme 49. 
Preparation of the phosphorane () from the 
phosphonium bromide salt (2) was carried out with 
n-butyllithium as before, and crotonaldehyde was added 
subsequently with the reaction mixture being stirred 
overnight at room temperature. Product was isolated as a 
clear oil in over 60% yield, and the diagnostically 
useful u.v. spectrum was taken immediately. The u.v. 
spectrum with Xmax 290 nm was consistent with the 
expected reaction product, ethyloct-2 , 4, 6-trienoate 
(21.2), and the predicted139 value for Xmax is summarised 
in table 3. 
caic. Table 3. 	>'inax of (221) 
Parent 3-monosubstituted a3unsaturated ester 	208 
Two double bonds extending conjugation 	2 x 30 
'y or higher substituent 	 18 
>calc 	286 nm 
+ 
Et0 2C..,,PPh 3 





















However, the proton n.m.r. spectrum was not 
consistent with the triene structure, and decoupling 
studies confirmed that the triene ester undergoes 
rearrangement over a period of a few hours at room 
temperature to the thermodynamically more stable 
conjugated 1-ethoxycarbonyl 6-methylcyclohex-1, 3-diene 
() (scheme 49). Observation of this rearrangement 
made consideration of the stability of the target polyene 
fragment very important. 
Studies in the synthesis of leukotriene A4 methyl 
ester (4) (scheme 24) by McKillop 106 illustrated that 
reagents which afford unsaturated carbonyl compounds as 
the aldehyde directly can lead to a significant 
improvement in overall yield. With this in mind the 
reactivity of triphenylphosphoranyl idenecrotonaldeihyde 
(ii) with crotonaldehyde () was investigated (scheme 
50). 
Reduction of methyl 4-bromocrotonate () with DIBAL 
in dichloroihane gave the allylic alcohol () in 77% 
yield, which was then routinely oxidised with manganese 
dioxide to give 4-bromo but-'2-en-1-al (ni) in 90% yield 
(scheme 50)100. Treatment of this bromide (227) with 
triphenyiphosphine in acetone gave yellow crystalline 
phosphonium bromide salt 
(). 
The phosphorane, 
triphenylphosphoranyl idencrotonaldehyde (j .) was 
liberated by treatment of the phosphonium bromide () 
with an ice/water solution of sodium hydroxide, and the 
phosphorane (4) was crystallised with acetone (scheme 
50)106. 
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Reaction of the phosphorane 	with crotonaldehyde 
(222) 	in refluxing dichioroinethane gave oct-2,4,6- 
triene-1-al () as the major product in 57% yield 
(scheme 50). However, the presence of extra olefin peaks 
in the proton n.iu.r. indicated the presence of the 
rearranged products (210) and (ZJ), and aromatic peaks 
between 6 7.50 - 8.00 and the presence of a singlet 
aldehyde peak indicated that undesired aromatization had 
also occurred giving (22) as a minor product (scheme 
50). 
Having investigated the reactivity of 3-ethoxy-
carbonylallylidenetriphenyiphophorane () in scheme 48 
and scheme 49 and triphenyiphosphoranylidene-
crotonaldehyde (4) in scheme 50, it was intended to 
apply these two Wittig reagents to the extension of the 
central aldehyde intermediate, aldehyde (ZU) as shown 
in scheme 51. 
Considerable synthetic effort was directed towards 
attempting to bring about the condensation of the 
stabilised Wittig reagent (m) with the aldehyde (212). 
The reaction was initially attempted by treating the 
phosphonium salt, ethoxycarbonylallyltriphenyl-
phosphonium bromide (.j) with DABCO in tetrahydrofuran 
and stirring the mixture at room temperature for one 
hour. Aldehyde (j) was then added and the reaction 
mixture was refluxed overnight, and care was taken to use 
an excess of the phosphonium salt (Z), and less than 
one equivalent of DABCO to avoid epimerisation of the 
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after refluxing overnight, t.1.c. studies showed no 
evidence of the desired triene ester products (3) and 
() (scheme 51), although a burgundy red gum was 
observed on the bottom of the reaction flask. 
Treatment of the phosphoniuin salt (.j) suspended in 
tetrahydrofuran with TMEDA and n-butyllithium at -78°C, 
follwed by addition of aldehyde (j) at room temperature 
and refluxing as before was found to give similar 
results. The observation of the bright red gum was 
rationalised as being the result of a Michael addition of 
the phosphoniuiu ylide (2) to the phosphonium salt 
(), followed by trans-ylidation of the intermediate 
product (23) (scheme 52). 
It was considered that the use of the isolated 
crystalline phosphorane (j) might improve the 
situation, and this was attempted in both dichioromethane 
at room temperature and in refluxing 1,2 dichloroethane 
overnight. Neither system resulted in the isolation of 
any of the desired triene ester products (m) and (.aA) 
(scheme 51). 
Seebach successfully applied a stabilised Wittig 
reagent of type (21) to the synthesis of the aglycone 
of elaiophylin () (scheme 23). However, in the case 
of the aglycone of elaiophylin, the relevant aldehyde 
(1.3.) is saturated, and therefore more reactive although 
the presence of the a methyl group causes some steric 
hindrance. The carbonyl function of the aldehyde (j . ) 
(scheme 51) under consideration in this synthesis is 
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and this is compounded by the steric hindrance of the 
a methyl group. It was considered that the combination 
of these electronic and steric factors was responsible 
for the failure of the reactions illustrated in scheme 
51. 
Studies continued with an investigation of the 
reactivity of triphenyiphosphoranyl idene-crotonaldehyde 
(4) with aldehyde () as shown in scheme 53. However 
the phosphorane (14) was found to be insufficiently 
reactive in refluxing dichloromethane, tetrahydrofuran or 
dichioroethane to condense with the unsaturated a methyl 
aldehyde (fl). It was appreciated that in the studies 
in the synthesis of leukotriene A4 methyl ester by 
McKillop106 , the carbonyl function constituent in the 
aldehyde (1.4) is saturated, and reaction proceeds to 
give the all trans isomer. In the case of the present 
study, it was anticipated that if reaction had occurred, 
it would be likely that the aldehyde (.240) (scheme 53) 
product would be isolated as a mixture of isomers. It 
was considered that a strategy involving isomerisation of 
an unsaturated aldehyde could result in undesired 
oxidation and would be synthetically unreliable. The 
reactivity of formylinethylenetriphenyiphosphorane (238) 
with aldehyde (j) was also investigated although t.l.c. 
studies showed the formation of complex mixtures. The 
phosphorane (2..3) was found to be prone to polymerisation 
and decomposition and its use was not pursued further 
(scheme 53). 
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the pentanal fragment was carried out in a stepwise 
fashion as illustrated in scheme 54. Reduction of the 
diene ester (213) with DIBAL in dichloromethane at -78°C 
for 3 hours gave (2E, 4E, 6R, 7S) -7- (t-butyldimethyl-
silyoxy) -4,6, 8-trimethy lnon-2,4-dien-1-ol (24) in 68% 
yield. 
Oxidation was carried out efficiently using 0.5mol% 
of tetrapropylammoniuin perruthenate (TPAP) and 1.5 
equivalents of N-methylmorpholine-N-oxide (NNO) to give 
(2E, 4E, 6R, 7S) -7- (t-butyldiinethylsilyloxy) -4,6, 8-tn- 
methylnon-2,4-dien-l-al (242) (scheme 54) in 69% yield. 
The aldehyde (242) was characterised only by its mass 
spectrum (H.R.M.S. Found 311.2406, j+ requires 311.2406) 
and in view of its anticipated instability, it was 
reacted 	immediately 	with 	ethoxycarbonylmethylene- 
tniphenyiphosphorane (l) in dichloromethane for 60 
hours at room temperature. This led to the isolation of 
the triene ester product in 62% yield as a mixture of the 
geometrical isomers (213) and (3) in the ratio of 8:1 
respectively, and no epimerisation of the exposed chiral 
centre was observed. 
It had become clear to us that as the polyene chain 
is extended, the ratio of the desired all trans isomer to 
the alternative geometrical isomers is increased. In 
view of this the cis isomers were extended at each stage 
of the synthesis along with the desired trans geometrical 
isomers. 
The proton n.m.r. spectrum of a purified sample of 
(233) was studied in detail. The H-3 resonance at 6 7.34 
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was clearly the most deshielded signal in the olefin 
region, and decoupling studies led to the assignment of 
H-5, H-4, H-2 and H-7 at o 6.58, ô 6.21, ô 5.84 and 
a 5.75. The geometry of the triene ester (rn) was 
established firmly as (2E,4E,6E) by the characteristic 
coupling constant of 15.3 Hz observed as follows; the H-3 
resonance is observed as a doublet of doublets with the 
trans alkene coupling J2,3 = 15.3 Hz and the vicinal 
coupling J43 = 11.0 Hz. The H-S resonance is observed 
as a doublet with fine splitting with the trans alkene 
coupling J45 = 15.3 Hz and the fine splitting J5,7 = 
0.6 Hz. The H-4 resonance is observed as a doublet of 
doublets with the trans alkene coupling 354 = 15.3 Hz 
and the vicinal coupling J34 = 11.1 Hz. Finally the H-2 
resonance is observed as a doublet with slightly reduced 
trans alkene coupling constant J32 = 14.9 Hz, which may 
be indicative of some twisting in the molecule. 
Having carefully interpreted the proton n.m.r. 
spectrum of ethyl (2E,4E, 6E,8R,9S)-9-(t-butyldimethyl- 
silyloxy)-6,8,lO-trimethylundec-2,4,6-trienoate 	(Zn), 
extensive nuclear Overhauser enhancement 	(nO.e.) 
studies were carried out and these are illustrated in 
Figure 6. 
The normal 360 MHz proton spectrum of triene ester 
(2 3 ) between & 1.5 and 6 7.5 is illustrated in spectrum 
(a), Figure 6. Having established the all trans geometry 
from the coupling constants, the n.O.e. studies were 
interpreted in consultation with Dr. I.H. Sadler and Dr. 
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enhancement of the 4-H and the 8-H resonances of 12% and 
5% respectively (spectrum b). Irradiation of the 7-H 
gave rise to enhancement of the 5-H and the 9-H 
resonances of 9% and- 1% respectively (spectrum c). 
Irradiation of the 5-H gave rise to enhancement of the 
3-H and the 7-H resonances of 8% and 5% respectively 
(spectrum d). Irradiation of the 4-H gave rise to 
enhancement of the 2-H and the 6-Me resonances of 8% and 
2% respectively (spectrum e). Irradiation of H-3 gave 
rise to enhancement of the 5-H resonance of 7% (spectrum 
f) and irradiation of the 2-H gave rise to an enhancement 
of the 4-H resonance of 5% (spectrum g, Figure 6). 
From a synthetic perspective, these results confirm 
that the triene ester (m) is in the extended 
conformation in solution, and therefore it is anticipated 
that when the ester function is transformed to the 
aldehyde, the carbonyl terminus will be accessible for 
coupling to the tetramic acid fragment. 
The ultraviolet spectrum (u.v.) of triene ester (233) 
showed Xmax 305 run and c 7885 dm3mol 1cm 1. The 
calculated Xmax is shown in table 4. 
caic. Table 4 	Xmax 	of (233) 
Parent 13-monosubstituted c3 unsaturated ester 	208 
Two double bonds extending conjugation 	2 x 30 
Two y or higher substituents 	 2 x 18 
calc 
Xmax 	 304 nm 
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The Xmax 305 nm observed was found to be in very close 
agreement with the predicted value. The absorption 
7885 din3mol 1cm 1 observed was more intriguing as 
typically a triene ester would have an absorption of 
greater than 10,000 units. It was considered that the 
lower value observed was the result of the polyene being 
twisted out of plane in solution. 
The final spectroscopic investigation of the triene 
ester (233) was carried out with the intention of 
assigning the carbon resonances in the 1 3C n.m.r. 
spectrum. This was carried out by using two dimensional 
13C 1 H chemical-shift-correlation spectroscopy with a 
pulse sequence that suppresses proton-proton coupling by 
semi-selective refocussing140 1 and where quaternary 
carbon atom resonances are not observed. The spectrum 
produced is illustrated in Figure 7, and the contours of 
the cross peaks identify the connections. From the 
previous assignment of the proton resonances, the carbon 
resonances can be completely assigned. In the spectrum 
illustrated in Figure 7, the olefinic carbon resonances 
are easily assigned unambiguously. The 8-C, 9-C and 
10-C and the ester CH2, 6-Me, Sit-Bu and SiMe carbon 
resonances were also unambiguously assigned. Assignment 
of the 10-Me's, 8-Me and ester Me resonances was less 
straightforward due to the similarity of their respective 
13C and 'H chemical shifts, and the presence of small 
amounts of ether and tetramethylsilane was also observed. 
The final synthetic study in this project is 
illustrated in scheme 55. Reduction of the triene ester 
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(m) with DIBAL in dichioromethane over the extended 
period of 6 hours gave the triene alcohol (24) in 65% 
yield, and catalytic oxidation with TPAP as before was 
used to afford the polyene aldehyde (24.0). Immediate 
reaction with phenacyltriphenyiphosphorane (244) in 
dichloromethane at room temperature over 5 days gave rise 
to a clear oil product which was assigned to a mixture of 
the aldehyde (jQ) and the required Wittig product (24) 
(scheme 55). However, subsequent spectroscopic data 
revealed only traces of the required Wittig product, and 
the presence of significant quantities of unreacted 
aldehyde, and clearly this synthetic procedure required 
to be investigated at greater length. 
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2.4 Summary and Future Work 
The synthesis of the tetramic acid fragment, 
(5S) -5-[2 '-(t-butyloxycarbonyl) ethyl]-1-methyl-3-[5"-
(3"-methylisoxazole)] tetramic acid (12.1) conserving the 
stereochemical integrity of the C-5 asymmetric centre, 
has been achieved by reaction of the oxazolidine-2,5-
dione () with the anion generated from methyl 
3-methyl-5-isoxazoleacetate (.j.Q) (scheme 32). 	The 
-methoxycarbonyl derivatives of glutamic acid were found 
to be convenient precursors of the oxazolidine-2,5-dione 
(12) as the by-products of the reaction were volatile 
and did not interfere with crystallisation of product. 
This 3-isoxazoyl tetrainic acid had been previously 
converted into the enoyl tetrainic acid (flj) (scheme 
33)13, and future studies are intended to establish the 
most advantageous synthetic routes to the two novel 
activated tetraiuic acids (175) and (176) (scheme 33). 
The catalytic version of the Sharpless asymmetric 
epoxidation was applied to the preparation of 	the 
pentanal fragment, (2R, 3S)-2, 4-dimethyl-3-(t-butyl-
dimethylsilyloxy)-pentan-l-al (aQQ) (scheme 36, scheme 
40). It was established experimentally that the 
catalytic version of the asymmetric epoxidation could 
afford the chiral epoxide () in high yield and 
enantioselectivity, and it was considered that this 
methodology would provide the most flexible and overall 
the most highly stereocontrolled route to the pentanal 
fragment and its stereoisomers. Future studies were to 
involve the preparation of each of the remaining three 
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stereoisomers of the pentanal fragment, aldehyde (ZQ.Q), 
in their enantiomerically pure form. 
The construction of the polyene fragment and its 
coupling to the pentanal fragment was achieved in a 
manner compatible with the priority of conserving the 
stereochemical integrity of the C12' C13' asymmetric 
centres constituent in the polyene chain of a-lipomycin 
(n). This involved coupling sub-units of the polyene 
fragment to the pentanal fragment in a stepwise Wittig 
olefination procedure, with an intermediate isomerisation 
(scheme 44, scheme 46, scheme 54), and interesting 
comparison was made with previous studies in the 
synthesis of polyene natural products 100 ' 104 ; 105 . 
It was anticipated that future studies would involve 
a major synthetic effort towards coupling the tetramic 
acid moiety to the polyene chain. The condensation of 
the activated tetramic acids (j) and (176) with the 
polyene aldehyde (jQ) (scheme 56) to provide the 
protected aglycone (4.) of a-lipomycin were considered 
to represent two promising synthetic strategies, and the 
significance of the achievement of this coupling 
conserving the stereochemical integrity of the three 
consitituent chiral centres should not be underestimated. 
The final synthetic hurdle to be overcome in future 
studies was to accomplish the attachment of the sugar 
moiety, D-digitoxose QjJ, to the polyene chain in a 
stereocontrolled manner, and relevant methodology for the 
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It was considered that the total synthesis of 
a-lipomycin and its stereoisoniers in their 
enantioinerically pure form would facilitate study of 
structure-activity relationships and would contribute to 
a rationalisation of the structure and function of the 
biologically active polyene tetramic acids. 
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3. Experimental 
All solvents were distilled before use. 	Unless 
otherwise stated, petrol refers to the fraction of 
petroleum ether boiling in the range 40-60°C. Benzene, 
toluene and diethylether (ether) were dried by storage 
over sodium wire. Dichioromethane, dimethylformamide 
(DMF) and acetonitrile were dried by distillation from 
calcium hydride. Tetrahydrofuran (THF) and dioxane were 
dried by distillation from potassium or sodium 
benzophenone ketyl immediately before use. Chloroform 
was dried by distillation from phosphorus pentoxide and 
methanol was dried by distillation from magnesium-iodine. 
Dimethyl sulphoxide (DMSO) was dried by distillation from 
lithium aluminium hydride at reduced pressure and was 
stored under nitrogen over 4A molecular sieves. 
Triethylamine, di-isopropylamine and tetramethyl-
ethylenediamine (TMEDA) were distilled from calcium 
hydride and stored under nitrogen over potassium 
hydroxide pellets. Dry carbon dioxide gas for 
carboxylation reactions was obtained by sublimation of 
commercially available dry ice followed by passage 
through concentrated sulphuric acid, then through a 
column of silica gel dissicant. Anhydrous solutions of 
t-butyl hydroperoxide were prepared as described by 
Sharpless. All reactions involving the use of strong 
bases were performed under an inert atmosphere of 
nitrogen, which was purified by passage through a column 
of silica gel (60H) impregnated with chromium III oxide. 
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Ethereal solutions of diazomethane were prepared from 
j-methyl-N-nitroso-p-toluenesulphonamide in an 'Aldrich' 
mini-diazald apparatus. 
Flash column chromatography refers to the technique 
described by Still, and thin layer chromatography 
(t.l.c.) was carried out on aluminium sheets precoated 
with silica gel 60GF-254 (Merck 5735) in the following 
systems: (A) 100% ether, (B) .50% ether-petrol, (C) 30% 
ether-petrol, (D) 20% ether-petrol, (E) 10% ether-petrol, 
(F) 5% ether-petrol, (G) 10% MeOH-CHC13, (H) 25% ethyl 
acetate-toluene. Visualisation of the compounds was 
achieved by a suitable combination of the following 
methods: iodine vapour, u.v. absorption at 254 nm, acid 
potassium permanganate solution, neutral potassium 
permanganate solution, phosphomolybdic acid solution and 
2,4-dinitrophenyihydrazine in 2% HC1-methanol solution. 
High performance liquid chromatography was carried out 
using a Waters system with two 6000A pumps, a U6K model 
injector, a 660 automatic gradient controller and a 
Waters u.v. detector (Model 441) operating at 254 or 
229 nm, and normal phase separations were attempted with 
a Waters Associates tporasil column. 
Infrared spectra were recorded on a Perkin Elmer 781 
spectrophotometer in the solvent indicated. Ultraviolet 
(u.v.) spectra were recorded in distilled, dried methanol 
on a Pye-Unicam SP8-400 spectrophotometer. Mass spectra 
and high resolution mass spectra (H.R.M.S.) were recorded 
on a Kratos MS50TC spectrometer. 1 H n.m.r. spectra were 
recorded on either Bruker WP80 (80 MHz), WP200 (200 MHz) 
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or WH360 (360 MHz) machines in the solvent indicated, 
using tetrainethylsilane (ThS) as the external standard 
(6=0.00). Carbon-13 n.m.r. spectra were recorded on 
either a Bruker WP200 machine operating at 50.3 MHz or a 
Bruker WH360 machine operating at 90 MHz. Samples were 
dissolved in the solvent indicated and chemical shifts 
were measured relative to TMS as the external standard 
(6=0.00). Elemental analyses were carried out on a 
Carlo Erba elemental analyser model 1106. 
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N-Methoxycarbonyl-L-Glutamic acid (&i) (MOC-Glu) 
L-Glutamic acid (147 g, 1 mol) was dissolved in a 
mixture of sodium bicarbonate (lM, 1L) and sodium 
hydroxide (4M, 800 ml) and the stirred solution was 
cooled in an ice/salt bath. Methyl chloroforivate (142 g, 
1.5mol) was added dropwise over 30 minutes and the 
reaction mixture was allowed to warm to room temperature 
and stirred overnight. The liquors were washed with 
ether (2 x 600m1), cooled in an ice-bath and acidified to 
pHi with conc. HC1. The aqueous solution was saturated 
with sodium chloride before it was extracted with ethyl 
acetate (3 x 800inl). The combined organic extracts were 
dried (MgSO4) before removing the solvent in vacuo to 
give the title compound as a golden syrup. 
Crystallisation was observed on standing in an 
ultrasonic bath under petrol to give the title compound 
(123 g, 0.60mol, 60%), vmax. (CH2C12) 3600-2500 (NH), 
1745 (C=O), 1510 (amide II of urethane), 1380, 1250, 
1050 cm-1; 6H  (200 MHz, CDC13 + 1 drop TFA) 1.85-2.60 
(4H, in, Glu 0- and oc-CH2 1 s), 3.75 (3H, s, urethane CH3), 
4.50 (lH, br in, Glu c-CH) , 6.70 (lH, br s, Glu NH) , 10.25 
(acid CO2H); m/Z (FAB) 132, 126, 114, 92, 74, 49; 
H.R.M.S. Found 206.0665, C7H1206N (MH) requires 
206. 0665. 
cy-Benzyl-N-methoxycarbonyl-glutamate, 	dicyclohexylamine 
salt (162) (MOC-Glu(OH-DCHA) -OBzl) 
Triethylamine (9.7 ml, 69.8nunol) and benzyl bromide 
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(9.1 ml, 76.8mmol) were added sequentially to a solution 
of MOC-Glu (14.3 g, 69.8mmol) in dry diinethylformamide 
(20 ml) at 0°C. The reaction mixture was allowed to warm 
to room temperature and stirred overnight. The reaction 
mixture was poured into iced water (600ml) and the oil 
was extracted with ethyl acetate (3x300m1). The combined 
organic extracts were washed with water (2x200ml), dried 
(MgSO4), and concentrated in vacuo to approximately 
200m1. Ether (lOOmi) was added and the solution was 
cooled to 0°C before dicyclohexylamine (14.6m1, 73.3xnmol) 
was added slowly over 30 minutes. Ether was added as 
necessary to keep the mixture mobile as the product 
precipitated. The reaction mixture was left standing in 
the refrigerator overnight. The solids were filtered 
off, washed well with ether, dried and recrystallised 
from ethanol/ether to give the title compound as white 
crystals (18.30g, 38.4mmol, 55%), m.p. 152°C; (Found: C, 
65.5; H, 8.5.; N, 5.9. 	C26H40N206 requires C, 65.5, H, 
8.5; N, 5.9%); [a]D25  -16.5° (C 1.04 in 	CHC13); umax 
(CH2C12) 2940 (CH), 1730 (C=O), 1630, 1510 cm' (amide II 
of urethane); oH (200MHz, CDC13) 1.08-2.00 (22H, iii, 
dicyclohexylamine CH2's), 2.18 (2H, 5, Glu 3-CH2), 2.86 
- (2H, br s, Glu -y-CH2), 3.52 (3H, s urethane CH3), 4.15 
(lH, br s, Glu a-CH), 5.06 (2H, s benzyl CH2), 7.22 (5H, 
br s, benzyl CH's), 7.40 (1H, br s, Glu NH), 9.20 (2H, br 
s, dicyclohexylamine NH2); 0C  (50.3MHz, CDC13) 24.41, 
24.71, 28.61 (dicyclohexylamine CH2's), 51.49 (urethane 
CH3), 52.02 (dicyclohexylamine CH's), 54.76 (Glu a-CH), 
66.19 (benzyl CH2), 127.58, 127.73, 128.06 (benzyl CH's), 
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135.41 (benzyl quat. C), 156.59, 172.16, 177.98 (MOC CO 
and Glu CO's); m/Z (FAB) 477, 461, 445, 387, 296, 272, 
242, 212, 182; H.R.M.S. Found 477.2964, C26H41N206 (NH) 
requires 477.2964. 
c-Benzy1-N-methoxYCarbOnV1g1Utamate (163) (MOC-Glu-OBz 1) 
A solution of citric acid (8.88 g, 42minol) in water 
(lOOmi) was added slowly to a stirred suspension of 
MOC-Glu (OH.DCHA)-OBzl (18.31 g, 38.4nunol) in ethyl 
acetate (300inl). The mixture was stirred vigorously for 
3 hours. The layers were separated and the aqueous layer 
extracted with ethyl acetate (60m1). The combined 
organic extracts were washed with water (200ml) and brine 
(200inl) before being dried (MgSO4). Removal of the 
solvent in vacuo gave a golden syrup which on tritutation 
with petrol in an ultrasonic bath gave crystals which 
were recrystallised from ethyl acetate/petrol to give the 
title compound as white crystals (7.83 g, 26.9mmol, 70%), 
m.p. 73°C; (Found: C, 56.7; H, 5.70; N, 4.79, C14H17N06 
requires C, 57.0 ; H, 5.8; N, 4.7%); (a]D25  -25.6° (C 
0.71 in MeOH); vmax. (CH2C12) 3440 (acid OH stretch), 
2960 (CH), 1750-1680 (C=O), 1510 (amide II of urethane), 
1200 cm'; oH (200MHz, CDC13) 1.91-2.18 (2H, in, Glu 
3-CH2), 2.35-2.43 (2H, d, Glu 7-CH2), 3.61 (3H, s, 
urethane CH3), 4.43 (lH, in, Glu a-CH), 5.13 (2H, s, 
benzyl CH2), [5.89, 5.94] (1H, split due to rotational 
isomerism, Glu NM), 7.30 (5H, 5, benzyl CH's), 10.40 (1H, 
acid CO2H) o (50.3 MHz, CDC13) 26.76, 29.58 (Glu 3- and 
y-CH3s), 52.13 (urethane CH3), 53.01 (Glu a-CH), 66.96 
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(benzyl CH2), 127.89, 128.11, 128.25 (benzyl CH's), 
134.83 (benzyl quat. C), 156.66, 171.73, 177.10 (MOC CO 
and Glu CO's); m/Z (FAB) 297, 296, 279, 250, 206, 181, 
160, 142; H.R.M.S. Found 296.1139, C14H18N106 (MH) 
requires 296.1134. 
a-BenzVl-y-t-butylN-lflethoxvcarbonvlcTlutamate (164) 
(MOC-Glu (0 t-Bu)-OBzl 
Isobutylene (approx. lOOml) was condensed into a 
nitrogen filled tube containing a solution of 
MOC-Glu-OBzl (10.47g, 35. 49inmol) in dichioromethane 
(lOOxnl) at -78°C. Concentrated sulphuric acid (lml) was 
added and the tube was sealed and allowed to warm to room 
temperature before standing for 10 days. The reaction 
vessel was cooled to -78°C and opened, and a solution of 
sodium carbonate (1M, 20ml) was added. The excess of 
isobutylene was allowed to evaporate overnight with the 
rest being removed in vacuo. The organic layer was 
separated and dried (MgSO4), and the solvent was removed 
in vacuo. The resultant oil was dissolved in ethyl 
acetate (lOOml), washed with water (50m1), and dried 
(MgSO4). Removal of the solvent in vacuo gave the 
required di-ester as a pale yellow oil which could not be 
crystallised (11.21g, 31.94inmol, 90%), (Found C, 61.9; H, 
7.3; N, 4.0%); [cr]D25  -26.7 0 (C 0.24 in MeOH), vmax. 
(CH2C12) 3350 (NH), 2980 (CH), 1760-1690 (C=O), 1530 
(amide II of urethane), 1150, 1050 cm-1; 5H  (200MHz, 
CDC13) 1.82 (9H, s, t-Bu), 2.25-2.60 (1H, m, Glu 3-CH2), 
2.60-2.95 (1H, in, Glu y-CH2), 4.02 (3H, s, urethane, 
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CH3), 4.75-4.92 (1H, in, Glu a-CH), 5.55 (2H, s, benzyl 
CH2), [6.32, 6.40] (1H, split due to rotational 
isomerism, Glu NH), 7.70 (5H, s, benzyl CH's); oc 
(50.3MHz, CDC13) 27.10, 31.12 (Glu 3- and 7-CH2 1 s), 27.73 
(t-Bu CH3's), 51.90 (urethane CH3), 53.28 (Glu a-CH), 
66.74 (benzyl CH2), 80.02 (t-Bu quat. C), 127.91, 128.07, 
128.28 (benzyl CH's) , 135.25 (benzyl quat. C), 156.50, 
171.62, 171.75 (MOC CO and Glu CO's).; m/Z (FAB) 352, 296, 
278, 261, 250, 206, 188, 181, 160; H.R.M.S. Found 
352.1760, C1020106 (MH+) requires 352.1760. 
-t-Butyl-N-methoxycarbonylglutamate (165) 
(MOC-Glu (0 t-Bu)-OH) 
Aqueous sodium hydroxide (1M, 27m1, 27inmol) was added 
dropwise during 15 minutes to a stirred solution of 
MOC-Glu (0 t-Bu)-OBzl (9.35g, 26.6mmol) in acetone 
(50m1). The reaction mixture was stirred for a further 
30 minutes before removal of the acetone in vacuo. The 
aqueous layers were washed with ether (2x20m1), cooled to 
0°C, and acidified to pH4 with 1M HC1. The aqueous 
solution was extracted with ethyl acetate (3x50m1) and 
the combined organic extracts were washed with water 
(2x50m1) and then brine (lx50ml) and dried (MgSO4). 
Removal of the solvent in high vacuo gave a pale yellow 
syrup which crystallised on trituration with petrol in an 
ultrasonic bath to give the title compound as white 
crystals (5.90g, 22.6mmol, 85%), (Found C, 50.4; H, 7.3; 
N, 5.5. C11H19N06 requires C, 50.6; H, 7.4; N, 5.4%) ; 
[a]D25 -5.0° (C 1.21 in MeOH); vmax. (CH2C12) 3300 (NH), 
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2980 (CH), 1760-1680 (C=O), 1530 (amide II of urethane), 
1250 cm-1 ; oH (200MHz, CDC13) 1.38 (9H, s, t-Bu) 
1.82-2.24 (lH, in, Glu (3-CH2), 2.27-2.40 (1H, in, Glu 
'y-CH2), 3.62 (3H, S, urethane CH3), 4.26-4.36 (1H, in, Glu 
cr-CH), (5.72, 6.43] 	(].H, split due to rotational 
isomerism, Glu NH), 9.95 (1H, br. s, acid OH), 
(50.3MHZ, CDC13) 27.06, (30.98, 31.36] (split due to 
rotational isomerism, Glu f3- and y-CH2's), 27.76 (t-Bu 
CH3's), 52.29 (urethane CH3), 52.86 (Glu a-CH), 80.92 
(t-Bu quat. C), 	(156.87, 157.35], 	(172.07, 172.43], 
(175.15, 175.47] (split due to rotational isomerism, MOC 
CO and Gly CO's); m/Z (FAB) 262, 246, 206, 188, 160; 
H.R.M.S. Found 262.1291, C11H20N06 	(NH4 ) 	requires 
262. 1291. 
-t-Butyl-N-methyl-N-methoxvcarbony1cilutamate (166) 
(Me, MOC-Glu (0 t-Bu)-OH 
Methyl iodide (7.78g, 54.9mmol) was added to a 
solution of MOC-Glu (0 t-Bu)-OH (1.79g, 6.86mmol) in 
anhydrous tetrahydrofuran (SOml). The solution was 
cooled to 0°C and a dispersion of sodium hydride (80% in 
mineral oil; 0.62g, 20.7minol) was then added portionwise. 
The reaction mixture was allowed to warm to room 
temperature and stirred for 5 days. Ethyl acetate 
(lOOmi) and water (ca. loinl) were added and most of the 
solvent was removed in vacuo. The residues were 
partitioned between water (70ml) and ether (40ml). The 
ethereal layer was extracted with 5% aqueous NaHCO3 
(40ml) and the combined aqueous extracts were acidified 
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to pH3 with 2M HC1. The oily product was extracted into 
ethyl acetate (4x501n1) and the combined extracts were 
washed with water (lx40ml); 5% aq. sodium thiosuiphate 
(2x60m1), water (50m1) and brine (50m1) and then dried 
(MgSO4). Removal of the solvent in vacuo gave a clear 
yellow oil which crystallised upon trituration with 
petrol in an ultrasonic bath. Recrystallisation from 
ether/petrol gave the title compound as white crystals 
(0.603g, 2.19inmol, 32%), m.p. 66°C; (Found C, 51.91; H, 
7.74; N, 5.12. C12H21N06 requires C, 52.36; H, 7.69; N, 
5.09%); [a]D25  -24.2° (C 0.98 in CHC13); vmaX. (CH2C12) 
2980 (CH), 1770-1660 (C=O), 1270 cm-1; 5H  (200MHz, CDC13) 
1.41 (9H, s, t-Bu), 1.92-2.05 (1H, m, Glu j3-CH2), 2.26 
(1H, m, Glu 7-CH2), [2.82, 2.85] (3H, split due to 
rotational isomerism, NMe), [3.67, 3.70] (split due to 
rotational isomerism, urethane CH3), 4.61-4.77 (1H, m, 
Glu a-CH), 9.82 (1H, br. s, acid CO2H); 8c (50.3MHz, 
CDC13) [23.64, 23.88], [31.44, 31.84] (split due to 
rotational isomerism, Glu 3- and y-CHf s), 27.86 (t-Bu 
CH3 1 5), 30.86 (Glu cx-CH), 53.01 (urethane CH3), [57.75, 
58.06] (split due to rotational isomerism, NMe), 80.70 
(t-Bu quat. C), [156.93, 157.62], [171.74, 171.88], 
175.61 (split due to rotational isomerism, MOC CO and Glu 
CO's); m/Z (FAB) 276, 262, 220, 206, 188, 174; H.R.M.S. 
Found 276.1447, C12H22N106 (MH+) requires 276.1447. 
(S) -4-r2 '-(t-Butyloxycarbonyl)ethyll-3-methyloxazolidine-
2,5-dione (167) 
A solution of Me, MOC-Glu (0 t-Bu)-OH (554mg, 
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2.Onunol) in thionyl chloride (2m1) was stirred at 0°C for 
10 minutes before a pressure of ç,. 20mmHg was applied to 
the reaction flask. The reaction mixture was then warmed 
to 60°C for 20 minutes, the pressure being maintained at 
20nunHg throughout to remove all volatile by-products and 
excess thionyl chloride. The reaction mixture was then 
allowed to cool to room temperature before being allowed 
to attain atmospheric pressure. The resultant brown oil 
was triturated with petrol in an ultrasonic"bath and the 
anyhydride crystallised. Recrystallisation from 
ether/petrol gave the title conmound as white crystals 
(235mg, 0.97mmol, 48%), m.p. 80°C; (a]D25  -45° (C 1.90 in 
CHC13); umax. 2980 (CH), 1850, 1785, 1725 (cyclic 
anhydride and amide C=O), 1155 (C-O), 975 cm -1 ; &H 
(200MHz, CDC13) 1.40 (9H, s, t-Bu), 2.03-2.42 (4H, in. Glu 
13- and 7-CH2's), 2.94 (3H, s, Me), 4.21 (1H, dd, JlOHz, 
5Hz, 4-H); 6c (50.3MHz, CDC13) 23.66, 29.05 (Glu 13- and 
yCH2s), 27.77 (t-Bu CH3's), 28.43 (C-4), 50.95 (NNe), 
81.26 (t-Bu quat. C), 151.66, 168.28, 170.85 (anhydride 
and ester CO's); m/Z (FAB) 240, 234, 218, 202, 188. 
Methyl 3-methyl-5-isoxazoleacetate (170) 
This was prepared as described by Micetich 118 , b.p. 
120°C lBmmHg (lit. 118 , 67°C 0.2mmHg); vmax. (CH2C12) 2960 
(CH), 1740 (CO), 1610 (aromatic), 1440, 1210, 1020 cm -1 ; 
6H (80MHz, CDC13) 2.25 (3H, s, 3-CH3), 3.70 (3H, s, 
CO2CH3), 3.78 (2H, s, 5-CH2), 6.10 (lH, 5, 4-H). 
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(5S)-5-[2'-(t-Butvloxycarbonvl)ethyll - 1-Tflethvl - 3 - f 5"-
(3"-methylisoxazole) itetrainic acid (171) 
A solution of di-isopropylamine (78mg, 0.78mmol) in 
tetrahydrofuran (distilled, dried) was cooled to -23°C 
and n-butyllithiuiu (0.49ml, 0.78nunol, 1.6M in hexanes) 
was added dropwise. The solution was stirred 
magnetically for 30 minutes before being cooled to -78°C. 
A solution of methyl 3-methyl-5-isoxazoleacetate (121mg, 
0.78inmol) in tetrahydrofuran (5m1) was then added 
dropwise followed by TMEDA (91mg, 0.78mmol). The 
solution was then stirred for a further 30 minutes before 
a solution of (4S) -4-[2 '-(t-butyloxycarbonyl)ethyl]-3-
methyloxazolidine-2,5-dione (85mg, 0.35ininol) in 
tetrahydrofuran (51n1) was added dropwise during 15 
minutes. The reaction mixture was stirred for a further 
4 hours at -78°C and then allowed to warm at room 
temperature during 2 hours. Removal of the solvent i n  
vacuo gave a pale yellow gum which was partitioned 
between ether (lOud) and water (lOmi). The aqueous layer 
was further extracted with ether (lOud) before being 
acidified to pHl (2M HC1). The tetramic acid 
crystallised from the solution as yellow needles and was 
collected by filtration (56mg, 0.17nunol, g. 48%), m.p. 
150°C; [a]D25 -37.0° (C 0.25 in MeOH); oH (200MHz, CDC13) 
1.40 (9H, s, t-Bu), 2.16 (4H, m, Glu 3- and -y-CH2's), 
2.24 (3H, s, isoxazole 3 11 -CH3), 2.96 (3H, s, NNe), 4.08 
(1H, in, 5-H), 6.69 (1H, s, isoxazole 4"-H); m/Z (FAB) 
323, 267, 249, 221, 194, 164, 138; H.R.M.S. Found 
323.1607, C16H23N205 (MH) requires 323.1607. 
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EthoxvcarbonvlmethvlenetriphenvlphOSphOniUlfl 	bromide 142 
(180) 
Triphenyiphosphine (141.8g, 0.541mo1) was dissolved 
in toluene (250ml, distilled, dried) and ethyl bromo-
acetate (60.Oml, 0.5411no1) was added slowly dropwise 
overnight. The product was collected by filtration as a 
white solid and was washed with toluene and dried in a 
vacuum oven to give the title compound as a white powder 
(225.3g, 0.525mol, 97%), m.p. 158°C, (Found C, 61.8; H, 
5.2. C22H22BrO2P requires C, 61.6; H, 5.2%); vmax. 
(CH2C12) 2980 (CH), 1730 (CO), 1440 vs (PPh), 1310, 1110 
cm-1 ; Xmax. (MeOH) 270nm (€ 4855 dm3mol 1cnr 1 ); oH 
(80MHz, CDC13) 0.56 (3H, t, J = 7Hz, ester CH3), 3.50 
(2H, q, J = 7Hz, ester CH2), 4.95 (2H, d, J = 14Hz, 
PCH2), 7.14-7.60 (15H, in, Ph's); in/Z (FAB) 249, 321, 275, 
183; H.R.M.S. Found 349.1358, C22H22P102 (M of positive 
ion) requires 349.1357. 
Ethoxycarbonylmethylenetriphenylphophorane 142 (181) 
Ethoxycarbonylmethylenetriphenyiphosphonium bromide 
(86.3g, 0.201mo1) was suspended between dichioromethane 
(350m1) and water (lOOxnl). Sodium hydroxide (8.9g in 
60m1 of water) was added dropwise until the aqueous layer 
remained pink to phenolphthalein. The organic layer was 
separated and the aqueous layer was extracted with 
dichloromethane (50m1). The combined organic extracts 
were washed with water (200ml) and dried (MgSO4). 
Removal of the solvent in vacuo and recrystallisation 
from ethyl acetate/petrol gave the title compound as a 
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white solid (56.3g, 0.162inol, 80%), m.p. 123-125°C 
(lit. 142 , 125°C); (Found C, 76.0; H, 6.0. C22H21P02 
requires C, 75.8; H, 6.1%); pinax. (CH2C12) 2980 (CH), 
1620 (CO), 1440 vs (PPh), 1310, 1100 1; 8H (80MHz, 
CDC13) 0.95 (3H, t, J = 7Hz, ester CH3), 2.84 (1H, br s, 
CH), 3.85 (2H, q, J = 7Hz, ester CH2), 7.39-7.69 (15H, in, 
Ph's); m/Z (FAB) 349, 321, 303, 279, 262, 201, 183; 
H.R.M.S. Found 349.1358, C22H22P102 (MH) requires 
349.1358. 
Ethyl (E) -4-methylpent-2-enoate 143 (183) 
Freshly distilled isobutyraldehyde (72.1g, 1.00mol) 
was added to a solution of ethoxycarbonylmethylenetri-
tphenylphosphorane (219.5g, 0.630mo1) in dichioromethane 
(400m1, dried, distilled). The reaction mixture was 
allowed to stir overnight and initial removal of 
triphenyiphosphine oxide was by trituration with 40 0 -60 0 
petrol and filtration. Further purification of product 
was by flash column chromatography with ether as eluent. 
Final purification of product by distillation gave the 
title compound as a clear liquid (68.9g, 0.484rno1, 77%), 
b.p. 58°C 18mrnHg; t.1.c. -A RF  0.59; pmax. (CH2C12) 2960 
(CH), 1710 (conj. C=0), 1650 (C=C), 1370, 1300, 1190 
Xmax. (MeOH) 222nm (€ 6310);  oH  (80MHz, CDC13) 1.07 
(6H, d, J = 7Hz, 4-Me's), 1.25 (3H, t, J = 7Hz, ester 
CH3), 2.40 (1H, in, 4-H), 4.17 (2H, q, J = 7Hz, ester 
5.74 (lH, dd, J = 16Hz, 1.5Hz, 2-H), 6.92 (lii, dd, 
J = 16Hz, 6Hz, 3-H); 0C  (50.3MHz, CDC13) 14.05 (ester 
59.93 (ester CH2), 118.43, 155.20 (C-2, C-3), 
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166.72 (CO), in/Z (FAB) 143, 140, 138; H.R.M.S. Found 
143.1072, C8H1502 (MJP) requires 143.1072. 
(E) -4-Methylpent-2-en-1-ol 143 (184) 
Neat DIBAL (35.51111, 0.199mo1) was added to a solution 
of ethyl (E)-4-methylpent-2-enoate (11.3g, 80nunol) in 
ether (300m1, dried), the temperature being maintained-at 
-78°C. The reaction mixture was stirred for a further 
two hours at -78°C and then the mixture was poured 
slowly into cold 6M aqueous HC1 (200iul)., brine (2xl5Oml) 
and dried (MgSO4). Removal of the solvent in vacuo gave 
a crude oil product. Final purification was by 
distillation giving the title compound as a colourless 
oil (7.10g, 71inmol, 89%); b.p. 70°C 18mmHg (lit. 143 , 64°C 
20IninHg); (Found C, 72.2; H, 12.4. C6H120 requires C, 
72.0; H, 12.1%); t.1.c. -A RF 0.42; vmax. (CH2C12) 3600 s 
(OH stretch), 3460 (OH), 2960 (CH), 1660 w (C=C), 1460, 
1380 (OH bend), 970 cm-1; 6H  (80MHz, CDC13) 0.89-0.97 
(6H, d, J = 7Hz, 4-CH3 1 s), 2.18 (lH, m, 4-H), 3.34 (1H, 
br s exc. D20, 1-OH) , 3.95 (2H, d, J = 7Hz, CH2), 5.52 
(2H, m, 2-H, 3-H); oc (50.3MHZ, CDC13) 21.82 (4CH3 1 s), 
30.28 (4-C), 62.77 (CH2), 125.68, 139.14 (2-C, 3-C); xn/Z 
(FAB) 100, 99, 95, 82, 69, 59, 55, 41; H.R.M.S. Found 
100.0848, C6H120 (M+)  requires 100.0888. 
(2S3S)-2,3-Epoxy-4-methylpentanol 144 (186) 
Method A 	Stoichiometric Sharpless Epoxidation 
To a flame dried nitrogen filled flask charged with 
dichioromethane (400m1, freshly distilled, dried) and 
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cooled to -23°C were added titanium tetraisopropoxide 
(14.50ml, 48.71mmol) and L-(+)-diethyltartrate (10.28g, 
49.86mmol) in dichloroinethane (lOml). The solution was 
stirred for 10 minutes then (E)-4-methylpent-2--enol 
(500g, 49.92inmol) in dichioromethane (lOxnl) and finally 
a solution of t-butyl hydroperoxide (freshly prepared, 
anhydrous, 3.70M in toluene, 27.00inl, 99.90mmol) were 
added to the reaction mixture at -23°C. The reaction 
mixture was stored at -20°C in the freezer for 38 hours 
and then dimethyl sulphide (14.66m1,. 199.62mmol) was 
injected by syringe into the reaction mixture at -23°C 
and the reaction mixture was stirred for 40 minutes. The 
cold reaction mixture was then added to a saturated 
aqueous solution of sodium fluoride (50g in 600ml) and 
the mixture was left stirring at room temperature for 23 
hours. The aqueous layer was saturated with sodium 
chloride and the mixture was filtered through celite. 
The aqueous layer was extracted with dichloromethane 
(2x400m1) and the combined organic layers were dried 
(Na2SO4). Removal of the solvent in vacuo gave crude 
product containing a mixture of the required epoxide, 
dimethyl sulphoxide and recovered tartrate ester. The 
epoxide product was removed from recovered tartrate ester 
by Kugelrohr distillation (95°C 18mntHg) giving the 
desired product contaminated with DMSO. Final 
purification was by flash column chromatography (ether 
eluent) giving the title compound as a colourless oil 
(3.1g, 26.46mmol, 53%) 
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Method B 	Catalytic Sharpless Epoxidation 
To a flame dried nitrogen filled flask charged with 
dichioromethane (400ml, freshly distilled, dried) and 
cooled to -23°C were added titanium tetraisopropoxide 
(1.20m1, 4.04inmol) and L-(+)-diethyl tartrate (l.Og, 
5.14inmol) in dichloroinethane (loml). Molecular sieves 
(0.80g, 4A activated powder) were added as received from 
Aldrich. The solution was stirred for 10 minutes then 
(E) -4-methylpent-2-enol (4.0g, 39. 94mmol) in dichloro-
methane (lOmi, distilled, dried) and finally a solution 
of t-butyl hydroperoxide (freshly prepared, anhydrous, 
3.19M in toluene, 18.80m1, 59.91mmol) were added to the 
reaction mixture at -23°C. The reaction mixture was 
stored at -20°C in the freezer for 40 hours and then 
dimethylsuiphide (11.84ml, 161.22mmol) was injected by 
syringe into the reaction mixture at -23°C and the 
reaction mixture was stirred for 40 minutes. The cold 
reaction mixture was then added to a saturated aqueous 
solution of sodium fluoride (54g in 600ml) and the 
mixture was left stirring for 23 hours at room 
temperature. The aqueous layer was saturated with sodium 
chloride and the mixture was filtered through celite. 
The aqueous layer was extracted with dichioromethane 
(2x400m1) and the combined organic layers were dried 
(Na2SO4). Removal of the solvent in vacuo gave 6.80g of 
crude product containing a mixture of the required 
epoxide, dixnethylsulphoxide and recovered tartrate ester. 
The epoxide product was removed from recovered tartrate 
ester by Kugelrohr distillation (95°C lBmmHg) giving the 
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desired product contaminated with DMSO. 	Final 
purification was by flash column chromatography (ether 
eluent) giving the title compound as a colourless oil 
(3.7g, 31.56mmol, 79%); b.p. 95°C 18mirtHg (lit. 144 , 
80-90°C 15mmHg); (Found C, 60.24; H, 10.30. C6H1202 
requires C, 62.04; H, 10.41%); Ea]D25 -34° (C 1.02 in 
CHC13); t.1.c. -A RF 0.32; vlUaX. (CH2C12) 3600 (OH 
stretch), 3460 (OH), 2960 (CH), 1460 (OH bend), 1070, 900 
(epoxide C-O stretch) cm-1; 8H  (200MHz, CDC13) 0.92 (3H, 
d, J = 7Hz, CH3), 0.97 (3H, d, J = 7Hz, CH3), 1.56 (1H, 
m, 4-H), 2.73 (1H, d of d, J = 7Hz, 2.5Hz, 3-H), 2.80 
(1H, br s exc. D20, 1-OH), 2.95 (1H, m, 2-H), 3.60-3.90 
(2H, ABX, J = 15Hz, 5Hz, CH2) ; o (50.3MHz, CDC13) 18.06, 
18.67 (4-CH3's), 29.77 (4-C), 57.45 (3-C), 61.08 (2-C), 
61.86 (CH2); m/Z (FAB) 117, 99, 93, 79, 73, 58, 42, 32; 
H.R.M.S. Found 117.0915, C6H1302 (MH) requires 117.0915. 
(2S, 3S) -2. 3-Epoxv-4-methylpentyl (-) camphanate 129 (190) 
(2S, 3S) -2, 3-Epoxy-4-methylpentanol (55mg, 0. 473nuuol) 
was treated with (-)camphanic acid chloride (0.113g, 
0.521mmol) dissolved in dichioromethane (lOml, distilled, 
dried) containing triethylamine (53mg, 0.521Tnmol) and 
N,N dimethylaminopyridine (2.9mg, 0.024inmol, 0.05 
equivalent). The reaction mixture was stirred under 
nitrogen for 48 hours and was then partitioned between 
dichloromethane and water. The organic layer was then 
washed with citric acid, saturated sodium bicarbonate, 
brine and dried (Na2SO4). Solvent was removed in vacuo 
affording the crude title compound as a clear oil (0.098g 
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. 0.331iniuol, 70%); vmax. (CH2C12) 2960 (CH), 1770 
(C=O), 1070, 950 (epoxide C-O stretch) cm-1; 6H  (200MHz, 
CDC13) 0.90-1.10 (15H, overlapping doublets, J = 7.5Hz, 
4-CH3s, 2'-CH3, 6 1 -CH3 1 s), 1.43-2.57 (5H, overlapping m, 
4-H, 3'-H's, 4'-H's), 2.62-2.67 (1H, dd, 3 = 6Hz, 3 = 
2Hz, 3-H), 2.97-3.05 (1H, ddd, 3 = 6Hz, 3 = 4Hz, 3 = 2Hz, 
2-H), 4.13 (1H, dd, 3 = 12Hz, 3 = 6Hz, 1-H), (1H, dd, J = 
12Hz, 3 = 4Hz, 1-H'); m/Z (FAB) 297, 279, 254, 227, 195, 
181, 167. 
Reaction of 	(2S,3S)-2. 3-eoxv-4-methy1pentano1 with 
lithium dimethyl cuprate; (2R, 3S)-2,4-dimethylpentane-
1,3-dio1 144 (187) 
To a suspension of copper(I) iodide (24.7g, 130xninol) 
in anhydrous ether at -40°C was added a solution of 
methyllithium (1.051s1 in ether, 250.Oml, 263.5mmol). The 
resultant solution was stirred for 30 minutes before the 
dropwise addition of (2S, 3S) -2, 3-epoxy-4-methylpentanol 
(2.00g, 17.22mmol) in anhydrous ether (20m1). The 
reaction mixture was then stored at -15°C for 15 hours 
before it was allowed to warm to room temperature during 
a further 2 hours. The reaction was quenched with 
methanol (lOOmi) and the mixture was added to saturated 
aqueous ammonium chloride (250m1). The layers were 
separated and the aqueous layer was extracted with ether 
(3x250m1). The combined organic extracts were washed 
with saturated aqueous sodium chloride (250m1) and dried 
(MgSO4). Removal of the solvent in vacuo gave the 
product as a mixture of regioisomers which were separated 
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by flash column chromatography (ether eluent). The first 
to be eluted was (2R. 3S)-2 , 4-diinethylpentane-1, 3-diol 
(ji) (1.98g, 14.98inmol, 87%); b.p. 130°C 18nunHg; (Found 
C, 63.8; H, 12.2. C7H1602 requires C, 63.6; H, 12.2%) ; 
E1D25 +37 0 (C 1.02 in MeOH); t.l.ô. -A RF 0.21; vmaX. 
(CH2C12) 3620 (OH stretch), 3580-3100 (OH), 2920 (CH), 
1390 (OH bend), 1070 (C-O stretch) cm -1 ; oH (200MHz, 
CDC13) 0.84, 0.88 (3H, d, J = 7Hz; 3H, d, J = 7Hz, 
4-CH3ts), 0.94 (3H, d, J = 7Hz, 2-CH3), 1.81 (2H, in, 2-H, 
4-H), 3.20 (2H, br S, OH's), 3.30 (1H, dd, J = 7.5Hz, J = 
7.5Hz, 3-H), 3.58-3.73 (2H, ABq, CH2); oc (50.3MHz, 
CDC13) 13.55, 14.79 (4-CH3 1 s), 19.55 (2-CH3), 28.89 
(4-C), 36.73 (2-C), 66.81 (CH2), 80.61 (3-C); m/Z (FAB) 
133, 119, 115, 106, 98, 93; H.R.M.S. Found 133.1229, 
C7H1702 (MH) requires 133.1229. 
The second product to be eluted was (2R,3R)-3,4-
dimethylentane-1,2-diol (0.23g, 1.72inmol, 10%); 0H 
(200MHz, CDC13) 0.73, 0.81 (3H, d, J = 7Hz; 3H, d, J = 
7Hz,, 4-CH3's), 0.92 (3H, d, J = 7Hz, 3-CH3), 1.50 (1H, in, 
4-H), 2.06 (1H, in, 3-H), 2.85 (2H, br 5, OH's), 3.53 (lii, 
in, 2-H), 3.57-3.80 (2H, ABq, CH2); 0C  (50.3MHz, CDC13) 
9.27, 15.93 (4-CH3 1 s), 20.87 (3-CH3), 26.69 (4-C), 40.81 
(3-C), 64.41 (CH2), 73.60 (2-C). 
(2R. 3S) -2, 4-Dimethyl-3-hydroxy-1- (4 '-nitrobenzoyloxy) - 
Pentane (193) 
(2R,3S)-2,4-diinethylpentane-1,3-dio1 	 (5.32g, 
40.24mrnol) was dissolved in dry pyridine (20m1). 
4-Nitrobenzoyl chloride (9.46g, 50.98inmol), dissolved in 
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dichioromethane (201u1, distilled, dried), was added to 
the cold (0°C) magnetically stirred solution under N2 
over a 30 minute period. The cooling was then removed 
and the mixture was stirred at room temperature for 14 
hours. Concentration followed by ázeotropic removal of 
pyridine (toluene) followed by flash column 
chromatography (10% MeOH:CHC13) gave title compound as a 
yellow crystalline solid (9.75g., 34.67mmol, 86%); 
in.p.69°C; (Found C, 59.5; H, 6.8; N, 5.0. C14H1905N 
requires C, 59.8; H, 6.8; N, 5.0%); vmax. (CH2C12) 3620 
(OH stretch), 3500 (OH), 2960 (CH) 1730 (C=O), 1610 
(aromatic ring), 1530 (conjugated NO2), 1350 (OH bend), 
1270, 1100 cm-1 ; Xmax. (MeOH) 260nm (e 4220); &H (200MHz, 
CDC13) 0.81, 0.90 (3H, d, 3 = 7Hz; 3H, d, 3 = 7Hz, 
4-CH3 1 s), 0.96 (3H, d, 3 = 7Hz, 2-CH3), 1.82 (1H, in, 
4-H), 2.05 (1H, m, 2-H), 2.40 (1H, br 5, OH), 3.22 (1H, 
dd, 3 = 7Hz, J 7Hz, 3-H), 4.30-4.50 (2H, ABq, CH2), 
8.12-8.16 (4H, In, aromatic CH's) ; 8c (50.3MHZ, CDC13) 
14.36, 15.11 (4-CH3's), 19.90 (2-CH3), 29.75 (4-C), 36.01 
(2-C), 68.11 (CH2), 77.52 (3-C), 123.39, 130.49 (aromatic 
CH's), 135.37 (aromatic 1 1 -C), 150.63 (aromatic 4 1 -C), 
164.28 (C=O); m/Z (FAB) 282, 264, 248, 237, 226, 217, 
181, 168, 150, 134, 104, 98; H.R.N.S. Found 282.1341, 
C14H2005N (NH) requires 282.1341. 
Attempted preparation of (2R, 3S) -2, 4-dimethyl-3-(t-butyl-
djmethylsilyloxv)-1-(4 '-nitrobenzoyloxy)-pentane (195) 
In a dried round bottomed flask with a magnetic 
stirrer and under nitrogen was added (2R,3S)-2,4- 
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dixnethyl-3-hydroxy-1-(4 '-nitrobenzoyloxy) -pentane (1.12g, 
3.98mmol), dry dimethylformamide (20m1, distilled, dried, 
stored over sieves), iiuidazole (1.35g, 19.90mmol, freshly 
recrystallised from 40 0 -60 0 petrol and t-butyldimethyl-
silyl chloride (1.50g, l . •Oinmol). Powdered preactivated 
molecular sieves were added as received from Aldrich. 
The reaction mixture was stirred at 50 ° C for 48 hours and 
was then added to a 1:1 mixture of ether:petrol (30ml) 
and brine (20m1). The layers were separated and the 
organic layer was washed with brine (lOmi) and dried 
(MgSO4). Purification was by flash column chromatography 
(10% MeOH:CHC13). The first product to be eluted was 
(2R. 35) -2 . 4-dimethyl-3-(t-butvldimethvlsilvloxv) -1- (4 '-
nitrobenzoyloxy)-pentane () (0.87g, 2.19mmol, 55.2%): 
vmax. (CH2C12) 2980 (CH), 1730 (C=O), 1610 (aromatic 
ring), 1530 (conj. NO2), 1270, 1100, 840 (Si-0) cm -1 ; 
Xmax. (MeOH) 260nm (c 6560) oH  (CDC13, 200MHZ) 0.07 (6H, 
s, Si-CH3) 0.88, 0.98 ((9H, s, t-Bu) overlapping (6H, d, 
J = 7Hz, 4-CH3's)), 1.02 (3H, d, J = 7Hz, 2-CH3), 1.85 
(1H, in, 4-H), 2.15 (1H, in, 2-H), 3.44 (lH, t, J = 6Hz, 
3-H), 4.10-4.38 (2H, ABX, CH2), 8.17-8.35 (4H, AA'BB', 
aromatic CH's) ; O (50.3MHz, CDC13) -4.09 (Si Me's), 
14.63, 19.63 (4-Me's), 16.49 (2-Me), 25.82 (Si t-Bu quat. 
C), 26.04 (Si t-Bu Me's), 29.59 (4-C), 34.67 (2-C), 66.93 
(CH2), 123.47, 130.58 (aromatic CH's), 135.37 (aromatic 
l'-C), 150.63 (aromatic 4 1 -C), 164.28 (C=O); m/Z (FAB) 
391, 327, 307, 289, 273, 264, 254, 242, 224, 154. 
The second product to be eluted was (2R,3S)-1,3 
bjs(4'nitrobenzoyloxy)-2,4-diinethvl pentane (j) (Ca. 
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0.18g); 6H  (CDC13, 200MHz) 0.07 (6H, S, Si-CH3's), 0.88 
(9H, s, t-Bu), 0.98 (6H, d, J = 7Hz, 4-CH3's), 1.15 (3H, 
d, J = 7Hz, 2-CH3), 2.15 (1H, m, 4-H), 2.45 (1H, in, 2-H), 
4.37 (2H, ABX, CH2), 5.17 (1H, dd, J = 7Hz, J = 7Hz, 
3-H), 8.20 (8H, two sets of overlapping AA'BB', aromatic 
CH's); ÔC (50.3MHz, CDC13) 14.63, 19.63 (4-Me's), 16.49 
(2-Me), 29.59 (4-C), 34.67 (2-C), 66.93 (CH2), 80.78 
(3-C), 123.47, 130.58 (aromatic CH's), 135.37 (aromatic 
1 1 ,1 11 -C's), 150.63 (aromatic 4 1 , 4 11 -C's), 164.28, 164.44 
(C=O's); m/Z (FAB) 431, 414, 399, 398, 392, 391, 327, 
308, 307, 289, 273, 264, 242, 224, 154, 136, 120, 107; 
H'.R.M.S. Found 431.1454, C21H2308N2 (MH) requires 
431,1454. Subsequent elution of (2R,3S)-2,4-dimethyl- 
3-hydroxy-1-(4 '-nitrobenzoy1oy) -pentane (193) and 
(2R, 3S)-2 4-dimethylpentane-1, 3-diol (187) was observed 
with each being identical to previously prepared samples 
by t.l.c. 
(2R, 3S) -2 4-dimethyl-3-hydroxy-1- (ivaloy1oxy) -entane 
(198) 
(2R,3S)-2,4-dimethylpentane-1,3-diol 	 (4.18g. 
31.62xnmol) was dissolved in pyridine (20m1, distilled, 
dried over KOH). Pivaloyl chloride (3.81g, 31.62inmol), 
dissolved in dichioromethane (20m1, freshly distilled, 
dried) was added to the cold (0°C) magnetically stirred 
solution under N2 over 30 minutes. The cooling was then 
removed and the mixture was stirred at room temperature 
for 22 hours. Concentration was followed by azeotropic 
removal of pyridine (toluene) and the residue was washed 
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with dilute citric acid. 	Initial purification was by 
flash column chromatography (1:1 ether:petrol) and final 
purification was by Kugelrohr distillation giving product 
as a clear oil (6.00g, 27.82mmol, 88%); b.p. 88°C 18mmHg; 
(Found C, 66.8; H, 11.3. C12H2403 requires C, 66.6, H, 
11.2%); [o]D26  -1.98° (C 1.16 in CHC13); t.l.c. -B RF 
0.22; vlflaX. (CH2C12) 3620 (OHstretch), 3500 (OH), 2970 
(CH), 1730 (C=O), 1480, 1365 (CH of C(CH3)3), 1270, 1170 
CM-1; 6H  (80MHz, CDC13) 0.75-0.90 (6H, overlapping pair 
of doublets, 4-CH3's), 0.91-0.95 (3H, d, J = 5Hz, 2-CH3), 
[1.13, 1.15] (9H, split by ', t-Bu), 
1.55-2.05 (lH, m, 4-H), 2.33 (1H, br s, OH), 3.02-3.17 
(1H, dd, J = 5Hz, J = 5Hz, 3-H) , 4.07-4.14 (2H, d, J = 
6Hz, CH2) ; o (50.3MHz, CDC13) 14.19, 15.23 (4-CH3 1 s) 
19.99 (2-CH3), 27.06 (t-Bu CH3's), 29.83 (4-C), 36.07 
(2-C), 38.75 (t-Bu quat. C), 66.67 (CH2), 77.81 (3-C), 
178.75 (CO); m/Z (FAB) 217, 199, 133, 115, 98, 86, 72, 
59, 43, 30; H.R.M.S. Found 217.1804, C12H2503 (MH) 
requires 217.1804. 
(2R. 3S) -2, 4-dimethyl-3- (t-butyldimethylsilyloxy) -1-
(IDivaloyloxy) -entane (199) 
In a dried round bottomed flask with a magnetic 
stirrer and under nitrogen 	(2R, 3S) -2, 4-dimethyl-3- 
hydroxy-1-(pivaloyloxy)pentane (8.00g, 37. 22mmol), 
dimethyl formamide (20m1, distilled, dried), imidazole 
(6.33g, 93.05nmiol, recrystallised from petrol) and 
recently purchased t-butyldiinethylsilylchloride (6.73g, 
44.66mmol). The reaction mixture was warmed to 60°C and 
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was then stirred at room temperature for one week. The 
reaction mixture was then added to a 1:1 mixture of 
ether:petrol (30ml) and brine (20ml). The layers were 
separated and the organic layer was washed with brine and 
dried (MgSO4). Solvent was removed in vacuo and initial 
purification was by flash column chromatography (1:1 
ether:petrol) and final purification was by Kugelrohr 
distillation giving the title compound as a clear oil 
(10.86g, 33.91inmol, 88%); b.p. 136°C 16nimHg; (Found C, 
65.7; H, 11.6. 	C18H3803Si requires C, 65.4; H, 11.6%); 
1a1D26 +17.4° (C 1.3 in CHC13); t.l.c. -B RF 0.50; 
(CH2C12) 2960 (CH), 1725 (C=O), 1470, 1270 (SiCH3), 1170 
(Si-O), 880 (SiCH3); oH (200MHz, CDC13) 0.03 (6H, S, Si 
CH3's) 0.86-0.88 (3H, d, J = 7Hz; 3H, d, J = 7Hz 
4-CH3 1 s), 0.89 (9H, s, Si t-Bu), 0.93 (3H, d, 3 = 7Hz, 
2-CH3), 1.19 (9H, S, pivalate CH3 1 s), 1.77 (lH, in, 4-H), 
1.95 (lH, in, 2-H), 3.37 (lH, dd, 3 = 7Hz, J = 6Hz, 3-H), 
3.80-4.26 (2H, ABX, CH2); 0C  (50.3MHz, CDC13) -4.04 
(Si-CH3s), 14.97, 17.41 (4-CH3's), 18.33 (Si t-Bu quat. 
C), 20.18 (2-CH3), 25.82 (Si t-Bu CH3's), 27.17 (pivalate 
CH3's), 31.45 (4-C), 36.72 (2-C), 38.73 (CH2), 78.88 
(3-C), 178.38 (C=O); m/Z (FAB) 331, 315, 287, 273, 227, 
201, 187, 159, 129, 115, 98, 86, 74; H.R.M.S. Found 
331.2668, C18H3903Si (MH) requires 331.2668. 
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Preparation of (2R, 3S) -2 .4-dimethvl-3-(t-butvldimethyl-
silyloxv)-pentan-1-ol (196) from (2R,3S)-2.4-dimethyl-
3-(t-butyldimethylsilyloxy) -1-(4 '-nitrobenzoyloxy)pentane 
(195) 
(2R, 3S) -2 ,4-dimethyl-3- (t-butyldiinethylsilyloxy) -1- 
(4 '-nitrobenzoyloxy)pentane (5.57g, 14. O8inmol) dissolved 
0 
in dioxane (20m1, distilled, dried) was treated with 
sodium hydroxide (0.56g, g. 14.1mmol) in water (20m1) at 
50°C for 36 hours with magnetic stirring and under 
nitrogen. Dioxane solvent was reduced in vacuo and the 
aqueous layer was extracted with dichloromethane 
(3x50m1). The combined organic extracts were dried 
(MgSO4), and the solvent was removed in vacuo. Initial 
purification was by flash column chromatography (1:1 
ether:petrol) and final purification by Kugelrohr 
distillation gave (2R, 3S)-2 ,4-dimethyl-3-(t-butyldi--
methylsilyloxy)-pentan-l-ol as a clear oil (2.93g, 
11.89mmol, 84%); b.p. 106°C 16mmHg; (Found C, 63.3; H, 
12.3. C13H3002Si requires C, 63.4; H, 12.3%) ; 1a1D 26 
+1.27 0 •(C 0.94 in CHC13); t.l.c. -B RF 0.41; vmax. 
(CH2C12) 3620 (OH stretch), 3520 (OH), 2960 (CH), 1470, 
1250 (Si CH3), 1130s (Si-O), 870 (Si CH3) cm -1 ; 5 H 
(200MHz, CDC13) [0.07-0.10] (6H, split due to de -e 
--c.4:, SiCH3ts), 0.88 (3H, d, 4-CH3), 0.90 (9H, s, 
Si t-Bu), 0.93 (3H, d, 4-CH3), 0.98 (3H, d, J = 6Hz, 
2-CH3), 1.81-1.84 (2H, overlapping multiplet, 4-H, 2-H), 
2.57 (1H, br S, OH), 3.42 (lH, t, J = 5Hz, 3-H), 
3.57-3.67 (2H, ABX, CH2); ô (CDC13, 50.3MHz) -4.10 
(SiCH3ts), 16.22 18.24 (4-CH3), 18.96 (2-CH3), 26.04 (Si 
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t-Bu CH3's), 32.99 (4-C), 37.52 (2-C); m/Z (FAB) 247, 
187, 133, 119, 115, 105, 96, 90, 84, 76, 71; H.R.M.S. 
Found 247.2093, C13H3102Si (MH) requires 247.2093. 
Preparation of (2R. 3S) -2.4-dimethy1-3-(t-butvldimethyl-
silyloxv)-pentan-1-ol (196) from (2R,3S)-2,4-dimethyl-3-
(t-butyldimethvlsilvloxv)-1-(PiValOVlOXV)Pefltafle (199) 
(2R,3S)-2,4-dimethyl-3-(t-butyldimethylsilyloxy)-1-
(pivaloyloxy)pentane (10.80g, 3.73minol) dissolved in 
dichloromethane (freshly distilled, dried) and cooled to 
-78°C was treated with DIBAL (16.17m1, 91.13mmol, neat, 
dissolved in dichloromethane). After 3 hours the 
reaction is quenched at -78°C with methanol (vigorous). 
The reaction mixture was transferred to a 21 separating 
funnel containing a saturated solution of sodium-
potassium tartrate, and subsequent extraction was with 
methylene chloride (3x300m1). The combined organic 
layers were dried (NgSO4) and initial purification was by 
flash column chromato graphy (1:1 ether:petrol) and final 
purification was by Kugelrohr distillation giving title 
compound as a clear oil • (5.70g, 23.37mmol, 71%); b.p. 
136°C 18inmHg; identical to sample prepared previously. 
(2R. 3S) -2. 4-Diinethvl-3- (t-butvldimethvlsilvloxv) -pentan-
1-al (200) 
(2R, 3S) -2, 4-dimethyl-3- (t-butyldimethylsilyloxy) - 
pentan-l-ol (0.230g, 0.933mmo1) in dimethyl suiphoxide 
(5m1, distilled, dried, stored over sieves) and toluene 
(5ml, distilled, dried) was stirred under N2 at room 
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temperature and was treated with 1-ethyl-3-(3-dimethyl-
aminopropyl) carbodiiniide 	hydrochloride 	(2.80g, 
0.537inmol), pyridine (3.80m1, 3.26minol) in toluene 
(2.5nil) and trifluoroacetic acid (0.03m1, 0.467inmol) in 
toluene (2.5m1). The reaction was stirred at room 
temperature for 24 hours and was then partitioned between 
ether and water, and then the organic layer was washed 
with citric acid, NaHCO3, brine and dried (Na2SO4). 
Care was taken to store the aldehyde under a nitrogen 
atmosphere and purification was by flash column 
chromatography (1:1 ether:petrol) giving the title 
compound as a clear oil (0.160g, 0.645inmol, 71%); (Found 
C, 63.8; H, 11.4. C13H2802Si requires C, 63.9; H, 
11.6%); [a]D26  +25.53° (C 1.085 in CHC13); t.l.c. -B RF 
0.76; viflaX. (CH2C12) 2960 (CH), 1720 (C=0), 1465, 1250 br 
(Si CH3), 1040, 840 (Si (CH3)2) cm'; 6H  (200MHz, CDC13) 
[0.024, 0.039] (6H, split due to c1 Si 
CH3's), 0.83-1.00 (15H, m, Si t-Bu CH3 1 s, 4-CH3's), 1.07 
(3H, d, J = 7Hz, 2-CH3), 1.83 (1H, in, 4-H), 2.52 (1H, rn, 
2-H), 3.65 (1H, overlapping dd, 3-H), 9.75 (1H, d, J = 
5Hz, 1-H) ; 6c (50.3MHz, CDC13) [-4.50, -4.31] (split due 
to rotational isomerism, SiCH3ts), 18.60 (4-CH3), 25.73 
(Si t-Bu CH3 1 s), 32.68 (4-C), 49.74 (2-C), 79.02 (3-C), 
204.50 (C=0); in/Z (FAB) 244, 106; H.R.M.S. Found 




Triphenyiphosphine (78.60g, 0.299mo1) was dissolved 
in toluene (200m1, distilled, dried) and methyl-2-bromo-
propionate (100.10g, 0.599mo1) was added dropwise. The 
reaction mixture was warmed to 50°C and was then allowed 
to cool to room temperature and was stirred for 18 hours. 
The resulting solid was collected by filtration, washed 
with ether (3xlOOml) and dried in vacuo to give the title 
compound as a white powder (114.43g, 0.267mo1, 98%); m.p. 
165°C (lit. 145 , m.p. 178-180 0 C); vmaX. (CH2C12) 2960 
(CH), 1740 (C=O), 1590 (aromatic), 1440 vs (PPh), 1110 
CM-1; 6H  (CDC13, 80MHz), 1.58 (3H, dd, 3HP = 18Hz, JHH = 
8 Hz, 1-CH3), 3.42 (3H, s, ester eli3), 6.75 (1H, m, 1-H), 
7.50-8.10 (15H, in, aromatic CH's); m/Z (FAB) 349, 289, 
262, 201, 183, 165, 133; H.R.M.S. Found 349.1357, 
C22H22P102 (N4 of positive ion) requires 349.1357. 
1-Methoxycarbonylethylidenetriphenylphosphorane 145 (208) 
To a stirred solution of 1-methoxycarbonylethyl-
triphenylphosphonium bromide (20.36g, 47.5minol) dissolved 
in dichloromethane (lOOml) at 0°C was added 1M sodium 
hydroxide solution with vigorous stirring until the 
phenolthalein indicator remained pink. The layers were 
immediately separated, the aqueous layer being extracted 
with dichloromethane (2x70m1), and the combined organic 
layers being dried (MgSO4). Removal of solvent in vacuo 
gave a green solid which was recrystallised from 1:1 
ethyl acetate:petrol to give title compound as a green 
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solid (14.37g, 41.31nimol, 87%); m.p. 145°C (lit. 145 , m.p. 
152-153°C); (Found C, 76.0; H, 6.0. C22H2102P requires 
C, 75.8; H, 6.1%); vntax. (CH2C12) 3040 (CH), 1620 s 
(C=O), 1430 s (PPh), 1320, 1110 cm -1 ; 6H (80MHz, CDC13) 
1.60 (3H, d, J = 16HZ, CH3CP), 3.33 (3H, s, ester CH3), 
7.18-9.05 (15H, m, aromatic CH's); in/Z (FAB) 349, 333, 
317, 291, 279, 262, 201, 183, 165, 133; H.R.M.S. Found 
349.1357, C22H22P102 (NH) requires 349.1357. 
Methyl (2E. 4R, 5S)-5-(t-butyldimethylsilyloxy)-2 .4,6-
triinethylhept-2 -enoate (209) 
(2R, 3S) -2, 4-dimethyl-3- (t-butyldimethylsilyloxy) - 
pentan-1-al 	(0.77g, 	3.15inmol) 	was 	treated 	with 
1-methoxycarbonylethylidenetriphenyiphosphorane (1.65g, 
4.72mmol) in benzene (20inl, distilled, dried) and the 
resulting orange solution was gently refluxed (80°C) for 
3 days under an atmosphere of nitrogen. Solvent was 
reduced in vacuo to half its original volume and diluted 
with petrol (loinl). The precipitate was filtered off, 
washed with petrol (3 Cml) and the combined filtrates were 
evaporated in vacuo to give a yellow oil. Purification 
was by flash column chromatography (10% ether:petrol) 
giving the title compound as a colourless liquid (0.80g, 
2.55imuol, 80%); (Found C, 64.9; H, 11.0. C17H3403Si 
requires C, 64.9; H, 10.9%); [a]D26  +7.4° (C 1.44 in 
CHC13); t.1-c-  -D RF 0.43; pmax. (CH2C12) 2960 (CH), 1710 
(C=O), 1460, 1240 (S1CH3), 840 (Si (CH 3)2) dm - 1 ; xmax. 
224nm (MeOH), ( e 6396 dm3mol 1cm 1 ); oH  (200MHz, CDC13) 
[0.01, 0.03] (6H, split due to 	 7, Si 
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CH3's), 0.82-0.89 (6H, overlapping pair of doublets, 
6-CH3 1 s), [0.89, 0.91) (9H, split due to rotational 
isomerism, Si t-Bu CH3's), 0.93-0.96 (3H, d, J = 7Hz, 
4-CH3), 1.68-1.81 (1H, m, 6-H), 1.82 (3H, S, 2-CH3), 
2.61-2.74 (1H, m, 4-H), 3.35-3.37 (iH, overlapping dd, J 
= 6Hz, J = 6Hz, 5-H), 3.70 (3H, s, ester CH3), 6.84 (lH, 
d, S = 10Hz, 3-H); 6C  (CDC13, 50.3MHZ) -3.94 (SiMe), 
12.29, 17.79 18.22, 19.34 (6-Me's, 4-Me, 2-Me), 25.94 (Si 
t-Bu Me's), 32.48 (6-C), 36.67 (4-C), 51.38 (ester Me), 
80.45 (5-C), 125.81 (2-C), 145.66 (3-C), 168.62 (C=0); 
in/Z (FAB) 314, 313, 299, 279, 271, 263, 257, 243, 225, 
213, 203, 187, 183, 173, 161, 147, 139, 133; H.R.M.S. 
Found 314.2271, C17H3403Si (M) requires 314.2271. 
(2E. 4R. 5S) -5- (t-butyldimethylsilyloxy) -2 • 4,6- 
trimethyl hept-2-en-1-ol (211) 
To a magnetically stirred solution of methyl 
(2E, 4R, 5S) -5-(t-butylsilyloxy) -2,4, 6-trimethylhept-2-
enoate (1.39g, 4.41miuol) dissolved in dichioroinethane 
(40m1, distilled, dried) in a 100ml dried, round bottomed 
flask, under nitrogen and cooled to -78°C was added 
DIBAL (neat, 1.97m1, 11.04mmol dissolved in lOmi 
dichloromethane). 	After 75 minutes, the reactionwas 
quenched with methanol (0.5m1) 	and the mixture 
transferred to a 21 separating funnel containing a 
saturated solution of sodium potassium tartrate (150ml) 
and dichioromethane (250m1). Vigorous shaking gave 
clouds of precipitate in the aqueous layer. The organic 
layer was separated and the aqueous layer was 
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exhaustively extracted with dichloromethane (4x300m1). 
The combined organic extracts were dried (MgSO4) and 
solvent was removed in vacuo. Purification was by flash 
column chromatography (1:1 ether:petrol) which gave the 
title compound as a clear liquid (0.86g, 3.04xnmol, 69%); 
(Found C, 67.1; H, 12.1. C16H3402Si requires C, 67.1; H, 
12.0%); [a]D26 +4.57 (C 0.52 in CHC13); t.l.c. -B •RF 
0.38; vlflax. (CH2C12) 3600 (OH), 2960 (CH), 1670 (C=C), 
1460, 1380, 1250 (SiCH3), 1050, 840 (Si(CH3)2) cm -1 ; ÔH 
(200MHz, CDC13) 1-0.01, 0.011 (6H, split due to 
rotational isomerism, SiCH3 1 s), 0.77-0.87 (6H, 
overlapping pair of doublets, 6-CH3's); [0.90, 0.93] (9H, 
split due to Si t-Bu CH3ts), 0.94 
(3H, overlapping doublet, 4-CH3), 1.60 (3H, s, 2-CH3), 
1.65-1.80 (1H, m, 6-H), 2.45-2.68 (1H, m, 4-H), 3.28 (1H, 
overlapping dd, J = 6Hz, 3 = 6Hz, 5-H), 5.45 (1H, d, 3 = 
10Hz, 3-H) ; 6c (CDC13, 90.6MHz) -3.95 (Si Me), 13.57, 
18.14, 18.54, 19.77 (6-Me's, 4-Me, 2-Me), 26.00 
(Si t-Bu Me's), 32.22 (6-C), 35.77 (4-C) , 68.99 (CH2) 
80.86 (5-C), 129.51 (3-C), 133.04 (2-C); m/Z (FAB) 281, 
267, 261, 251, 225, 221, 207, 201; m/Z (C.I., ammonia) 
303, 285, 269, 261, 243, 233, 221, 207, 187, 165, 137, 
115, 82, 73, 67, 55, 41, 27; H.R.M.S. (C.I., ammonia) 
286.2254, C16H3402Si requires 286.2328. 
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(2Ey 4R, 5S) -5- (t-butyldiinethylsilvloxv) -2 .4, 6-trimethyl 
hept-2-en-1-al (212) 
Method A 
(4R, 5S) -5- (t-butyldimethylsilyloxy) -2,4, 6-trimethyl 
hept-2-en-1-ol (0.63g, 2.20mmol) was dissolved in petrol 
(30m1, distilled, dried). The mixture was treated at 
room temperature under nitrogen with freshly prepared 
activated Mn02 (1.35g, 15.5mmo1). The reaction mixture 
was stirred at room temperature for 130 hours and was 
then diluted with ether (80inl) and was filtered through a 
short column of silica. Removal of solvent in vacuo gave 
a light green oil which was purified by flash column 
chromatography (10% ether:petrol) giving the title 
compound as a clear oil (0.37g, 1.32mmol, 60%). 
Method B 
(4R, 5S) -5- (t-butyldimethylsilyloxy) -2,4, 6-trimethyl 
hept-2-en-1-ol (0.21g, 0.734mmol) was dissolved in 
dichloromethane (20inl, distilled, dried) containing 4A 
molecular sieves (preactivated used as received from 
Aldrich) 	and N-methylmorpholine, 	N-oxide 	(0.129g, 
1. 101inmol). solid tetrapropylammonium perruthenate 137 
(1.25mg, 3.67xlo 3inmol, 0.5mol%) was then added and the 
resulting green mixture was stirred for 6 hours at room 
temperature under nitrogen. The mixture was diluted with 
dichloroiuethane, washed with aqueous sodium sulphite, 
brine and aqueous copper (II) sulphate. The 
dichioromethane solution was then dried (MgSO4) and crude 
reaction product was isolated as a light green oil. 
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Purification was by flash column chromatography (10% 
ether:petrol) giving the title compound as a clear oil 
(0.15g, 0.514mmol, 70%); (Found C, 67.30; H, 11.37; N, 
0.72. C16H3202Si requires C, 67.54; H, 11.34; N, 0.00%) ; 
t.l.c. -E RF 0.32; vinax. (CH2C12) 2960 (CH), 1680 (3 
unsat. C=0), 1460, 1050 cm-1 ; Xmax. 232nm, (€ 9940 
dm3mol 1cnr1 ); oH (80MHz, CDC13) [-0.02, 0.05] (6H, split 
due to coJcCLt - , S1CH3's), 0.75-0.95 (15H, 
overlapping in, 6-CH3's, Si t-Bu CH3's), 0.95-1.07 (3H, d, 
J = 8Hz, 4-CH3), 1.12-1.35 (1H, In, 6-H), 1.72 (3H, d, J = 
1Hz, 2-CH2), 2.67-3.00 (lH, in, 4-H), 3.35-3.50 (1H, dd, J 
= 6Hz, J = 6Hz, 5-H), 6.55-6.73 (1H, dd, J = 10Hz, J = 
1Hz, 3-H), 9.37 (1H, S, 1-H); °c (CDC13, 90.6MHZ) -3.90 
(Si Me's), 9.14, 18.13, 18.40, 18.75 (6 Me's, 4-Me, 
2-Me), 25.95 (Si t-Bu Me's and quat. C), 33.25 (6-C), 
36.42 (4-C), 80.46 (5-C), 130.00 (2-C), 158.00 (3-C), 
194.80 (1-C); iu/Z (FAB) 284, 268, 242, 228, 222, 214, 
208, 200; H.R.M.S. Found 284.2171, C16H3202Si (M) 
requires 284.2171. 
Ethvl(2E,4E,6R.7S)-7-(t-butyldimethylsilyloxy)-4,6,8-
trimethylnorj-2 , 4-dienoate (213) 
(4R, 5S) -5- (t-butyldimethylsilyloxy) -2,4, 6-trimethyl-
hept-2-en-1-al (0.570g, 2.01mmol) was treated with 
ethoxycarbonylmethylenetriphenyiphosphorane (1.93g, 
5.02nunol) in benzene (25m1, distilled, dried) and the 
solution was gently refluxed (80 •C) for 60 hours. 
Solvent was removed in vacuo and the residue was purified 
by flash column chromatography (10% ether:petrol) to give 
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the title compound as a 4:1 mixture of 2E and 2Z isomers 
(0.47g, 1.33mmol, 66%). The isomeric mixture was 
dissolved in a solution of iodine (5mg) in dichioro-
methane (20m1) and the resulting mixture was stirred at 
room temperature for 12h in sunlight. The solution was 
then washed with saturated aqueous Na2S203 (51n1) and then 
extracted with ethylacetate (3x4ml). The extracts were 
washed with saturated aqueous sodium chloride, dried 
(MgSO4) and evaporated to give the title compound as a 
8:1 mixture of 2E and 2Z isomers (0.47g, almost 
quantitative) as a light yellow liquid. This liquid was 
used for the next reaction without purification, although 
a pure sample of ethyl (2E.4E,6R,7S)-7-(t-butvldiinethyl-
silyloxy) -4,6, 8-trimethylnon-2 ,4-dienoate could be 
obtained by flash column chromatography (5% ether:petrol) 
of the isomerised product; (Found C, 67.8; H, 10.6. 
C20H3803Si requires C, 67.7; H, 10.8%); [a]D25  +1.29° (C 
1.01 in CHC13); t.l.c. -F RF 0.38; pmax. (CH2C12) 2960 
(CH), 1710s (C=O), 1620 (C=C), 1460, 1180, 840 cm -1 . 
Xmax. 268nm, (E 14160 dm3mol 1cm 1 ) ; o (360MHz, CHC13) 
(0.00, 0.02], (6H, split due to 
Si CH3ts), 	0.77-0.90 	(15H, 	overlapping m, 	8-CH3's, 
Si t-Bu CH3's), 0.94-0.98 (3H, d, J = 5Hz, 6-CH3), 
1.22-1.35 (3H, t, J = 7Hz, ester CH3), 1.62-1.73 (1H, m, 
8-H), 1.75 (3H, s, 4-CH3), 2.62-2.77 (1H, m, 6-H), 3.37 
(1H, overlapping dd, 3 = 5Hz, 3 = 5Hz, 7-H), 4.12-4.30 
(2H, q, 3 = 7.5Hz, ester CH2), 5.71-5.78 (1H, d, 3 = 
15Hz, 2-H), 6.02 (1H, d, 3 = 10Hz, 5-H), 7.26-7.34 (1H, 
d, 3 = 15.7Hz, 3-H); 5c (CDC13, 50.3MHz) -3.90 (SiMe's), 
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12.92 (4-Me), 13.50, 13.94, 18.26, 19.17 (8-Me's, 6-Me, 
ester me), 25.98 (Si t-Bu Me's and quat. C), 32.82 (8-C), 
36.46 (6-C), 60.07 (ester CH2), 80.66 (7-C), 131.00 
(4-C), 115.28 (2-C), 145.50 (5-C), 150.09 (3-C), 195.50 
(1-C); m/Z (FAB) 355, 339, 331, 323 1 311, 297, 279, 187; 
H.R.M.S. Found 355.2668, C20H3903Si (MH) requires 
355.2668. 
Methoxycarbonvlallvltriphenvlphosphoniuin bromide 138 (216) 
Triphenylphosphine (39.09g, 0.149mo1) was dissolved 
in toluene (300m1, distilled, dried) and methyl 
4-bromocrotonate (26.68g, 0.149mol) in toluene (50m1) was 
added slowly dropwise. The product was collected by 
filtration as a white solid and recrystallisation from 
L 
1:1 ethyacetate:petrol gave the title compound as white 
needles (59.83g, 0.136mo1, 91%), in.p. 187°C 	(lit. 138 , 
m.p. 189-191 6 C); vmaX. (CH2C12) 2980 (CH) , 1730 (C=0), 
1660 (C=C), 1440 (PPh) cm-1; 8H  (80MHz, CDC13) 3.61 (3H, 
S, ester CH3), 5.33 (2H, dd, J = 16Hz, 6Hz, PCH2), 
6.35-6.80 (2H, m, CH's), 7.80 (15H, m, Ph's); m/Z (FAB) 
361, 347, 329, 295, 275, 262, 201, 183; H.R.M.S. Found 
361.1357, C23H2202P1 (M of positive ion) requires 
361.1357. 
EthoxvcarbonvlallvltriPhenvlPhosiDhonium bromide 138 (218) 
Triphenyiphosphine (25.33g, 96.6inmol) was dissolved 
in toluene (200m1, distilled, dried) and ethyl 4-bromo-
crotonate (25g, 75% pure, 97.Ommol) in toluene (50m1) was 
added slowly dropwise and the mixture was stirred at room 
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temperature for 24 hours. The product was collected by 
filtration as a yellow solid, washed with benzene and 
recrystallised from acetonitrile and dried in a vacuum 
oven to give the title compound as a white solid 
(32.48g, 71.38mmol, 73.6%), m.p. 180°C (lit. 138 
189-191°C); vmax. (CH2C12) 2980 (CH), 1720 (C=O), 1650 
(C=C), 1440 (PPh) cm-1; 6H  (80MHz, CDC13) 0.86 (3H, t,. J 
= 7Hz, ester CH3), 3.79 (2H,. q, J = .7Hz, ester CH2), 4.81 
(2H, dd, J = 16Hz, 7Hz, PCH2), 5.90-6.70 (2H, m, CH's), 
7.45 (15H, in, Ph's); m/Z (FAB) 375, 369, 347, 329, 301, 
295, 275, 269, 262, 217, 201, 183; H.R.M.S. Found 
375.1514, C24H2402P1 (M ion) requires 375.1514. 
3 -Ethoxycarbonvlallyl idenetriphenylphosphorane 138 (219) 
3 -Ethoxycarbonylallylidenetriphenylphosphorane 	was 
prepared by the method of Howe. 	M.p. 184°C (lit. 138 , 
in.p. 186-188 0 C), vmax. (CH2C12) 2980 (CH), 1720 (C0), 
1660w (C=C), 1440 (PPh) cIfl 1 ; ô} (80MHz, CDC13) 1.12 (3H, 
t, J = 7Hz, ester CH3), 3.87 (2H, q, J = 7Hz, ester CH2), 
5.12 (1H, br s, PCH), 6.30-6.75 (2H, in, CH's), 7.65 (15H, 
in, Ph's); m/Z (FAB) 375, 347, 301, 295, 275, 262, 201, 
183; H.R.M.S. Found 375.1514, C24H2402P1 (MH) requires 
375.1514. 
Ethyl 5-tDhenv1ient-2. 4-dienoatc 146 (221 
Ethoxycarbonylal lyltriphenylphosphonium 	bromide 
(3.34g, 7.5mmol, dried over phosphorus pentoxide for 18 
hours) was placed in a round bottomed flask equipped with 
magnetic stirring and tetrahydrofuran (lOOm]., distilled, 
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dried) was added under nitrogen. 	Tetramethylethylene 
diamine (0.75m1, 0.5xnmol, dried) was added and the 
stirred suspension was cooled to -78°C and treated 
dropwise with n-butyllithium (4.40m1, 1.6M in hexanes, 
7.Ommol) giving an orange suspension. The mixture was 
stirred for 1 hour and then benzaldehyde (0.531g, 
5.01inmol) was added in tetrahydrofüran (lO.Oml). The 
burgundy red reaction mixture was allowed to warm to room 
temperature and was then stirred for 18 hours overnight. 
The reaction mixture was diluted with petrol and was 
washed with saturated aqueous ammonium chloride (3x5Oinl) 
and the organic layer was dried (MgSO4) and concentrated 
to give a residue which was treated with petrol to 
precipitate triphenyiphosphine oxide which was removed by 
filtration. Purification was by flash column 
chromatography (1:1 ether:petrol) which gave the title 
compound as a clear oil (0.83g, 4.12mmol. 55%, mixture of 
isomers), vfllaX. (CH2C12) 2980 (CH), 1710 (C=O), 1630 
(C=C), 830 (aromatic) cm -1 ; 6H (CDC13, 80MHz) 1.17-1.45 
(3H, two overlapping t, J = 7Hz, ester CH3), 4.05-4.40 
(2H, two overlapping q, J = 7Hz, ester CH2), 5.90-6.20, 
6.30-6.50, 6.70-7.05 (1H, 1H, 2H, three in, 2-, 3-, 4-, 
5-H'S), 7.20-7.55 (5H, in, aromatic CH's); m/Z (FAB) 203, 
202, 187, 173, 163, 157, 147, 135; H.R.M.S. Found 
203.1072, C13H1502 (MH) requires 203.1072. 
182 
Reaction 	of 	3 -ethoxvcarbonvlallvl iderietriphenyl- 
phosphorane (219) with crotonaldehyde (222); 
Rearrangement of ethyl oct-2 .4, 6-trienoate (223) to 
(l-ethoxvcarbonvl) 6-methvlcvclohex-1. 3-diene' 47 (225) 
Ethoxycarbonylal lyltriphenylphosp1üum bromide 
(5.01g, 11.25inmol, dried over phosphorus pentoxide for 18 
hours) was placed in a round bottomed flask equipped with 
magnetic stirring and tetrahydrofuran (lOOmi, distilled, 
dried) was added under nitrogen. TNEDA (1.12m1, 
0.75mmol) was added and the stirred suspension was cooled 
to -78°C and treated dropwise with n-butyllithium 
(6.60m1, 1.6M in hexanes, 10.5xninol) giving an orange 
suspension. The mixture was stirred for 1 hour at -78°C 
and then crotonaldehyde (0.53g, 7.52inmol) was added in 
tetrahydrofuran (lOmi). The burgundy red reaction 
mixture was allowed to warm to room temperature and was 
then stirred for 18 hours overnight. The reaction 
mixture was diluted with petrol and was washed with 
saturated aqueous ammonium chloride (3x60m1). The 
organic layer was dried (MgSO4) and concentrated to give 
a residue which was treated with petrol to precipitate 
tripheny1phohine oxide which was removed by filtration. 
Purification was by flash column chromatography (20% 
ether:petrol) and the rearranged product, (1-ethoxy-
carbonvl)-6-methvlcyclohex-1,3-diene was collected as a 
clear oil (0.77g, 4.66mmol, 62%); vmax. (CH2C12) 2960 
(CH), 1690 (C=O), 1240 (OEt), 1090 cm -1 ; Xmax. 294nm ( 
20, 122 dm3molcnr 1 ) a (200MHz, CDC13) 0.95-0.99 (3H, 
d, J = 7Hz, 6-CH3), 1.25-1.32 (3H, d, J = 7Hz, ester 
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CH3), 2.03-2.57 (2H, ABX, 5-CH2), 2.74-2.82 (1H, in, 6-H), 
4.12-4.25 (2H, q, J = 7Hz, ester CH2), 6.02 (2H, m, 3-H, 
4-H), 6.93 (1H, in, 2-H); iu/Z (FAB) 167, 166, 165, 153, 
149, 147, 145, 135; H.R.M.S. Found 167.1072, C10H1502 
(MH+) requires 167.1072. 
(2E) 4-Broinobut-2--en-l-o1- 0° (226) 
Neat DIBAL (62.2m1, 0.349mo1) was added to a solution 
of methyl 4-bromocrotonate (25.0g, 0.139mo1) in 
dichioromethane (400m1, distilled, dried) at -78°C and 
the reaction mixture was stirred for 1.5 hours at this 
temperature. Temperature was maintained at -78°C and the 
reaction was quenched with 50% aqueous acetic acid 
(16m1), and the resulting inorganic solid was removed by 
filtration. The aqueous layer was exhaustively extracted 
with dichloromethane (3x150m1) and the combined organic 
layers were dried (MgSO4). Removal of solvent in vacuo 
gave the title compound as a light brown oil (16.16g, 
0.107mol, ca. 77%); 3600 (OH stretch), 3420 (OH), 2920 
(CH), 1620 (C=C), 1380, 1200, 1080, 1000 cm-1 ; oH 
(200MHz, CDC13) 3.57 (1H, br 5, OH) , 3.94 (2H, in, 1-CH2), 
4.10 (2H, in, 4-CH2), 5.87 (2H, in, 2-CH, 3-CH); m/Z (FAB) 
149, 133, 123, 106, 93. 
(2E)-4-Bromobut-2-en-l-a1 148 (227) 
A mixture of 4-bromobut-2-en-l-ol (l.00g, 6.62mmol) 
activated Mn02 (13.29g, 152.90inmol, freshly prepared) and 
dichioromethane (30inl, distilled, dried) was stirred at 
room temperature for 5 hours. The insoluble material was 
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diluted with ether (30ml) and ethylacetate (170ml) and 
was filtered through a short column of dry flash silica 
to give a pale yellow solution. Solvent was removed in 
vacuo, the water bath temperature being maintained below 
35°C, to give the crude title compound a a clear light 
green oil (0.90g, 6.04mmol, . 90%); pmaX. (CH2C12) 2840 
(CH), 1680 (C=0), 1620 (C=C), 1050, 970 cm-1; 6H  (200MHz, 
CDC13) 4.06-4.09 (2H, d, T = 10Hz, CH2), 6.15-6.27 (1H, 
dd, J = 10Hz, J = 10Hz, 2-HO, 6.78-6.93 (lH, overlapping 
d of t, 3-H), 9.55 (1H, d, J = 10Hz, 1-H). 
4-Triphenyiphosphonium bromide but-2-en-l-al 149 (228) 
The phosphoniuin salt was prepared essentially 
according to Castells 149 . Reaction of 4-bromobut-
2-en-l-cl (13.41g, 0.09mol) with triphenyiphosphine 
(26.33g, 0.1mol) in acetone (60m1, distilled, dried) at 
room temperature for 16 hours gave a pale yellow 
crystalline precipitate which was collected by 
filtration, washed with ether and dried in a vacuum oven 
to give the title compound as yellow crystals (26.26g, 
0.064iuol, . 71%); m.p. 173°C (lit. 149 , m.p. 174-176 0 C); 
vmaX. (CH2C12) 2960 (CH), 1610 (C=C), 1110 CM-1 ; oH 
(200MHz, CDC13) 5.22 (2H, dd, J = 16Hz, 7Hz, PCH2), 
5.82-6.92 (2H, In, CH's), 9.37 (1H, d, J = 10Hz, 1-H); m/Z 
(FAB) 333, 331, 315, 301, 289, 279, 262, 201, 183, 165, 
154, 136; H.R.M.S. Found 331.1252, C22H2001P1 (M of 
positive ion) requires 331.1252. 
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Triphenylphosphoranylidene-crotonaldehyd&- 49 (146) 
The phosphorane was prepared essentially according to 
Castells 149 . 	 4-Triphenyiphosphonium 	bromide 
but-2-en-l-al 	(3.68g, 	8.95nunol) 	dissolved 	in 
dichloroniethane (50m1) in 	a separating funnel was 
treated with sodium hydroxide (0.36g 	. 8.95mmol) 
suspended between ice-water and dichloroiuethane. 	The 
layers were immediately separated and the burgundy red 
organic layer was dried (MgSO4). Trituration of the 
crude dichioromethane extract with cold acetone gave the 
title compound as deep red crystals (1.71g, 5.19mmol, ca. 
58%); m.p. 160°C (lit. 149 , m.p. 153-155 0 C); vinax. 
(CH2C12) 2960 (CH), 1660 (C=O), 1610 (C=C), 1520, 1430 
(PPh), 1110 cm-1 ; 6H'(8OMHZ, CDC13) 5.25 (1H, br s, PCH), 
5.70-6.87 (2H, in, 2-H, 3-H), 7.70 (15H, in, aromatic 
CH's), 9.35 (1H, d, J = 7Hz, 1-H); m/Z (FAB) 333, 331, 
315, 309, 301, 295, 279, 262, 201, 183; H.R.M.S. Found 
331.1252, C22H2001P1 (MH) requires 331.1252. 
Oct-2, 4, 6-trien-1-a1 15 ° (229) 
Crotonaldehyde (1.00g, 	14.27mmol) 	in dichloro- 
methane (lOinl) was added to a burgundy red solution of 
triphenyiphosphoranylidene-crotonaldehyde (5.18g, 
15.70mmol) in dichioromethane (30m1, distilled, dried). 
The reaction mixture was warmed to reflux and then 
allowed to cool to room temperature and stirred for 18 
hours overnight. The reaction mixture was concentrated 
to give a residue which was triturated with petrol to 
precipitate triphenyiphosphine oxide which was removed by 
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filtration. 	Purification was by flash column 
chromatography (25% ethyl acetate: toluene) which gave the 
title compound (mixture of geometrical isomers) as a pale 
green oil (0.99g, 8.13mmol, ga. 57%); vutaX. (CH2C12) 3020 
(CH), 1660 (C0), 1590w (CC), 1430, 1090 cm-1 ; xmax. 
320nm, oH  (200MHz, CDC13) 1.95-2.00 (3H, d, J = 10Hz, 
CH3), 6.02-6.20 (1H, d of d of q, 7-H), 6.72-6.97 (1H, 
dd, 2-H), 7.25-7.32 (4H, m, 6-H, 4-H, 5-H, 3-H), 
9.42-9.50 (1H, d, J = 10Hz, 1-H); m/Z (C.I. ammonia) 122, 
119, 115, 107, 105, 93, 91, 79, 43, 41. 
(2E. 4E, 6R. 7S) -7- (t-butvldimethvlsilyloxv) -4. 6. 8-tn-
methylnon-2,4-dien-l-ol (241) 
To a magnetically stirred solution of ethyl (6R,7S)-
7- (t-butyldimethylsilyloxy) -4,6, 8-trimethylnon-2, 4-
dienoate (0.47g, 1.33inmol) dissolved in dichloromethane 
(25m1, distilled, dried) in a looml dried, round bottomed 
flask, under nitrogen and cooled to -78°C was added DIBAL 
(3.33ml, 3.33inmol, lM solution in dichloromethane). 
After 3 hours the reaction was quenched with methanol 
(5ml) and the mixture transferred to a 250ml separating 
funnel containing a saturated solution of sodium 
potassium tartrate (lOOml) and dichioromethane. Vigorous 
shaking gave clouds of precipitate in the aqueous layer. 
The organic layer was separated and the aqueous layer was 
exhaustively extracted with dichloroinethane (4x300ml). 
The combined organic extracts were dried (MgSO4) and 
solvent was removed in vacuo. Purification was by flash 
column chromatography (1:1 ether:petrol) which gave the 
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title compound as a clear liquid (0.28g, 0.90inmol, 68%); 
[]D26 -2.49° (C 1.125 in CHC13); t.l.c. -B RF 0.35; 
vmax. (CH2C12) 3600 (OH), 2960 (CH), 1610w (C=C), 1460, 
1380, 1090, 840 cm-1 ; Xmax. 228nm (e 20950 dm3mol 1ciu 1 ); 
5H (200MHz, CDC13) [0.02, 0.03) (6H, split due to 
SiCH3s), 0.84-0.93 (15H, 
overlapping in, 8-CH3's, Si t-Bu CH3's), 0.94-0.98 (3H, .d, 
3 = 7.5Hz, 6-CH3), 1.62-1.73 (1H, in, 8-H), 1.75 (3H, s, 
4-Cl!3), 2.60-2.75 (1H, in, 6-H), 3.31 (lH, dd, 3 = 5Hz, 3 
= 5Hz, 7-H), 4.19 (2H, d, 3 = 6Hz, CH2), 5.60 (1H, d, 3 = 
10Hz, 5-H), 5.75 (lH, in, 2-H), 6.25 (1H, d, 3 = 15Hz, 
3-H); 6C  (CDC13, 90.6MHz) -3.87 (SiNe), 12.44 (4-Me), 
18.76, 19.45, 20.66 (8-Me's, 6-Me), 26.00 (Si t-Bu Me's), 
32.51 (8-C), 36.03 (6-C), 68.84 (CH2), 80.81 (7-C), 
124.68 (5-C), 133.04 (4-C), 136.70 (2-C), 137.24 (3-C); 
m/Z (FAB) 312, 311, 303, 279, 187, 171, 159, 147, 143, 
133; H.R.M.S. Found 312.2484, C18H3602Si (W 4 ) requires 
312.2484. 
Preparation 	of 	ethyl 	(2E,4E,6E,8R,9S)-9-(t-butyldj- 
inethylsilyloxy) -6,8 , 10-trimethylundec-2 , 4, 6-trienoate 
(233) and intermediate preparation of (6R7S)-7-(t-butyl-
dimethylsilyloxy)-4 .6 ,8-trimethylnon-2 ,4-dien-l-al (242) 
(6R, 7S) -7- (t-butyldimethylsilyloxy) -4,6, 8-trintethyl-
non-2,4-dien-1-ol (0.41g, 1.31inmol) was dissolved in 
dichioroniethane (lOnil, distilled, dried) containing 4A 
molecular sieves (preactivated, used as received from 
Aldrich) and N-methylmorpholine-N-oxide (0.23g. 
1.97mmol). 	Solid tetrapropylanuitonium perruthenate 
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(2.33mg, 6.55xnol, 0.5mol%) was then added and the 
resultant green mixture was stirred for 24 hours at room 
temperature under nitrogen. The mixture was diluted with 
dichioromethane, washed with aqueous sodium sulphite, 
brine and aqueous copper (II) sulphate. The 
dichioromethane solution was then dried (MgSO4) and 
solvent was removed in vacuo giving (6R,7S)-7-(t-butyl-
diinethylsilyloxy) -4,6, 8-trimethylnon-2 , 4-dien-l-al as a 
pale green liquid (0.28g, ga. 0.90minol, 69%); in/Z (FAB) 
311, 295, 285, 279, 239, 227, 213, 201, 187, 147; 
H.R.M.S. Found 311.2406, C18H3502Si (MH) requires 
311.2406. 
The pale green liquid aldehyde (0.228g, 0.737mmo1) 
was immediately treated with ethoxycarbonylmethylene-
triphenyiphosphorane (l.00g, 7.03imnol) in dichioromethane 
(15ml) and the reaction mixture was stirred under 
nitrogen for 60 hours at room temperature. The reaction 
mixture was diluted with petrol and purification was by 
flash column chromatography (10% ether: petrol). Solvent 
was removed in vacuo at a temperature of less than 30°C 
to give ethyl (BR 9S)-9-(t-butyldimethylsilyloxy)-
6,8,10-trimethylundec-2,4,6-trienoate as a 8:1 mixture of 
E and Z isomers respectively (0.174g, 0.457mmo1, ca. 
62%), [°]D25  -4.85° (C 1.135 in CHC13); t.1.c. -E RF 
0.38; vmax. (CH2C12) 2960 (CH), 1710 (C=O), 1460, 1240 
(SiCH3), 840 (Si(CH3)2) cm -1 ; Xmax. 305nm (MeOH), (€ 7885 
dm3mol1citr1); 6H  (200MHz, CDC13) [-0.05, 0.01] (6H, 
split due to di- pc , SiCH3's), 0.80-0.93 
(15H, overlapping in, 10-CH3's, Si t-Bu CH3's), 0.93-0.98 
189 
(3H, d, J = 10Hz, 8-CH3), 1.22-1.32 (3H, t, J = 7Hz, 
ester CH3), 1.55-1.70 (1H, m, 8-H), 1.75 (3H, 5, 4-CH3), 
2.57-2.77 (1H, m, 8-H), 3.35 (1H, dd, J = 5Hz, 5Hz, 9-H), 
4.15-4.25 (2H, q, J = 7.5Hz, ester CH2), 5.75 (1H, d, 
= 7.9Hz, 7-H), 5.84 (1H, d, J3 , 2 = 14.9Hz, 2-H), 
6.21 (1H, dd, J5 1 4 = 15.3Hz, J34 = 11.1Hz, 4-H), 6.58 
(1H, dd, J4 1 5 = 15.3Hz, J7,5 = 0.6Hz, 5-H), 7.34 (1H, 
ddd, J2,3 = 15.3Hz, J43 = 10.9Hz, J5, ' 3 = 0.5Hz, 3-H); 6,-
(CDC13, 90.6MHz) -3.87 (Si Me's), 12.29 (6-Me), 14.21, 
18.12, 18.55, 19.43 (10-Me's, 8-Me, ester Me), 26.04 (Si 
t-Bu Me's and quat. C), 32.69 (10-c), 36.60 (8-C), 59.92 
(ester CH2), 80.92 (9-C), 119.51 (2-C), 123.50 (4-C), 
131.96 (6-C), 141.81 (7-C), 145.31 (3-C), 146.30 (5-C), 
167.11 (1-C) ; m/Z (FAB) 381, 365, 355, 351, 339, 331, 
323, 309, 303, 187; H.R.M.S. Found 381.2825, C22H4103Si 
(NH+) requires 381.2825. 
Attempted preparation of 1-phenyl-1-oxo-8.10, 12-tn-
4hv1-11- (t-butyldiinethvlsilvloxv) -tridec-2 .4,6,8-
tetraene (245) 
To a magnetically stirred solution of ethyl 
(8R, 7S) -9- (t-butyldimethylsilylOXY) -6,8, 10-trimethyl-
undec-2,4,6-tnienOate (0.190g, 0.50inmol) dissolved in 
dichioromethane (15m1, distilled, dried) under nitrogen 
and cooled to -78°C was added DIBAL (1.5m1, 1.5inmol, 1M 
solution in dichloromethane). After 6 hours the reaction 
was quenched with methanol (5m1) and the mixture was 
transferred to a 250m1 separating funnel containing a 
saturated solution of sodium potassium tartrate (lOOrni) 
190 
and dichioromethane. Vigorous shaking gave clouds of 
precipitate in the aqueous layer. The organic layer was 
separated and the aqueous layer was exhaustively 
extracted with dichioromethane (4x300m1). The combined 
organic extracts were dried (MgSO4) and solvent was 
removed in vacuo to give crude (8R.9S)-9-(t-butvldi-
methylsilvloxv)-6, 8,10-triinethylundec-2 .4, 6-trien-l-ol 
(243) as a clear oil (0.110g, ca. 0.325mmol, 65%); vmax. 
(CH2C12) 3600 (OH), 2960 (CH), 1610 (C=C), 1470, 1220, 
840 cm-1; 8H  (200MHz, CDC13) (0.02, 0.03] (6H, split due 
to 	 ., 	SiCH3's), 	0.84-0.93 	(15H, 
overlapping m, 10-CH3 1 s, Si t-Bu CH3's), 0.94-0.98 (3H, 
d, 3 = 7.5Hz, 8-CH3), 1.62-1.73 (1H, m, 10-H), 1.75 (3H, 
s, 6-CH3), 2.60-2.75 (1H, m, 8-H), 3.31 (1H, dd, 3 = 5Hz, 
3 = 5Hz, 9-H), 4.19 (2H, d, 3 = 6Hz, CH2), 5.42 (1H, d, J 
= 7Hz, 	7-H), 	5.55 	(lH, 	m, 	2-H), 	5.70-5.85 	(2H, 
overlapping dd, 4-H, 3-H); m/Z (FAB) 338, 325, 309, 295, 
281, 267, 207, 187, 179, 165, 147, 135. 
The clear oil alcohol (0.110g, ca. 0.325mmo1) was 
dissolved in dichioromethane (loml, distilled, dried) 
containing 4A molecular sieves (preactivated, used as 
received from Aldrich) and N-methylmorpholine-N-oxide 
(0.06g, 0.53mmol). Solid tetrapropylammonium 
perruthenate (0.62g, 1.76mol, 0.5mol%) was then added 
and the resultant green mixture was stirred for 24 hours 
at room temperature under nitrogen. The mixture was 
diluted with dichloroniethane, washed with aqueous sodium 
sulphite, brine and aqueous copper (II) sulphate. The 
dichloromethane solution was then dried (MgSO4) and 
191 
solvent was removed in vacuo giving crude (8R,9S)-9-
(t-butyldimethylsilvloXv) -6,8, l0-trimethvlundec-2 , 4,6-
trien-l-al (jQ) as a pale green oil (0.071g, 0.211inmol, 
. 65%), m/Z (FAB) 325, 311, 295, 281, 267, 251, 221, 
207, 187, 177, 159, 147, 133. 
This crude aldehyde 	(0.071g, 	0.211inmol) 	was 
immediately treated with 	(0.401g, 	1.055mmol) 	-of 
phenyacyltriphenyiphosphOrane in dichioromethane (5m1). 
The reaction was stirred under nitrogen for 5 days at 
room temperature. The reaction mixture, was diluted with 
petrol 	and purification was by 	flash column 
chromatography (10% ether:petrol). Solvent was removed 
in vacuo to give a clear oil mixture 	of (8R,9S-9- 
(t-butvldiinethvlsilvloxv) -6,8, 10-triinethylundec-2 , 4,6- 
trien-1-al 	and 	(].OR,11S)-l-phenyl-l-oxo-8,10,12-tri- 
methyl-il- (t-butyldimethylsilvloxv) -tridec-2 .4,6,8-
tetraene (0.06g), m/Z (FAB) 432, 419, 391, 367, 353, 337, 
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4.2 	Appendix 2 	 Courses Attended 
Organic Research Seminars, (Various Lecturers) 
X-Ray Crystallography, (Dr. 0. Kennard et al., University 
of Cambridge 
Medicinal Chemistry, (Various speakers, I.C.I. and 
Beecham Pharmaceuticals) 
Mass Spectrometry, (various speakers, Kratos) 
Current Topics in Organic Chemistry, (Various Lecturers, 
University of Edinburgh) 
Nuclear Magnetic Resonance, (Dr. I.H. Sadler, University 
of Edinburgh) 
Mass Spectrometry, (Professor K.R. Jennings, University 
of Warwick) 
The Elements of Cell Biology, (Dr. J. Phillips, 
University of Edinburgh, Department of Biochemistry) 
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